variant_id;variant_name;genomic_annotation;gene_name;interpretation;condition;number_of_stars
3232058;NM_000546.6(TP53):c.629A>G (p.Asn210Ser);GRCh37,NC_000017.10:g.7578220T>C GRCh38,NC_000017.11:g.7674902T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
3232053;NM_000546.6(TP53):c.272G>C (p.Trp91Ser);GRCh37,NC_000017.10:g.7579415C>G GRCh38,NC_000017.11:g.7676097C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
3232051;NM_000546.6(TP53):c.166G>A (p.Glu56Lys);GRCh37,NC_000017.10:g.7579521C>T GRCh38,NC_000017.11:g.7676203C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
3232049;NM_000546.6(TP53):c.1171G>A (p.Asp391Asn);GRCh37,NC_000017.10:g.7572938C>T GRCh38,NC_000017.11:g.7669620C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
3232048;NM_000546.6(TP53):c.1148T>C (p.Leu383Pro);GRCh37,NC_000017.10:g.7572961A>G GRCh38,NC_000017.11:g.7669643A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
3232047;NM_000546.6(TP53):c.1061A>T (p.Gln354Leu);GRCh37,NC_000017.10:g.7573966T>A GRCh38,NC_000017.11:g.7670648T>A;TP53;Benign;Hereditary cancer-predisposing syndrome;1
3148769;NM_000546.6(TP53):c.757A>C (p.Thr253Pro);GRCh37,NC_000017.10:g.7577524T>G GRCh38,NC_000017.11:g.7674206T>G;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
3147994;NM_000546.6(TP53):c.812A>T (p.Glu271Val);GRCh37,NC_000017.10:g.7577126T>A GRCh38,NC_000017.11:g.7673808T>A;TP53;Likely pathogenic;Li-Fraumeni syndrome 1;1
3076193;NM_000546.6(TP53):c.806G>A (p.Ser269Asn);GRCh37,NC_000017.10:g.7577132C>T GRCh38,NC_000017.11:g.7673814C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
3074199;NM_000546.6(TP53):c.199C>G (p.Pro67Ala);GRCh37,NC_000017.10:g.7579488G>C GRCh38,NC_000017.11:g.7676170G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
3071811;NM_000546.6(TP53):c.959A>C (p.Lys320Thr);GRCh37,NC_000017.10:g.7576887T>G GRCh38,NC_000017.11:g.7673569T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
3071734;NM_000546.6(TP53):c.1023C>A (p.Phe341Leu);GRCh37,NC_000017.10:g.7574004G>T GRCh38,NC_000017.11:g.7670686G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
3068296;NM_000546.6(TP53):c.1133C>A (p.Ser378Tyr);GRCh37,NC_000017.10:g.7572976G>T GRCh38,NC_000017.11:g.7669658G>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
3011115;NM_000546.6(TP53):c.1037A>G (p.Glu346Gly);GRCh37,NC_000017.10:g.7573990T>C GRCh38,NC_000017.11:g.7670672T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2993845;NM_000546.6(TP53):c.785G>A (p.Gly262Asp);GRCh37,NC_000017.10:g.7577153C>T GRCh38,NC_000017.11:g.7673835C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2969522;NM_000546.6(TP53):c.619G>A (p.Asp207Asn);GRCh37,NC_000017.10:g.7578230C>T GRCh38,NC_000017.11:g.7674912C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2915501;NM_000546.6(TP53):c.479T>C (p.Met160Thr);GRCh37,NC_000017.10:g.7578451A>G GRCh38,NC_000017.11:g.7675133A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2891760;NM_000546.6(TP53):c.943T>C (p.Ser315Pro);GRCh37,NC_000017.10:g.7576903A>G GRCh38,NC_000017.11:g.7673585A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2886753;NM_000546.6(TP53):c.505A>T (p.Met169Leu);GRCh37,NC_000017.10:g.7578425T>A GRCh38,NC_000017.11:g.7675107T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2877402;NM_000546.6(TP53):c.148A>C (p.Ile50Leu);GRCh37,NC_000017.10:g.7579539T>G GRCh38,NC_000017.11:g.7676221T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2863364;NM_000546.6(TP53):c.894G>C (p.Glu298Asp);GRCh37,NC_000017.10:g.7577044C>G GRCh38,NC_000017.11:g.7673726C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2861491;NM_000546.6(TP53):c.259C>G (p.Pro87Ala);GRCh37,NC_000017.10:g.7579428G>C GRCh38,NC_000017.11:g.7676110G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2858983;NM_000546.6(TP53):c.812A>G (p.Glu271Gly);GRCh37,NC_000017.10:g.7577126T>C GRCh38,NC_000017.11:g.7673808T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2850523;NM_000546.6(TP53):c.655C>G (p.Pro219Ala);GRCh37,NC_000017.10:g.7578194G>C GRCh38,NC_000017.11:g.7674876G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2848843;NM_000546.6(TP53):c.10C>G (p.Pro4Ala);GRCh37,NC_000017.10:g.7579903G>C GRCh38,NC_000017.11:g.7676585G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2848594;NM_000546.6(TP53):c.492G>T (p.Lys164Asn);GRCh38,NC_000017.11:g.7675120C>A GRCh37,NC_000017.10:g.7578438C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2847409;NM_000546.6(TP53):c.1054G>C (p.Asp352His);GRCh37,NC_000017.10:g.7573973C>G GRCh38,NC_000017.11:g.7670655C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2841682;NM_000546.6(TP53):c.928A>C (p.Asn310His);GRCh37,NC_000017.10:g.7576918T>G GRCh38,NC_000017.11:g.7673600T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2840669;NM_000546.6(TP53):c.461G>C (p.Gly154Ala);GRCh37,NC_000017.10:g.7578469C>G GRCh38,NC_000017.11:g.7675151C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2832740;NM_000546.6(TP53):c.993G>T (p.Gln331His);GRCh37,NC_000017.10:g.7576853C>A GRCh38,NC_000017.11:g.7673535C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2831391;NM_000546.6(TP53):c.803A>G (p.Asn268Ser);GRCh37,NC_000017.10:g.7577135T>C GRCh38,NC_000017.11:g.7673817T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2831218;NM_000546.6(TP53):c.253C>G (p.Pro85Ala);GRCh37,NC_000017.10:g.7579434G>C GRCh38,NC_000017.11:g.7676116G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2831109;NM_000546.6(TP53):c.259C>T (p.Pro87Ser);GRCh37,NC_000017.10:g.7579428G>A GRCh38,NC_000017.11:g.7676110G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2827498;NM_000546.6(TP53):c.694A>T (p.Ile232Phe);GRCh37,NC_000017.10:g.7577587T>A GRCh38,NC_000017.11:g.7674269T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2826159;NM_000546.6(TP53):c.767C>A (p.Thr256Lys);GRCh37,NC_000017.10:g.7577514G>T GRCh38,NC_000017.11:g.7674196G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2825997;NM_000546.6(TP53):c.278T>G (p.Leu93Arg);GRCh37,NC_000017.10:g.7579409A>C GRCh38,NC_000017.11:g.7676091A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2820330;NM_000546.6(TP53):c.1070A>C (p.Lys357Thr);GRCh37,NC_000017.10:g.7573957T>G GRCh38,NC_000017.11:g.7670639T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2813114;NM_000546.6(TP53):c.29T>A (p.Val10Asp);GRCh37,NC_000017.10:g.7579884A>T GRCh38,NC_000017.11:g.7676566A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2812726;NM_000546.6(TP53):c.175G>T (p.Gly59Cys);GRCh37,NC_000017.10:g.7579512C>A GRCh38,NC_000017.11:g.7676194C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2811095;NM_000546.6(TP53):c.254C>T (p.Pro85Leu);GRCh37,NC_000017.10:g.7579433G>A GRCh38,NC_000017.11:g.7676115G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2809879;NM_000546.6(TP53):c.919G>A (p.Ala307Thr);GRCh37,NC_000017.10:g.7577019C>T GRCh38,NC_000017.11:g.7673701C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
2808296;NM_000546.6(TP53):c.773A>T (p.Glu258Val);GRCh37,NC_000017.10:g.7577508T>A GRCh38,NC_000017.11:g.7674190T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2795844;NM_000546.6(TP53):c.143A>G (p.Asp48Gly);GRCh37,NC_000017.10:g.7579544T>C GRCh38,NC_000017.11:g.7676226T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2783073;NM_000546.6(TP53):c.980A>G (p.Tyr327Cys);GRCh37,NC_000017.10:g.7576866T>C GRCh38,NC_000017.11:g.7673548T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2780373;NM_000546.6(TP53):c.533A>G (p.His178Arg);GRCh37,NC_000017.10:g.7578397T>C GRCh38,NC_000017.11:g.7675079T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
2774655;NM_000546.6(TP53):c.127T>G (p.Leu43Val);GRCh38,NC_000017.11:g.7676242A>C GRCh37,NC_000017.10:g.7579560A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
2774654;NM_000546.6(TP53):c.190C>T (p.Pro64Ser);GRCh37,NC_000017.10:g.7579497G>A GRCh38,NC_000017.11:g.7676179G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2774652;NM_000546.6(TP53):c.433C>G (p.Leu145Val);GRCh37,NC_000017.10:g.7578497G>C GRCh38,NC_000017.11:g.7675179G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2774651;NM_000546.6(TP53):c.544T>C (p.Cys182Arg);GRCh37,NC_000017.10:g.7578386A>G GRCh38,NC_000017.11:g.7675068A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2774649;NM_000546.6(TP53):c.709A>T (p.Met237Leu);GRCh37,NC_000017.10:g.7577572T>A GRCh38,NC_000017.11:g.7674254T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2774647;NM_000546.6(TP53):c.1064C>A (p.Ala355Asp);GRCh37,NC_000017.10:g.7573963G>T GRCh38,NC_000017.11:g.7670645G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2774646;NM_000546.6(TP53):c.1066G>A (p.Gly356Arg);GRCh37,NC_000017.10:g.7573961C>T GRCh38,NC_000017.11:g.7670643C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome;1
2768025;NM_000546.6(TP53):c.463A>C (p.Thr155Pro);GRCh37,NC_000017.10:g.7578467T>G GRCh38,NC_000017.11:g.7675149T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2765819;NM_000546.6(TP53):c.779C>T (p.Ser260Phe);GRCh37,NC_000017.10:g.7577502G>A GRCh38,NC_000017.11:g.7674184G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2764543;NM_000546.6(TP53):c.794T>G (p.Leu265Arg);GRCh37,NC_000017.10:g.7577144A>C GRCh38,NC_000017.11:g.7673826A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2762393;NM_000546.6(TP53):c.1097C>A (p.Ser366Tyr);GRCh37,NC_000017.10:g.7573930G>T GRCh38,NC_000017.11:g.7670612G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2759300;NM_000546.6(TP53):c.623A>C (p.Asp208Ala);GRCh37,NC_000017.10:g.7578226T>G GRCh38,NC_000017.11:g.7674908T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2758381;NM_000546.6(TP53):c.655C>A (p.Pro219Thr);GRCh37,NC_000017.10:g.7578194G>T GRCh38,NC_000017.11:g.7674876G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2758378;NM_000546.6(TP53):c.1031T>G (p.Leu344Arg);GRCh37,NC_000017.10:g.7573996A>C GRCh38,NC_000017.11:g.7670678A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2757988;NM_000546.6(TP53):c.488A>C (p.Tyr163Ser);GRCh37,NC_000017.10:g.7578442T>G GRCh38,NC_000017.11:g.7675124T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2757236;NM_000546.6(TP53):c.829T>G (p.Cys277Gly);GRCh37,NC_000017.10:g.7577109A>C GRCh38,NC_000017.11:g.7673791A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
2754115;NM_000546.6(TP53):c.446C>A (p.Ser149Tyr);GRCh37,NC_000017.10:g.7578484G>T GRCh38,NC_000017.11:g.7675166G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2748594;NM_000546.6(TP53):c.716A>T (p.Asn239Ile);GRCh37,NC_000017.10:g.7577565T>A GRCh38,NC_000017.11:g.7674247T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2747093;NM_000546.6(TP53):c.176G>C (p.Gly59Ala);GRCh37,NC_000017.10:g.7579511C>G GRCh38,NC_000017.11:g.7676193C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2746088;NM_000546.6(TP53):c.1043T>C (p.Leu348Ser);GRCh37,NC_000017.10:g.7573984A>G GRCh38,NC_000017.11:g.7670666A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2736423;NM_000546.6(TP53):c.499C>A (p.Gln167Lys);GRCh37,NC_000017.10:g.7578431G>T GRCh38,NC_000017.11:g.7675113G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2729592;NM_000546.6(TP53):c.308A>C (p.Tyr103Ser);GRCh37,NC_000017.10:g.7579379T>G GRCh38,NC_000017.11:g.7676061T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2719153;NM_000546.6(TP53):c.1121G>A (p.Gly374Asp);GRCh37,NC_000017.10:g.7572988C>T GRCh38,NC_000017.11:g.7669670C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2705758;NM_000546.6(TP53):c.163A>C (p.Thr55Pro);GRCh37,NC_000017.10:g.7579524T>G GRCh38,NC_000017.11:g.7676206T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2703874;NM_000546.6(TP53):c.572C>T (p.Pro191Leu);GRCh37,NC_000017.10:g.7578277G>A GRCh38,NC_000017.11:g.7674959G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2702402;NM_000546.6(TP53):c.339C>G (p.Phe113Leu);GRCh37,NC_000017.10:g.7579348G>C GRCh38,NC_000017.11:g.7676030G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2695282;NM_000546.6(TP53):c.170A>G (p.Asp57Gly);GRCh37,NC_000017.10:g.7579517T>C GRCh38,NC_000017.11:g.7676199T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2694309;NM_000546.6(TP53):c.63C>G (p.Asp21Glu);GRCh37,NC_000017.10:g.7579850G>C GRCh38,NC_000017.11:g.7676532G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2687713;NM_000546.6(TP53):c.496T>G (p.Ser166Ala);GRCh37,NC_000017.10:g.7578434A>C GRCh38,NC_000017.11:g.7675116A>C;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687712;NM_000546.6(TP53):c.490A>C (p.Lys164Gln);GRCh37,NC_000017.10:g.7578440T>G GRCh38,NC_000017.11:g.7675122T>G;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687709;NM_000546.6(TP53):c.454C>A (p.Pro152Thr);GRCh37,NC_000017.10:g.7578476G>T GRCh38,NC_000017.11:g.7675158G>T;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687708;NM_000546.6(TP53):c.443A>T (p.Asp148Val);GRCh37,NC_000017.10:g.7578487T>A GRCh38,NC_000017.11:g.7675169T>A;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687706;NM_000546.6(TP53):c.428T>A (p.Val143Glu);GRCh37,NC_000017.10:g.7578502A>T GRCh38,NC_000017.11:g.7675184A>T;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687704;NM_000546.6(TP53):c.427G>C (p.Val143Leu);GRCh37,NC_000017.10:g.7578503C>G GRCh38,NC_000017.11:g.7675185C>G;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687701;NM_000546.6(TP53):c.550G>C (p.Asp184His);GRCh37,NC_000017.10:g.7578380C>G GRCh38,NC_000017.11:g.7675062C>G;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687700;NM_000546.6(TP53):c.457C>G (p.Pro153Ala);GRCh38,NC_000017.11:g.7675155G>C GRCh37,NC_000017.10:g.7578473G>C;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687699;NM_000546.6(TP53):c.398T>G (p.Met133Arg);GRCh37,NC_000017.10:g.7578532A>C GRCh38,NC_000017.11:g.7675214A>C;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687698;NM_000546.6(TP53):c.382C>T (p.Pro128Ser);GRCh37,NC_000017.10:g.7578548G>A GRCh38,NC_000017.11:g.7675230G>A;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2687697;NM_000546.6(TP53):c.502C>A (p.His168Asn);GRCh37,NC_000017.10:g.7578428G>T GRCh38,NC_000017.11:g.7675110G>T;TP53;Uncertain significance;Prostate cancer, hereditary, 1;0
2683739;NM_000546.6(TP53):c.1040C>G (p.Ala347Gly);GRCh37,NC_000017.10:g.7573987G>C GRCh38,NC_000017.11:g.7670669G>C;TP53;Likely benign;Hereditary breast ovarian cancer syndrome;1
2679238;NM_000546.6(TP53):c.893A>C (p.Glu298Ala);GRCh37,NC_000017.10:g.7577045T>G GRCh38,NC_000017.11:g.7673727T>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679236;NM_000546.6(TP53):c.574C>G (p.Gln192Glu);GRCh37,NC_000017.10:g.7578275G>C GRCh38,NC_000017.11:g.7674957G>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679235;NM_000546.6(TP53):c.876A>T (p.Lys292Asn);GRCh37,NC_000017.10:g.7577062T>A GRCh38,NC_000017.11:g.7673744T>A;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679234;NM_000546.6(TP53):c.967C>G (p.Leu323Val);GRCh37,NC_000017.10:g.7576879G>C GRCh38,NC_000017.11:g.7673561G>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679232;NM_000546.6(TP53):c.445T>C (p.Ser149Pro);GRCh37,NC_000017.10:g.7578485A>G GRCh38,NC_000017.11:g.7675167A>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome;2
2679231;NM_000546.6(TP53):c.934A>G (p.Thr312Ala);GRCh37,NC_000017.10:g.7576912T>C GRCh38,NC_000017.11:g.7673594T>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679230;NM_000546.6(TP53):c.851C>G (p.Thr284Arg);GRCh37,NC_000017.10:g.7577087G>C GRCh38,NC_000017.11:g.7673769G>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679229;NM_000546.6(TP53):c.617T>G (p.Leu206Trp);GRCh37,NC_000017.10:g.7578232A>C GRCh38,NC_000017.11:g.7674914A>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679228;NM_000546.6(TP53):c.965C>G (p.Pro322Arg);GRCh37,NC_000017.10:g.7576881G>C GRCh38,NC_000017.11:g.7673563G>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2679227;NM_000546.6(TP53):c.1029G>C (p.Glu343Asp);GRCh37,NC_000017.10:g.7573998C>G GRCh38,NC_000017.11:g.7670680C>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary;1
2671888;NM_000546.6(TP53):c.776A>C (p.Asp259Ala);GRCh37,NC_000017.10:g.7577505T>G GRCh38,NC_000017.11:g.7674187T>G;TP53;Pathogenic;Malignant lymphoma, large B-cell, diffuse;0
2627017;NM_000546.6(TP53):c.325T>A (p.Phe109Ile);GRCh37,NC_000017.10:g.7579362A>T GRCh38,NC_000017.11:g.7676044A>T;TP53;Likely pathogenic;Li-Fraumeni syndrome;1
2585883;NM_000546.6(TP53):c.529C>G (p.Pro177Ala);GRCh37,NC_000017.10:g.7578401G>C GRCh38,NC_000017.11:g.7675083G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2585882;NM_000546.6(TP53):c.1159A>C (p.Thr387Pro);GRCh37,NC_000017.10:g.7572950T>G GRCh38,NC_000017.11:g.7669632T>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2585878;NM_000546.6(TP53):c.1023C>G (p.Phe341Leu);GRCh37,NC_000017.10:g.7574004G>C GRCh38,NC_000017.11:g.7670686G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2578516;NM_000546.6(TP53):c.970G>A (p.Asp324Asn);GRCh37,NC_000017.10:g.7576876C>T GRCh38,NC_000017.11:g.7673558C>T;TP53;Benign;Acute myeloid leukemia;0
2578514;NM_000546.6(TP53):c.977A>T (p.Glu326Val);GRCh37,NC_000017.10:g.7576869T>A GRCh38,NC_000017.11:g.7673551T>A;TP53;Likely pathogenic;Acute myeloid leukemia;0
2575177;NM_000546.6(TP53):c.805A>T (p.Ser269Cys);GRCh37,NC_000017.10:g.7577133T>A GRCh38,NC_000017.11:g.7673815T>A;TP53;Benign;Acute myeloid leukemia;0
2575170;NM_000546.6(TP53):c.952C>T (p.Pro318Ser);GRCh38,NC_000017.11:g.7673576G>A GRCh37,NC_000017.10:g.7576894G>A;TP53;Benign;Acute myeloid leukemia;0
2575169;NM_000546.6(TP53):c.806G>T (p.Ser269Ile);GRCh37,NC_000017.10:g.7577132C>A GRCh38,NC_000017.11:g.7673814C>A;TP53;Likely pathogenic;Acute myeloid leukemia;0
2565396;NM_000546.6(TP53):c.1097C>T (p.Ser366Phe);GRCh37,NC_000017.10:g.7573930G>A GRCh38,NC_000017.11:g.7670612G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2505496;NM_000546.6(TP53):c.494A>T (p.Gln165Leu);GRCh37,NC_000017.10:g.7578436T>A GRCh38,NC_000017.11:g.7675118T>A;TP53;Pathogenic;Acute myeloid leukemia;0
2502882;NM_000546.6(TP53):c.719G>A (p.Ser240Asn);GRCh37,NC_000017.10:g.7577562C>T GRCh38,NC_000017.11:g.7674244C>T;TP53;Pathogenic;Acute myeloid leukemia;0
2450759;NM_000546.6(TP53):c.682G>T (p.Asp228Tyr);GRCh37,NC_000017.10:g.7577599C>A GRCh38,NC_000017.11:g.7674281C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450758;NM_000546.6(TP53):c.972T>A (p.Asp324Glu);GRCh37,NC_000017.10:g.7576874A>T GRCh38,NC_000017.11:g.7673556A>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450754;NM_000546.6(TP53):c.1006G>C (p.Glu336Gln);GRCh37,NC_000017.10:g.7574021C>G GRCh38,NC_000017.11:g.7670703C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450751;NM_000546.6(TP53):c.1049T>C (p.Leu350Pro);GRCh37,NC_000017.10:g.7573978A>G GRCh38,NC_000017.11:g.7670660A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
2450750;NM_000546.6(TP53):c.938G>A (p.Ser313Asn);GRCh37,NC_000017.10:g.7576908C>T GRCh38,NC_000017.11:g.7673590C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450746;NM_000546.6(TP53):c.627A>C (p.Arg209Ser);GRCh37,NC_000017.10:g.7578222T>G GRCh38,NC_000017.11:g.7674904T>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450745;NM_000546.6(TP53):c.350G>A (p.Gly117Glu);GRCh37,NC_000017.10:g.7579337C>T GRCh38,NC_000017.11:g.7676019C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2450740;NM_000546.6(TP53):c.11C>A (p.Pro4Gln);GRCh37,NC_000017.10:g.7579902G>T GRCh38,NC_000017.11:g.7676584G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
2450739;NM_000546.6(TP53):c.598A>T (p.Asn200Tyr);GRCh37,NC_000017.10:g.7578251T>A GRCh38,NC_000017.11:g.7674933T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
2446885;NM_000546.6(TP53):c.513G>T (p.Glu171Asp);GRCh37,NC_000017.10:g.7578417C>A GRCh38,NC_000017.11:g.7675099C>A;TP53;Pathogenic;Acute myeloid leukemia;0
2430159;NM_000546.6(TP53):c.398T>A (p.Met133Lys);GRCh37,NC_000017.10:g.7578532A>T GRCh38,NC_000017.11:g.7675214A>T;TP53;Likely pathogenic;Breast carcinoma;0
2417541;NM_000546.6(TP53):c.324_326inv (p.Phe109Asn);GRCh37,NC_000017.10:g.7579361_7579363inv GRCh38,NC_000017.11:g.7676043_7676045inv;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2185665;NM_000546.6(TP53):c.517G>C (p.Val173Leu);GRCh37,NC_000017.10:g.7578413C>G GRCh38,NC_000017.11:g.7675095C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
2168377;NM_000546.6(TP53):c.218T>C (p.Val73Ala);GRCh37,NC_000017.10:g.7579469A>G GRCh38,NC_000017.11:g.7676151A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2137906;NM_000546.6(TP53):c.566C>A (p.Ala189Asp);GRCh37,NC_000017.10:g.7578283G>T GRCh38,NC_000017.11:g.7674965G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2135554;NM_000546.6(TP53):c.762C>G (p.Ile254Met);GRCh37,NC_000017.10:g.7577519G>C GRCh38,NC_000017.11:g.7674201G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2130489;NM_000546.6(TP53):c.164C>G (p.Thr55Ser);GRCh37,NC_000017.10:g.7579523G>C GRCh38,NC_000017.11:g.7676205G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2126647;NM_000546.6(TP53):c.1057G>T (p.Ala353Ser);GRCh37,NC_000017.10:g.7573970C>A GRCh38,NC_000017.11:g.7670652C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2125367;NM_000546.6(TP53):c.339C>A (p.Phe113Leu);GRCh37,NC_000017.10:g.7579348G>T GRCh38,NC_000017.11:g.7676030G>T;TP53;Likely pathogenic;Li-Fraumeni syndrome;1
2123066;NM_000546.6(TP53):c.1139A>G (p.His380Arg);GRCh37,NC_000017.10:g.7572970T>C GRCh38,NC_000017.11:g.7669652T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2122381;NM_000546.6(TP53):c.673G>T (p.Val225Phe);GRCh37,NC_000017.10:g.7577608C>A GRCh38,NC_000017.11:g.7674290C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2121740;NM_000546.6(TP53):c.364G>T (p.Val122Leu);GRCh37,NC_000017.10:g.7579323C>A GRCh38,NC_000017.11:g.7676005C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2119726;NM_000546.6(TP53):c.863A>C (p.Asn288Thr);GRCh37,NC_000017.10:g.7577075T>G GRCh38,NC_000017.11:g.7673757T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2113149;NM_000546.6(TP53):c.807C>G (p.Ser269Arg);GRCh37,NC_000017.10:g.7577131G>C GRCh38,NC_000017.11:g.7673813G>C;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;2
2108374;NM_000546.6(TP53):c.25A>G (p.Ser9Gly);GRCh37,NC_000017.10:g.7579888T>C GRCh38,NC_000017.11:g.7676570T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2095568;NM_000546.6(TP53):c.1174T>C (p.Ser392Pro);GRCh37,NC_000017.10:g.7572935A>G GRCh38,NC_000017.11:g.7669617A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2087249;NM_000546.6(TP53):c.130A>C (p.Met44Leu);GRCh37,NC_000017.10:g.7579557T>G GRCh38,NC_000017.11:g.7676239T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2081538;NM_000546.6(TP53):c.953C>G (p.Pro318Arg);GRCh37,NC_000017.10:g.7576893G>C GRCh38,NC_000017.11:g.7673575G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2080519;NM_000546.6(TP53):c.431A>G (p.Gln144Arg);GRCh37,NC_000017.10:g.7578499T>C GRCh38,NC_000017.11:g.7675181T>C;TP53;Uncertain significance;Li-Fraumeni syndrome,Prostate cancer, hereditary, 1;1
2078374;NM_000546.6(TP53):c.1086C>A (p.Ser362Arg);GRCh37,NC_000017.10:g.7573941G>T GRCh38,NC_000017.11:g.7670623G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2036477;NM_000546.6(TP53):c.896T>C (p.Leu299Pro);GRCh37,NC_000017.10:g.7577042A>G GRCh38,NC_000017.11:g.7673724A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2035647;NM_000546.6(TP53):c.314G>C (p.Gly105Ala);GRCh37,NC_000017.10:g.7579373C>G GRCh38,NC_000017.11:g.7676055C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2032550;NM_000546.6(TP53):c.560G>T (p.Gly187Val);GRCh37,NC_000017.10:g.7578289C>A GRCh38,NC_000017.11:g.7674971C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2029805;NM_000546.6(TP53):c.247G>A (p.Ala83Thr);GRCh37,NC_000017.10:g.7579440C>T GRCh38,NC_000017.11:g.7676122C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2026528;NM_000546.6(TP53):c.41T>A (p.Leu14Gln);GRCh37,NC_000017.10:g.7579872A>T GRCh38,NC_000017.11:g.7676554A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2024235;NM_000546.6(TP53):c.115G>T (p.Ala39Ser);GRCh37,NC_000017.10:g.7579572C>A GRCh38,NC_000017.11:g.7676254C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2020649;NM_000546.6(TP53):c.645T>A (p.Ser215Arg);GRCh37,NC_000017.10:g.7578204A>T GRCh38,NC_000017.11:g.7674886A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;2
2019530;NM_000546.6(TP53):c.482C>T (p.Ala161Val);GRCh37,NC_000017.10:g.7578448G>A GRCh38,NC_000017.11:g.7675130G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2006345;NM_000546.6(TP53):c.598A>C (p.Asn200His);GRCh37,NC_000017.10:g.7578251T>G GRCh38,NC_000017.11:g.7674933T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2005578;NM_000546.6(TP53):c.1096T>A (p.Ser366Thr);GRCh37,NC_000017.10:g.7573931A>T GRCh38,NC_000017.11:g.7670613A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
2003705;NM_000546.6(TP53):c.223C>A (p.Pro75Thr);GRCh37,NC_000017.10:g.7579464G>T GRCh38,NC_000017.11:g.7676146G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1998185;NM_000546.6(TP53):c.1066G>T (p.Gly356Trp);GRCh37,NC_000017.10:g.7573961C>A GRCh38,NC_000017.11:g.7670643C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1992967;NM_000546.6(TP53):c.485T>C (p.Ile162Thr);GRCh37,NC_000017.10:g.7578445A>G GRCh38,NC_000017.11:g.7675127A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1961562;NM_000546.6(TP53):c.1081G>A (p.Gly361Arg);GRCh37,NC_000017.10:g.7573946C>T GRCh38,NC_000017.11:g.7670628C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1950710;NM_000546.6(TP53):c.991C>G (p.Gln331Glu);GRCh37,NC_000017.10:g.7576855G>C GRCh38,NC_000017.11:g.7673537G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1941172;NM_000546.6(TP53):c.227C>T (p.Ala76Val);GRCh37,NC_000017.10:g.7579460G>A GRCh38,NC_000017.11:g.7676142G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1933263;NM_000546.6(TP53):c.889C>T (p.His297Tyr);GRCh37,NC_000017.10:g.7577049G>A GRCh38,NC_000017.11:g.7673731G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1909172;NM_000546.6(TP53):c.475G>A (p.Ala159Thr);GRCh37,NC_000017.10:g.7578455C>T GRCh38,NC_000017.11:g.7675137C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1799231;NM_000546.6(TP53):c.304A>G (p.Thr102Ala);GRCh37,NC_000017.10:g.7579383T>C GRCh38,NC_000017.11:g.7676065T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1799016;NM_000546.6(TP53):c.1125G>T (p.Gln375His);GRCh37,NC_000017.10:g.7572984C>A GRCh38,NC_000017.11:g.7669666C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1798385;NM_000546.6(TP53):c.1123C>A (p.Gln375Lys);GRCh37,NC_000017.10:g.7572986G>T GRCh38,NC_000017.11:g.7669668G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1797938;NM_000546.6(TP53):c.1121G>T (p.Gly374Val);GRCh37,NC_000017.10:g.7572988C>A GRCh38,NC_000017.11:g.7669670C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1797574;NM_000546.6(TP53):c.290T>C (p.Val97Ala);GRCh37,NC_000017.10:g.7579397A>G GRCh38,NC_000017.11:g.7676079A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1796813;NM_000546.6(TP53):c.284C>T (p.Ser95Phe);GRCh37,NC_000017.10:g.7579403G>A GRCh38,NC_000017.11:g.7676085G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1796426;NM_000546.6(TP53):c.281C>T (p.Ser94Leu);GRCh37,NC_000017.10:g.7579406G>A GRCh38,NC_000017.11:g.7676088G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1794698;NM_000546.6(TP53):c.110C>G (p.Ser37Cys);GRCh37,NC_000017.10:g.7579577G>C GRCh38,NC_000017.11:g.7676259G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1794493;NM_000546.6(TP53):c.1109A>T (p.Lys370Met);GRCh37,NC_000017.10:g.7573000T>A GRCh38,NC_000017.11:g.7669682T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1793771;NM_000546.6(TP53):c.260C>G (p.Pro87Arg);GRCh37,NC_000017.10:g.7579427G>C GRCh38,NC_000017.11:g.7676109G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1793227;NM_000546.6(TP53):c.256G>C (p.Ala86Pro);GRCh37,NC_000017.10:g.7579431C>G GRCh38,NC_000017.11:g.7676113C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1792511;NM_000546.6(TP53):c.251C>T (p.Ala84Val);GRCh37,NC_000017.10:g.7579436G>A GRCh38,NC_000017.11:g.7676118G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,not provided;1
1790705;NM_000546.6(TP53):c.23C>G (p.Pro8Arg);GRCh37,NC_000017.10:g.7579890G>C GRCh38,NC_000017.11:g.7676572G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1790682;NM_000546.6(TP53):c.239C>T (p.Pro80Leu);GRCh37,NC_000017.10:g.7579448G>A GRCh38,NC_000017.11:g.7676130G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1790091;NM_000546.6(TP53):c.1094A>C (p.His365Pro);GRCh37,NC_000017.10:g.7573933T>G GRCh38,NC_000017.11:g.7670615T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1787901;NM_000546.6(TP53):c.221C>G (p.Ala74Gly);GRCh37,NC_000017.10:g.7579466G>C GRCh38,NC_000017.11:g.7676148G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1786573;NM_000546.6(TP53):c.214_215inv (p.Pro72Gly);GRCh37,NC_000017.10:g.7579472_7579473inv GRCh38,NC_000017.11:g.7676154_7676155inv;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1785528;NM_000546.6(TP53):c.1078G>C (p.Gly360Arg);GRCh37,NC_000017.10:g.7573949C>G GRCh38,NC_000017.11:g.7670631C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1784158;NM_000546.6(TP53):c.19G>A (p.Asp7Asn);GRCh37,NC_000017.10:g.7579894C>T GRCh38,NC_000017.11:g.7676576C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1783578;NM_000546.6(TP53):c.196A>G (p.Met66Val);GRCh37,NC_000017.10:g.7579491T>C GRCh38,NC_000017.11:g.7676173T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1781085;NM_000546.6(TP53):c.1063G>A (p.Ala355Thr);GRCh37,NC_000017.10:g.7573964C>T GRCh38,NC_000017.11:g.7670646C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1779558;NM_000546.6(TP53):c.175G>A (p.Gly59Ser);GRCh37,NC_000017.10:g.7579512C>T GRCh38,NC_000017.11:g.7676194C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1778944;NM_000546.6(TP53):c.172C>G (p.Pro58Ala);GRCh37,NC_000017.10:g.7579515G>C GRCh38,NC_000017.11:g.7676197G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1778759;NM_000546.6(TP53):c.1056T>G (p.Asp352Glu);GRCh37,NC_000017.10:g.7573971A>C GRCh38,NC_000017.11:g.7670653A>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1778520;NM_000546.6(TP53):c.170A>T (p.Asp57Val);GRCh37,NC_000017.10:g.7579517T>A GRCh38,NC_000017.11:g.7676199T>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1775891;NM_000546.6(TP53):c.158G>T (p.Trp53Leu);GRCh37,NC_000017.10:g.7579529C>A GRCh38,NC_000017.11:g.7676211C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1775671;NM_000546.6(TP53):c.157T>C (p.Trp53Arg);GRCh37,NC_000017.10:g.7579530A>G GRCh38,NC_000017.11:g.7676212A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1775423;NM_000546.6(TP53):c.1046A>G (p.Glu349Gly);GRCh37,NC_000017.10:g.7573981T>C GRCh38,NC_000017.11:g.7670663T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1773570;NM_000546.6(TP53):c.1039G>T (p.Ala347Ser);GRCh37,NC_000017.10:g.7573988C>A GRCh38,NC_000017.11:g.7670670C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1771001;NM_000546.6(TP53):c.1030C>A (p.Leu344Met);GRCh37,NC_000017.10:g.7573997G>T GRCh38,NC_000017.11:g.7670679G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1769879;NM_000546.6(TP53):c.131T>C (p.Met44Thr);GRCh37,NC_000017.10:g.7579556A>G GRCh38,NC_000017.11:g.7676238A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1769875;NM_000546.6(TP53):c.131T>A (p.Met44Lys);GRCh37,NC_000017.10:g.7579556A>T GRCh38,NC_000017.11:g.7676238A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1769035;NM_000546.6(TP53):c.1024C>G (p.Arg342Gly);GRCh37,NC_000017.10:g.7574003G>C GRCh38,NC_000017.11:g.7670685G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1768734;NM_000546.6(TP53):c.995T>C (p.Ile332Thr);GRCh37,NC_000017.10:g.7574032A>G GRCh38,NC_000017.11:g.7670714A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1768732;NM_000546.6(TP53):c.995T>A (p.Ile332Asn);GRCh37,NC_000017.10:g.7574032A>T GRCh38,NC_000017.11:g.7670714A>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome;1
1767161;NM_000546.6(TP53):c.94C>G (p.Leu32Val);GRCh37,NC_000017.10:g.7579702G>C GRCh38,NC_000017.11:g.7676384G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1766672;NM_000546.6(TP53):c.935C>A (p.Thr312Asn);GRCh37,NC_000017.10:g.7576911G>T GRCh38,NC_000017.11:g.7673593G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1766454;NM_000546.6(TP53):c.929A>G (p.Asn310Ser);GRCh37,NC_000017.10:g.7576917T>C GRCh38,NC_000017.11:g.7673599T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1766148;NM_000546.6(TP53):c.919G>C (p.Ala307Pro);GRCh37,NC_000017.10:g.7577019C>G GRCh38,NC_000017.11:g.7673701C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1765377;NM_000546.6(TP53):c.899C>T (p.Pro300Leu);GRCh37,NC_000017.10:g.7577039G>A GRCh38,NC_000017.11:g.7673721G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1763670;NM_000546.6(TP53):c.850A>C (p.Thr284Pro);GRCh37,NC_000017.10:g.7577088T>G GRCh38,NC_000017.11:g.7673770T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1762926;NM_000546.6(TP53):c.831T>G (p.Cys277Trp);GRCh37,NC_000017.10:g.7577107A>C GRCh38,NC_000017.11:g.7673789A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1761541;NM_000546.6(TP53):c.799C>G (p.Arg267Gly);GRCh37,NC_000017.10:g.7577139G>C GRCh38,NC_000017.11:g.7673821G>C;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome;2
1760888;NM_000546.6(TP53):c.784G>C (p.Gly262Arg);GRCh37,NC_000017.10:g.7577154C>G GRCh38,NC_000017.11:g.7673836C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1759844;NM_000546.6(TP53):c.761T>C (p.Ile254Thr);GRCh37,NC_000017.10:g.7577520A>G GRCh38,NC_000017.11:g.7674202A>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
1759470;NM_000546.6(TP53):c.754C>G (p.Leu252Val);GRCh37,NC_000017.10:g.7577527G>C GRCh38,NC_000017.11:g.7674209G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1759327;NM_000546.6(TP53):c.1020G>T (p.Met340Ile);GRCh37,NC_000017.10:g.7574007C>A GRCh38,NC_000017.11:g.7670689C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1759315;NM_000546.6(TP53):c.751A>G (p.Ile251Val);GRCh37,NC_000017.10:g.7577530T>C GRCh38,NC_000017.11:g.7674212T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1759212;NM_000546.6(TP53):c.74T>G (p.Leu25Arg);GRCh37,NC_000017.10:g.7579839A>C GRCh38,NC_000017.11:g.7676521A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1759142;NM_000546.6(TP53):c.748C>G (p.Pro250Ala);GRCh37,NC_000017.10:g.7577533G>C GRCh38,NC_000017.11:g.7674215G>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1759140;NM_000546.6(TP53):c.748C>A (p.Pro250Thr);GRCh37,NC_000017.10:g.7577533G>T GRCh38,NC_000017.11:g.7674215G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1758655;NM_000546.6(TP53):c.738G>C (p.Met246Ile);GRCh37,NC_000017.10:g.7577543C>G GRCh38,NC_000017.11:g.7674225C>G;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome;1
1758050;NM_000546.6(TP53):c.727A>T (p.Met243Leu);GRCh37,NC_000017.10:g.7577554T>A GRCh38,NC_000017.11:g.7674236T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1757269;NM_000546.6(TP53):c.711G>C (p.Met237Ile);GRCh37,NC_000017.10:g.7577570C>G GRCh38,NC_000017.11:g.7674252C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
1757126;NM_000546.6(TP53):c.709A>C (p.Met237Leu);GRCh37,NC_000017.10:g.7577572T>G GRCh38,NC_000017.11:g.7674254T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1754112;NM_000546.6(TP53):c.653T>A (p.Val218Glu);GRCh37,NC_000017.10:g.7578196A>T GRCh38,NC_000017.11:g.7674878A>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
1753522;NM_000546.6(TP53):c.643A>T (p.Ser215Cys);GRCh37,NC_000017.10:g.7578206T>A GRCh38,NC_000017.11:g.7674888T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1752332;NM_000546.6(TP53):c.622G>A (p.Asp208Asn);GRCh37,NC_000017.10:g.7578227C>T GRCh38,NC_000017.11:g.7674909C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1751713;NM_000546.6(TP53):c.611A>T (p.Glu204Val);GRCh37,NC_000017.10:g.7578238T>A GRCh38,NC_000017.11:g.7674920T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1751128;NM_000546.6(TP53):c.601T>A (p.Leu201Met);GRCh37,NC_000017.10:g.7578248A>T GRCh38,NC_000017.11:g.7674930A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1750606;NM_000546.6(TP53):c.593A>G (p.Glu198Gly);GRCh37,NC_000017.10:g.7578256T>C GRCh38,NC_000017.11:g.7674938T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1748280;NM_000546.6(TP53):c.555C>G (p.Ser185Arg);GRCh37,NC_000017.10:g.7578375G>C GRCh38,NC_000017.11:g.7675057G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1745525;NM_000546.6(TP53):c.512A>G (p.Glu171Gly);GRCh38,NC_000017.11:g.7675100T>C GRCh37,NC_000017.10:g.7578418T>C;TP53;Pathogenic;Hereditary cancer-predisposing syndrome;1
1745001;NM_000546.6(TP53):c.504C>G (p.His168Gln);GRCh37,NC_000017.10:g.7578426G>C GRCh38,NC_000017.11:g.7675108G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1744933;NM_000546.6(TP53):c.503A>T (p.His168Leu);GRCh37,NC_000017.10:g.7578427T>A GRCh38,NC_000017.11:g.7675109T>A;TP53;Pathogenic;Hereditary cancer-predisposing syndrome;1
1743548;NM_000546.6(TP53):c.484A>G (p.Ile162Val);GRCh37,NC_000017.10:g.7578446T>C GRCh38,NC_000017.11:g.7675128T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1742298;NM_000546.6(TP53):c.466C>A (p.Arg156Ser);GRCh37,NC_000017.10:g.7578464G>T GRCh38,NC_000017.11:g.7675146G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1741887;NM_000546.6(TP53):c.460G>T (p.Gly154Cys);GRCh37,NC_000017.10:g.7578470C>A GRCh38,NC_000017.11:g.7675152C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1741120;NM_000546.6(TP53):c.1177G>T (p.Asp393Tyr);GRCh37,NC_000017.10:g.7572932C>A GRCh38,NC_000017.11:g.7669614C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1740219;NM_000546.6(TP53):c.438G>C (p.Trp146Cys);GRCh37,NC_000017.10:g.7578492C>G GRCh38,NC_000017.11:g.7675174C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1737684;NM_000546.6(TP53):c.1164A>T (p.Glu388Asp);GRCh37,NC_000017.10:g.7572945T>A GRCh38,NC_000017.11:g.7669627T>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1737291;NM_000546.6(TP53):c.1162G>C (p.Glu388Gln);GRCh37,NC_000017.10:g.7572947C>G GRCh38,NC_000017.11:g.7669629C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1735669;NM_000546.6(TP53):c.386C>A (p.Ala129Asp);GRCh37,NC_000017.10:g.7578544G>T GRCh38,NC_000017.11:g.7675226G>T;TP53;Benign;Hereditary cancer-predisposing syndrome;1
1735082;NM_000546.6(TP53):c.1155C>A (p.Phe385Leu);GRCh37,NC_000017.10:g.7572954G>T GRCh38,NC_000017.11:g.7669636G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
1735038;NM_000546.6(TP53):c.37C>G (p.Pro13Ala);GRCh37,NC_000017.10:g.7579876G>C GRCh38,NC_000017.11:g.7676558G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1734755;NM_000546.6(TP53):c.376T>C (p.Tyr126His);GRCh37,NC_000017.10:g.7578554A>G GRCh38,NC_000017.11:g.7675236A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1734453;NM_000546.6(TP53):c.373A>G (p.Thr125Ala);GRCh37,NC_000017.10:g.7579314T>C GRCh38,NC_000017.11:g.7675996T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1732774;NM_000546.6(TP53):c.356C>A (p.Ala119Asp);GRCh37,NC_000017.10:g.7579331G>T GRCh38,NC_000017.11:g.7676013G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1732327;NM_000546.6(TP53):c.1145A>T (p.Lys382Ile);GRCh37,NC_000017.10:g.7572964T>A GRCh38,NC_000017.11:g.7669646T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1730178;NM_000546.6(TP53):c.331C>G (p.Leu111Val);GRCh37,NC_000017.10:g.7579356G>C GRCh38,NC_000017.11:g.7676038G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1729287;NM_000546.6(TP53):c.323G>T (p.Gly108Val);GRCh37,NC_000017.10:g.7579364C>A GRCh38,NC_000017.11:g.7676046C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1721838;NM_000546.6(TP53):c.139C>G (p.Pro47Ala);GRCh37,NC_000017.10:g.7579548G>C GRCh38,NC_000017.11:g.7676230G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;2
1720306;NM_000546.6(TP53):c.964C>G (p.Pro322Ala);GRCh37,NC_000017.10:g.7576882G>C GRCh38,NC_000017.11:g.7673564G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1720175;NM_000546.6(TP53):c.929A>T (p.Asn310Ile);GRCh37,NC_000017.10:g.7576917T>A GRCh38,NC_000017.11:g.7673599T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1718571;NM_000546.6(TP53):c.876A>C (p.Lys292Asn);GRCh37,NC_000017.10:g.7577062T>G GRCh38,NC_000017.11:g.7673744T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1718564;NM_000546.6(TP53):c.383C>G (p.Pro128Arg);GRCh37,NC_000017.10:g.7578547G>C GRCh38,NC_000017.11:g.7675229G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1718262;NM_000546.6(TP53):c.229C>G (p.Pro77Ala);GRCh37,NC_000017.10:g.7579458G>C GRCh38,NC_000017.11:g.7676140G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1717844;NM_000546.6(TP53):c.113A>G (p.Gln38Arg);GRCh37,NC_000017.10:g.7579574T>C GRCh38,NC_000017.11:g.7676256T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1716142;NM_000546.6(TP53):c.1067G>C (p.Gly356Ala);GRCh37,NC_000017.10:g.7573960C>G GRCh38,NC_000017.11:g.7670642C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1714129;NM_000546.6(TP53):c.197T>G (p.Met66Arg);GRCh37,NC_000017.10:g.7579490A>C GRCh38,NC_000017.11:g.7676172A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1697592;NM_000546.6(TP53):c.935C>T (p.Thr312Ile);GRCh37,NC_000017.10:g.7576911G>A GRCh38,NC_000017.11:g.7673593G>A;TP53;Uncertain significance;not specified;1
1692473;NM_000546.6(TP53):c.415A>C (p.Lys139Gln);GRCh37,NC_000017.10:g.7578515T>G GRCh38,NC_000017.11:g.7675197T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1692471;NM_000546.6(TP53):c.129G>C (p.Leu43Phe);GRCh37,NC_000017.10:g.7579558C>G GRCh38,NC_000017.11:g.7676240C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1525853;NM_000546.6(TP53):c.418A>T (p.Thr140Ser);GRCh37,NC_000017.10:g.7578512T>A GRCh38,NC_000017.11:g.7675194T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1521256;NM_000546.6(TP53):c.540G>T (p.Glu180Asp);GRCh37,NC_000017.10:g.7578390C>A GRCh38,NC_000017.11:g.7675072C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1519634;NM_000546.6(TP53):c.401T>C (p.Phe134Ser);GRCh37,NC_000017.10:g.7578529A>G GRCh38,NC_000017.11:g.7675211A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1518844;NM_000546.6(TP53):c.751A>T (p.Ile251Phe);GRCh37,NC_000017.10:g.7577530T>A GRCh38,NC_000017.11:g.7674212T>A;TP53;Likely pathogenic;Li-Fraumeni syndrome;1
1517870;NM_000546.6(TP53):c.466C>G (p.Arg156Gly);GRCh37,NC_000017.10:g.7578464G>C GRCh38,NC_000017.11:g.7675146G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1515529;NM_000546.6(TP53):c.469G>C (p.Val157Leu);GRCh37,NC_000017.10:g.7578461C>G GRCh38,NC_000017.11:g.7675143C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1515391;NM_000546.6(TP53):c.89A>T (p.Asn30Ile);GRCh37,NC_000017.10:g.7579707T>A GRCh38,NC_000017.11:g.7676389T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1510904;NM_000546.6(TP53):c.1109A>C (p.Lys370Thr);GRCh37,NC_000017.10:g.7573000T>G GRCh38,NC_000017.11:g.7669682T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1510133;NM_000546.6(TP53):c.989T>G (p.Leu330Arg);GRCh37,NC_000017.10:g.7576857A>C GRCh38,NC_000017.11:g.7673539A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1509915;NM_000546.6(TP53):c.540G>C (p.Glu180Asp);GRCh37,NC_000017.10:g.7578390C>G GRCh38,NC_000017.11:g.7675072C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1509393;NM_000546.6(TP53):c.401T>A (p.Phe134Tyr);GRCh37,NC_000017.10:g.7578529A>T GRCh38,NC_000017.11:g.7675211A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1506044;NM_000546.6(TP53):c.147T>G (p.Asp49Glu);GRCh37,NC_000017.10:g.7579540A>C GRCh38,NC_000017.11:g.7676222A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1505620;NM_000546.6(TP53):c.79C>G (p.Pro27Ala);GRCh37,NC_000017.10:g.7579717G>C GRCh38,NC_000017.11:g.7676399G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1504304;NM_000546.6(TP53):c.720T>A (p.Ser240Arg);GRCh37,NC_000017.10:g.7577561A>T GRCh38,NC_000017.11:g.7674243A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1503185;NM_000546.6(TP53):c.632C>T (p.Thr211Ile);GRCh37,NC_000017.10:g.7578217G>A GRCh38,NC_000017.11:g.7674899G>A;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
1500748;NM_000546.6(TP53):c.416A>G (p.Lys139Arg);GRCh37,NC_000017.10:g.7578514T>C GRCh38,NC_000017.11:g.7675196T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1497451;NM_000546.6(TP53):c.993G>C (p.Gln331His);GRCh37,NC_000017.10:g.7576853C>G GRCh38,NC_000017.11:g.7673535C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1495821;NM_000546.6(TP53):c.892G>C (p.Glu298Gln);GRCh37,NC_000017.10:g.7577046C>G GRCh38,NC_000017.11:g.7673728C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1494469;NM_000546.6(TP53):c.881A>C (p.Glu294Ala);GRCh37,NC_000017.10:g.7577057T>G GRCh38,NC_000017.11:g.7673739T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1493447;NM_000546.6(TP53):c.672G>C (p.Glu224Asp);GRCh37,NC_000017.10:g.7578177C>G GRCh38,NC_000017.11:g.7674859C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1493091;NM_000546.6(TP53):c.1150A>T (p.Met384Leu);GRCh37,NC_000017.10:g.7572959T>A GRCh38,NC_000017.11:g.7669641T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1491657;NM_000546.6(TP53):c.175G>C (p.Gly59Arg);GRCh37,NC_000017.10:g.7579512C>G GRCh38,NC_000017.11:g.7676194C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1489700;NM_000546.6(TP53):c.544T>G (p.Cys182Gly);GRCh37,NC_000017.10:g.7578386A>C GRCh38,NC_000017.11:g.7675068A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1487358;NM_000546.6(TP53):c.322G>T (p.Gly108Cys);GRCh37,NC_000017.10:g.7579365C>A GRCh38,NC_000017.11:g.7676047C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1485939;NM_000546.6(TP53):c.10C>T (p.Pro4Ser);GRCh37,NC_000017.10:g.7579903G>A GRCh38,NC_000017.11:g.7676585G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1482750;NM_000546.6(TP53):c.1112C>A (p.Ser371Tyr);GRCh37,NC_000017.10:g.7572997G>T GRCh38,NC_000017.11:g.7669679G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1479275;NM_000546.6(TP53):c.560G>C (p.Gly187Ala);GRCh37,NC_000017.10:g.7578289C>G GRCh38,NC_000017.11:g.7674971C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1478891;NM_000546.6(TP53):c.444T>G (p.Asp148Glu);GRCh37,NC_000017.10:g.7578486A>C GRCh38,NC_000017.11:g.7675168A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1473030;NM_000546.6(TP53):c.157T>A (p.Trp53Arg);GRCh37,NC_000017.10:g.7579530A>T GRCh38,NC_000017.11:g.7676212A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1471105;NM_000546.6(TP53):c.926C>T (p.Pro309Leu);GRCh37,NC_000017.10:g.7576920G>A GRCh38,NC_000017.11:g.7673602G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1471049;NM_000546.6(TP53):c.124G>A (p.Asp42Asn);GRCh37,NC_000017.10:g.7579563C>T GRCh38,NC_000017.11:g.7676245C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1469551;NM_000546.6(TP53):c.337T>A (p.Phe113Ile);GRCh37,NC_000017.10:g.7579350A>T GRCh38,NC_000017.11:g.7676032A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1469089;NM_000546.6(TP53):c.901C>T (p.Pro301Ser);GRCh37,NC_000017.10:g.7577037G>A GRCh38,NC_000017.11:g.7673719G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1468494;NM_000546.6(TP53):c.1063G>T (p.Ala355Ser);GRCh37,NC_000017.10:g.7573964C>A GRCh38,NC_000017.11:g.7670646C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1465964;NM_000546.6(TP53):c.365T>C (p.Val122Ala);GRCh37,NC_000017.10:g.7579322A>G GRCh38,NC_000017.11:g.7676004A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1465351;NM_000546.6(TP53):c.292C>A (p.Pro98Thr);GRCh37,NC_000017.10:g.7579395G>T GRCh38,NC_000017.11:g.7676077G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1462102;NM_000546.6(TP53):c.349G>C (p.Gly117Arg);GRCh37,NC_000017.10:g.7579338C>G GRCh38,NC_000017.11:g.7676020C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1461784;NM_000546.6(TP53):c.665C>A (p.Pro222Gln);GRCh37,NC_000017.10:g.7578184G>T GRCh38,NC_000017.11:g.7674866G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1460570;NM_000546.6(TP53):c.368C>G (p.Thr123Ser);GRCh37,NC_000017.10:g.7579319G>C GRCh38,NC_000017.11:g.7676001G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1444043;NM_000546.6(TP53):c.293C>G (p.Pro98Arg);GRCh37,NC_000017.10:g.7579394G>C GRCh38,NC_000017.11:g.7676076G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1439164;NM_000546.6(TP53):c.865C>A (p.Leu289Ile);GRCh37,NC_000017.10:g.7577073G>T GRCh38,NC_000017.11:g.7673755G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1434495;NM_000546.6(TP53):c.836G>T (p.Gly279Val);GRCh37,NC_000017.10:g.7577102C>A GRCh38,NC_000017.11:g.7673784C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1431729;NM_000546.6(TP53):c.810T>A (p.Phe270Leu);GRCh37,NC_000017.10:g.7577128A>T GRCh38,NC_000017.11:g.7673810A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1425412;NM_000546.6(TP53):c.170A>C (p.Asp57Ala);GRCh37,NC_000017.10:g.7579517T>G GRCh38,NC_000017.11:g.7676199T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1417760;NM_000546.6(TP53):c.821_822inv (p.Val274Glu);GRCh37,NC_000017.10:g.7577116_7577117inv GRCh38,NC_000017.11:g.7673798_7673799inv;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1415322;NM_000546.6(TP53):c.52A>T (p.Thr18Ser);GRCh37,NC_000017.10:g.7579861T>A GRCh38,NC_000017.11:g.7676543T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1414768;NM_000546.6(TP53):c.1090G>A (p.Ala364Thr);GRCh37,NC_000017.10:g.7573937C>T GRCh38,NC_000017.11:g.7670619C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1414106;NM_000546.6(TP53):c.823T>G (p.Cys275Gly);GRCh37,NC_000017.10:g.7577115A>C GRCh38,NC_000017.11:g.7673797A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
1409387;NM_000546.6(TP53):c.989T>A (p.Leu330His);GRCh37,NC_000017.10:g.7576857A>T GRCh38,NC_000017.11:g.7673539A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1408611;NM_000546.6(TP53):c.485T>A (p.Ile162Asn);GRCh37,NC_000017.10:g.7578445A>T GRCh38,NC_000017.11:g.7675127A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1401526;NM_000546.6(TP53):c.233C>T (p.Ala78Val);GRCh37,NC_000017.10:g.7579454G>A GRCh38,NC_000017.11:g.7676136G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1395667;NM_000546.6(TP53):c.682G>A (p.Asp228Asn);GRCh37,NC_000017.10:g.7577599C>T GRCh38,NC_000017.11:g.7674281C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1395664;NM_000546.6(TP53):c.1021T>A (p.Phe341Ile);GRCh37,NC_000017.10:g.7574006A>T GRCh38,NC_000017.11:g.7670688A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1388326;NM_000546.6(TP53):c.185A>C (p.Glu62Ala);GRCh37,NC_000017.10:g.7579502T>G GRCh38,NC_000017.11:g.7676184T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1386302;NM_000546.6(TP53):c.1103A>G (p.His368Arg);GRCh37,NC_000017.10:g.7573006T>C GRCh38,NC_000017.11:g.7669688T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1386154;NM_000546.6(TP53):c.649G>T (p.Val217Leu);GRCh37,NC_000017.10:g.7578200C>A GRCh38,NC_000017.11:g.7674882C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1383522;NM_000546.6(TP53):c.781A>G (p.Ser261Gly);GRCh37,NC_000017.10:g.7577500T>C GRCh38,NC_000017.11:g.7674182T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1378428;NM_000546.6(TP53):c.566C>G (p.Ala189Gly);GRCh37,NC_000017.10:g.7578283G>C GRCh38,NC_000017.11:g.7674965G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1375764;NM_000546.6(TP53):c.413C>G (p.Ala138Gly);GRCh37,NC_000017.10:g.7578517G>C GRCh38,NC_000017.11:g.7675199G>C;TP53;Uncertain significance;Li-Fraumeni syndrome,Prostate cancer, hereditary, 1;1
1371608;NM_000546.6(TP53):c.323G>A (p.Gly108Asp);GRCh37,NC_000017.10:g.7579364C>T GRCh38,NC_000017.11:g.7676046C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1366616;NM_000546.6(TP53):c.689C>T (p.Thr230Ile);GRCh37,NC_000017.10:g.7577592G>A GRCh38,NC_000017.11:g.7674274G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1366182;NM_000546.6(TP53):c.181G>T (p.Asp61Tyr);GRCh37,NC_000017.10:g.7579506C>A GRCh38,NC_000017.11:g.7676188C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1365220;NM_000546.6(TP53):c.877G>C (p.Gly293Arg);GRCh37,NC_000017.10:g.7577061C>G GRCh38,NC_000017.11:g.7673743C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1364128;NM_000546.6(TP53):c.787A>T (p.Asn263Tyr);GRCh37,NC_000017.10:g.7577151T>A GRCh38,NC_000017.11:g.7673833T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1361888;NM_000546.6(TP53):c.147T>A (p.Asp49Glu);GRCh37,NC_000017.10:g.7579540A>T GRCh38,NC_000017.11:g.7676222A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1361776;NM_000546.6(TP53):c.220G>T (p.Ala74Ser);GRCh37,NC_000017.10:g.7579467C>A GRCh38,NC_000017.11:g.7676149C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1360099;NM_000546.6(TP53):c.359A>G (p.Lys120Arg);GRCh37,NC_000017.10:g.7579328T>C GRCh38,NC_000017.11:g.7676010T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1360091;NM_000546.6(TP53):c.774A>C (p.Glu258Asp);GRCh37,NC_000017.10:g.7577507T>G GRCh38,NC_000017.11:g.7674189T>G;TP53;Uncertain significance;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
1351017;NM_000546.6(TP53):c.440T>A (p.Val147Asp);GRCh37,NC_000017.10:g.7578490A>T GRCh38,NC_000017.11:g.7675172A>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
1350980;NM_000546.6(TP53):c.622G>T (p.Asp208Tyr);GRCh37,NC_000017.10:g.7578227C>A GRCh38,NC_000017.11:g.7674909C>A;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Lung adenocarcinoma;1
1350373;NM_000546.6(TP53):c.449C>T (p.Thr150Ile);GRCh38,NC_000017.11:g.7675163G>A GRCh37,NC_000017.10:g.7578481G>A;TP53;Uncertain significance;Acute myeloid leukemia,Li-Fraumeni syndrome;1
1349719;NM_000546.6(TP53):c.804C>G (p.Asn268Lys);GRCh37,NC_000017.10:g.7577134G>C GRCh38,NC_000017.11:g.7673816G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1349622;NM_000546.6(TP53):c.775G>C (p.Asp259His);GRCh37,NC_000017.10:g.7577506C>G GRCh38,NC_000017.11:g.7674188C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1347666;NM_000546.6(TP53):c.182A>T (p.Asp61Val);GRCh37,NC_000017.10:g.7579505T>A GRCh38,NC_000017.11:g.7676187T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1343497;NM_000546.6(TP53):c.263C>G (p.Ala88Gly);GRCh37,NC_000017.10:g.7579424G>C GRCh38,NC_000017.11:g.7676106G>C;TP53;Uncertain significance;not specified;1
1338658;NM_000546.6(TP53):c.416A>C (p.Lys139Thr);GRCh37,NC_000017.10:g.7578514T>G GRCh38,NC_000017.11:g.7675196T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;2
1332597;NM_000546.6(TP53):c.901C>G (p.Pro301Ala);GRCh37,NC_000017.10:g.7577037G>C GRCh38,NC_000017.11:g.7673719G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1319402;NM_000546.6(TP53):c.335G>A (p.Gly112Asp);GRCh37,NC_000017.10:g.7579352C>T GRCh38,NC_000017.11:g.7676034C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
1316970;NM_000546.6(TP53):c.748C>T (p.Pro250Ser);GRCh38,NC_000017.11:g.7674215G>A GRCh37,NC_000017.10:g.7577533G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
1316731;NM_000546.6(TP53):c.197T>C (p.Met66Thr);GRCh37,NC_000017.10:g.7579490A>G GRCh38,NC_000017.11:g.7676172A>G;TP53;Uncertain significance;not provided;1
1205464;NM_000546.6(TP53):c.1084A>G (p.Ser362Gly);GRCh37,NC_000017.10:g.7573943T>C GRCh38,NC_000017.11:g.7670625T>C;TP53;Uncertain significance;not provided;1
1172924;NM_000546.6(TP53):c.46C>A (p.Gln16Lys);GRCh37,NC_000017.10:g.7579867G>T GRCh38,NC_000017.11:g.7676549G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
1172923;NM_000546.6(TP53):c.866T>C (p.Leu289Pro);GRCh37,NC_000017.10:g.7577072A>G GRCh38,NC_000017.11:g.7673754A>G;TP53;Likely benign;Li-Fraumeni syndrome 1;3
1171953;NM_000546.6(TP53):c.1076C>G (p.Pro359Arg);GRCh37,NC_000017.10:g.7573951G>C GRCh38,NC_000017.11:g.7670633G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1171287;NM_000546.6(TP53):c.226G>A (p.Ala76Thr);GRCh37,NC_000017.10:g.7579461C>T GRCh38,NC_000017.11:g.7676143C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
1067910;NM_000546.6(TP53):c.472C>A (p.Arg158Ser);GRCh37,NC_000017.10:g.7578458G>T GRCh38,NC_000017.11:g.7675140G>T;TP53;Pathogenic;Li-Fraumeni syndrome;1
1061739;NM_000546.6(TP53):c.598A>G (p.Asn200Asp);GRCh37,NC_000017.10:g.7578251T>C GRCh38,NC_000017.11:g.7674933T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1061526;NM_000546.6(TP53):c.871A>C (p.Lys291Gln);GRCh37,NC_000017.10:g.7577067T>G GRCh38,NC_000017.11:g.7673749T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1061283;NM_000546.6(TP53):c.1060C>G (p.Gln354Glu);GRCh37,NC_000017.10:g.7573967G>C GRCh38,NC_000017.11:g.7670649G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1059527;NM_000546.6(TP53):c.1118A>T (p.Lys373Met);GRCh37,NC_000017.10:g.7572991T>A GRCh38,NC_000017.11:g.7669673T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1059163;NM_000546.6(TP53):c.301A>G (p.Lys101Glu);GRCh37,NC_000017.10:g.7579386T>C GRCh38,NC_000017.11:g.7676068T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1058730;NM_000546.6(TP53):c.455C>A (p.Pro152Gln);GRCh37,NC_000017.10:g.7578475G>T GRCh38,NC_000017.11:g.7675157G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1058186;NM_000546.6(TP53):c.522G>C (p.Arg174Ser);GRCh37,NC_000017.10:g.7578408C>G GRCh38,NC_000017.11:g.7675090C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;2
1057941;NM_000546.6(TP53):c.392A>G (p.Asn131Ser);GRCh37,NC_000017.10:g.7578538T>C GRCh38,NC_000017.11:g.7675220T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1055894;NM_000546.6(TP53):c.1025G>T (p.Arg342Leu);GRCh37,NC_000017.10:g.7574002C>A GRCh38,NC_000017.11:g.7670684C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1055289;NM_000546.6(TP53):c.350G>C (p.Gly117Ala);GRCh37,NC_000017.10:g.7579337C>G GRCh38,NC_000017.11:g.7676019C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1054765;NM_000546.6(TP53):c.377A>C (p.Tyr126Ser);GRCh37,NC_000017.10:g.7578553T>G GRCh38,NC_000017.11:g.7675235T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1054035;NM_000546.6(TP53):c.326T>A (p.Phe109Tyr);GRCh37,NC_000017.10:g.7579361A>T GRCh38,NC_000017.11:g.7676043A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1053808;NM_000546.6(TP53):c.640C>T (p.His214Tyr);GRCh37,NC_000017.10:g.7578209G>A GRCh38,NC_000017.11:g.7674891G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1053765;NM_000546.6(TP53):c.754C>T (p.Leu252Phe);GRCh37,NC_000017.10:g.7577527G>A GRCh38,NC_000017.11:g.7674209G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1053218;NM_000546.6(TP53):c.412G>A (p.Ala138Thr);GRCh37,NC_000017.10:g.7578518C>T GRCh38,NC_000017.11:g.7675200C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1047514;NM_000546.6(TP53):c.904G>A (p.Gly302Arg);GRCh37,NC_000017.10:g.7577034C>T GRCh38,NC_000017.11:g.7673716C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1046623;NM_000546.6(TP53):c.1064C>G (p.Ala355Gly);GRCh37,NC_000017.10:g.7573963G>C GRCh38,NC_000017.11:g.7670645G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1043464;NM_000546.6(TP53):c.97T>A (p.Ser33Thr);GRCh37,NC_000017.10:g.7579590A>T GRCh38,NC_000017.11:g.7676272A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1039474;NM_000546.6(TP53):c.292C>G (p.Pro98Ala);GRCh37,NC_000017.10:g.7579395G>C GRCh38,NC_000017.11:g.7676077G>C;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;2
1036853;NM_000546.6(TP53):c.719G>T (p.Ser240Ile);GRCh37,NC_000017.10:g.7577562C>A GRCh38,NC_000017.11:g.7674244C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1036209;NM_000546.6(TP53):c.575A>C (p.Gln192Pro);GRCh37,NC_000017.10:g.7578274T>G GRCh38,NC_000017.11:g.7674956T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1036023;NM_000546.6(TP53):c.623A>T (p.Asp208Val);GRCh37,NC_000017.10:g.7578226T>A GRCh38,NC_000017.11:g.7674908T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1035024;NM_000546.6(TP53):c.115G>A (p.Ala39Thr);GRCh37,NC_000017.10:g.7579572C>T GRCh38,NC_000017.11:g.7676254C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1027110;NM_000546.6(TP53):c.434T>G (p.Leu145Arg);GRCh37,NC_000017.10:g.7578496A>C GRCh38,NC_000017.11:g.7675178A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1026715;NM_000546.6(TP53):c.685T>G (p.Cys229Gly);GRCh37,NC_000017.10:g.7577596A>C GRCh38,NC_000017.11:g.7674278A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1026463;NM_000546.6(TP53):c.1179C>G (p.Asp393Glu);GRCh37,NC_000017.10:g.7572930G>C GRCh38,NC_000017.11:g.7669612G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1026336;NM_000546.6(TP53):c.289G>A (p.Val97Ile);GRCh37,NC_000017.10:g.7579398C>T GRCh38,NC_000017.11:g.7676080C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1026335;NM_000546.6(TP53):c.476C>A (p.Ala159Asp);GRCh37,NC_000017.10:g.7578454G>T GRCh38,NC_000017.11:g.7675136G>T;TP53;Pathogenic/Likely pathogenic;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Prostate cancer, hereditary, 1;2
1024822;NM_000546.6(TP53):c.862A>G (p.Asn288Asp);GRCh37,NC_000017.10:g.7577076T>C GRCh38,NC_000017.11:g.7673758T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1024800;NM_000546.6(TP53):c.988C>T (p.Leu330Phe);GRCh38,NC_000017.11:g.7673540G>A GRCh37,NC_000017.10:g.7576858G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1024359;NM_000546.6(TP53):c.909C>G (p.Ser303Arg);GRCh38,NC_000017.11:g.7673711G>C GRCh37,NC_000017.10:g.7577029G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1024017;NM_000546.6(TP53):c.571C>T (p.Pro191Ser);GRCh37,NC_000017.10:g.7578278G>A GRCh38,NC_000017.11:g.7674960G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1021934;NM_000546.6(TP53):c.568C>G (p.Pro190Ala);GRCh38,NC_000017.11:g.7674963G>C GRCh37,NC_000017.10:g.7578281G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1021810;NM_000546.6(TP53):c.978A>T (p.Glu326Asp);GRCh38,NC_000017.11:g.7673550T>A GRCh37,NC_000017.10:g.7576868T>A;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1021706;NM_000546.6(TP53):c.875A>C (p.Lys292Thr);GRCh37,NC_000017.10:g.7577063T>G GRCh38,NC_000017.11:g.7673745T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1021579;NM_000546.6(TP53):c.244C>T (p.Pro82Ser);GRCh37,NC_000017.10:g.7579443G>A GRCh38,NC_000017.11:g.7676125G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1021578;NM_000546.6(TP53):c.371G>C (p.Cys124Ser);GRCh37,NC_000017.10:g.7579316C>G GRCh38,NC_000017.11:g.7675998C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1020758;NM_000546.6(TP53):c.911C>T (p.Thr304Ile);GRCh38,NC_000017.11:g.7673709G>A GRCh37,NC_000017.10:g.7577027G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1020154;NM_000546.6(TP53):c.1020G>A (p.Met340Ile);GRCh37,NC_000017.10:g.7574007C>T GRCh38,NC_000017.11:g.7670689C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1019612;NM_000546.6(TP53):c.1009C>A (p.Arg337Ser);GRCh37,NC_000017.10:g.7574018G>T GRCh38,NC_000017.11:g.7670700G>T;TP53;Uncertain significance;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
1019369;NM_000546.6(TP53):c.632C>G (p.Thr211Ser);GRCh38,NC_000017.11:g.7674899G>C GRCh37,NC_000017.10:g.7578217G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1018290;NM_000546.6(TP53):c.402T>G (p.Phe134Leu);GRCh37,NC_000017.10:g.7578528A>C GRCh38,NC_000017.11:g.7675210A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1016947;NM_000546.6(TP53):c.43A>C (p.Ser15Arg);GRCh38,NC_000017.11:g.7676552T>G GRCh37,NC_000017.10:g.7579870T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1015453;NM_000546.6(TP53):c.1027G>C (p.Glu343Gln);GRCh37,NC_000017.10:g.7574000C>G GRCh38,NC_000017.11:g.7670682C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1015039;NM_000546.6(TP53):c.595G>A (p.Gly199Arg);GRCh38,NC_000017.11:g.7674936C>T GRCh37,NC_000017.10:g.7578254C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1011474;NM_000546.6(TP53):c.340T>G (p.Leu114Val);GRCh37,NC_000017.10:g.7579347A>C GRCh38,NC_000017.11:g.7676029A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1009427;NM_000546.6(TP53):c.944C>T (p.Ser315Phe);GRCh38,NC_000017.11:g.7673584G>A GRCh37,NC_000017.10:g.7576902G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1006477;NM_000546.6(TP53):c.874A>G (p.Lys292Glu);GRCh38,NC_000017.11:g.7673746T>C GRCh37,NC_000017.10:g.7577064T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
1005876;NM_000546.6(TP53):c.464C>T (p.Thr155Ile);GRCh37,NC_000017.10:g.7578466G>A GRCh38,NC_000017.11:g.7675148G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
1005829;NM_000546.6(TP53):c.409C>G (p.Leu137Val);GRCh38,NC_000017.11:g.7675203G>C GRCh37,NC_000017.10:g.7578521G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
1001614;NM_000546.6(TP53):c.880G>A (p.Glu294Lys);GRCh37,NC_000017.10:g.7577058C>T GRCh38,NC_000017.11:g.7673740C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
988617;NM_000546.6(TP53):c.576G>C (p.Gln192His);GRCh37,NC_000017.10:g.7578273C>G GRCh38,NC_000017.11:g.7674955C>G;TP53;Likely benign;Malignant tumor of esophagus;1
988616;NM_000546.6(TP53):c.840A>T (p.Arg280Ser);GRCh37,NC_000017.10:g.7577098T>A GRCh38,NC_000017.11:g.7673780T>A;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
988615;NM_000546.6(TP53):c.400T>G (p.Phe134Val);GRCh37,NC_000017.10:g.7578530A>C GRCh38,NC_000017.11:g.7675212A>C;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
976475;NM_000546.6(TP53):c.1141A>G (p.Lys381Glu);GRCh37,NC_000017.10:g.7572968T>C GRCh38,NC_000017.11:g.7669650T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
975959;NM_000546.6(TP53):c.1129A>C (p.Thr377Pro);GRCh37,NC_000017.10:g.7572980T>G GRCh38,NC_000017.11:g.7669662T>G;TP53;Uncertain significance;Li-Fraumeni syndrome 1;1
968647;NM_000546.6(TP53):c.28G>T (p.Val10Phe);GRCh37,NC_000017.10:g.7579885C>A GRCh38,NC_000017.11:g.7676567C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
968639;NM_000546.6(TP53):c.738G>T (p.Met246Ile);GRCh37,NC_000017.10:g.7577543C>A GRCh38,NC_000017.11:g.7674225C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
964952;NM_000546.6(TP53):c.850A>G (p.Thr284Ala);GRCh37,NC_000017.10:g.7577088T>C GRCh38,NC_000017.11:g.7673770T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
964680;NM_000546.6(TP53):c.520A>T (p.Arg174Trp);GRCh38,NC_000017.11:g.7675092T>A GRCh37,NC_000017.10:g.7578410T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
962629;NM_000546.6(TP53):c.626G>A (p.Arg209Lys);GRCh38,NC_000017.11:g.7674905C>T GRCh37,NC_000017.10:g.7578223C>T;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Li-Fraumeni syndrome;1
960924;NM_000546.6(TP53):c.823T>A (p.Cys275Ser);GRCh38,NC_000017.11:g.7673797A>T GRCh37,NC_000017.10:g.7577115A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
959616;NM_000546.6(TP53):c.1016A>T (p.Glu339Val);GRCh37,NC_000017.10:g.7574011T>A GRCh38,NC_000017.11:g.7670693T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
959232;NM_000546.6(TP53):c.721T>A (p.Ser241Thr);GRCh37,NC_000017.10:g.7577560A>T GRCh38,NC_000017.11:g.7674242A>T;TP53;Pathogenic/Likely pathogenic;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
956897;NM_000546.6(TP53):c.1030C>G (p.Leu344Val);GRCh37,NC_000017.10:g.7573997G>C GRCh38,NC_000017.11:g.7670679G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
956854;NM_000546.6(TP53):c.530C>A (p.Pro177His);GRCh37,NC_000017.10:g.7578400G>T GRCh38,NC_000017.11:g.7675082G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
954848;NM_000546.6(TP53):c.684C>A (p.Asp228Glu);GRCh37,NC_000017.10:g.7577597G>T GRCh38,NC_000017.11:g.7674279G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
954095;NM_000546.6(TP53):c.853G>C (p.Glu285Gln);GRCh37,NC_000017.10:g.7577085C>G GRCh38,NC_000017.11:g.7673767C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
953956;NM_000546.6(TP53):c.688A>G (p.Thr230Ala);GRCh37,NC_000017.10:g.7577593T>C GRCh38,NC_000017.11:g.7674275T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;2
953467;NM_000546.6(TP53):c.794T>A (p.Leu265Gln);GRCh37,NC_000017.10:g.7577144A>T GRCh38,NC_000017.11:g.7673826A>T;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
953426;NM_000546.6(TP53):c.656C>G (p.Pro219Arg);GRCh37,NC_000017.10:g.7578193G>C GRCh38,NC_000017.11:g.7674875G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
951578;NM_000546.6(TP53):c.1001G>A (p.Gly334Glu);GRCh37,NC_000017.10:g.7574026C>T GRCh38,NC_000017.11:g.7670708C>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
951459;NM_000546.6(TP53):c.677G>C (p.Gly226Ala);GRCh37,NC_000017.10:g.7577604C>G GRCh38,NC_000017.11:g.7674286C>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome;2
950660;NM_000546.6(TP53):c.182A>G (p.Asp61Gly);GRCh37,NC_000017.10:g.7579505T>C GRCh38,NC_000017.11:g.7676187T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
949463;NM_000546.6(TP53):c.611A>G (p.Glu204Gly);GRCh37,NC_000017.10:g.7578238T>C GRCh38,NC_000017.11:g.7674920T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
949408;NM_000546.6(TP53):c.356C>G (p.Ala119Gly);GRCh37,NC_000017.10:g.7579331G>C GRCh38,NC_000017.11:g.7676013G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
948225;NM_000546.6(TP53):c.484A>T (p.Ile162Phe);GRCh37,NC_000017.10:g.7578446T>A GRCh38,NC_000017.11:g.7675128T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
947223;NM_000546.6(TP53):c.534C>G (p.His178Gln);GRCh37,NC_000017.10:g.7578396G>C GRCh38,NC_000017.11:g.7675078G>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
947099;NM_000546.6(TP53):c.172C>A (p.Pro58Thr);GRCh37,NC_000017.10:g.7579515G>T GRCh38,NC_000017.11:g.7676197G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
945802;NM_000546.6(TP53):c.311A>T (p.Gln104Leu);GRCh37,NC_000017.10:g.7579376T>A GRCh38,NC_000017.11:g.7676058T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
945439;NM_000546.6(TP53):c.1089G>T (p.Arg363Ser);GRCh37,NC_000017.10:g.7573938C>A GRCh38,NC_000017.11:g.7670620C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
942021;NM_000546.6(TP53):c.260C>T (p.Pro87Leu);GRCh38,NC_000017.11:g.7676109G>A GRCh37,NC_000017.10:g.7579427G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
940878;NM_000546.6(TP53):c.113A>C (p.Gln38Pro);GRCh38,NC_000017.11:g.7676256T>G GRCh37,NC_000017.10:g.7579574T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
939133;NM_000546.6(TP53):c.985A>G (p.Thr329Ala);GRCh37,NC_000017.10:g.7576861T>C GRCh38,NC_000017.11:g.7673543T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
935999;NM_000546.6(TP53):c.100C>T (p.Pro34Ser);GRCh37,NC_000017.10:g.7579587G>A GRCh38,NC_000017.11:g.7676269G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
934410;NM_000546.6(TP53):c.379T>C (p.Ser127Pro);GRCh37,NC_000017.10:g.7578551A>G GRCh38,NC_000017.11:g.7675233A>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
933702;NM_000546.6(TP53):c.562C>G (p.Leu188Val);GRCh38,NC_000017.11:g.7674969G>C GRCh37,NC_000017.10:g.7578287G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
928344;NM_000546.6(TP53):c.131T>G (p.Met44Arg);GRCh37,NC_000017.10:g.7579556A>C GRCh38,NC_000017.11:g.7676238A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
927512;NM_000546.6(TP53):c.893A>G (p.Glu298Gly);GRCh37,NC_000017.10:g.7577045T>C GRCh38,NC_000017.11:g.7673727T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
927316;NM_000546.6(TP53):c.1097C>G (p.Ser366Cys);GRCh37,NC_000017.10:g.7573930G>C GRCh38,NC_000017.11:g.7670612G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;2
927085;NM_000546.6(TP53):c.944C>G (p.Ser315Cys);GRCh37,NC_000017.10:g.7576902G>C GRCh38,NC_000017.11:g.7673584G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
926778;NM_000546.6(TP53):c.5A>G (p.Glu2Gly);GRCh37,NC_000017.10:g.7579908T>C GRCh38,NC_000017.11:g.7676590T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
926556;NM_000546.6(TP53):c.684C>G (p.Asp228Glu);GRCh37,NC_000017.10:g.7577597G>C GRCh38,NC_000017.11:g.7674279G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
926470;NM_000546.6(TP53):c.891C>G (p.His297Gln);GRCh37,NC_000017.10:g.7577047G>C GRCh38,NC_000017.11:g.7673729G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
925213;NM_000546.6(TP53):c.861G>T (p.Glu287Asp);GRCh37,NC_000017.10:g.7577077C>A GRCh38,NC_000017.11:g.7673759C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
924379;NM_000546.6(TP53):c.599A>G (p.Asn200Ser);GRCh37,NC_000017.10:g.7578250T>C GRCh38,NC_000017.11:g.7674932T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
923838;NM_000546.6(TP53):c.76C>A (p.Leu26Ile);GRCh37,NC_000017.10:g.7579720G>T GRCh38,NC_000017.11:g.7676402G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
923486;NM_000546.6(TP53):c.253C>T (p.Pro85Ser);GRCh37,NC_000017.10:g.7579434G>A GRCh38,NC_000017.11:g.7676116G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
922531;NM_000546.6(TP53):c.576G>T (p.Gln192His);GRCh37,NC_000017.10:g.7578273C>A GRCh38,NC_000017.11:g.7674955C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
921142;NM_000546.6(TP53):c.692C>G (p.Thr231Ser);GRCh37,NC_000017.10:g.7577589G>C GRCh38,NC_000017.11:g.7674271G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
919894;NM_000546.6(TP53):c.854A>G (p.Glu285Gly);GRCh37,NC_000017.10:g.7577084T>C GRCh38,NC_000017.11:g.7673766T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
919639;NM_000546.6(TP53):c.619G>C (p.Asp207His);GRCh37,NC_000017.10:g.7578230C>G GRCh38,NC_000017.11:g.7674912C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
919580;NM_000546.6(TP53):c.703A>G (p.Asn235Asp);GRCh37,NC_000017.10:g.7577578T>C GRCh38,NC_000017.11:g.7674260T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
919370;NM_000546.6(TP53):c.205G>C (p.Ala69Pro);GRCh37,NC_000017.10:g.7579482C>G GRCh38,NC_000017.11:g.7676164C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
919322;NM_000546.6(TP53):c.507G>T (p.Met169Ile);GRCh37,NC_000017.10:g.7578423C>A GRCh38,NC_000017.11:g.7675105C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
919211;NM_000546.6(TP53):c.1102C>A (p.His368Asn);GRCh37,NC_000017.10:g.7573007G>T GRCh38,NC_000017.11:g.7669689G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
917693;NM_000546.6(TP53):c.359A>T (p.Lys120Met);GRCh37,NC_000017.10:g.7579328T>A GRCh38,NC_000017.11:g.7676010T>A;TP53;Uncertain significance;not specified;1
915695;NM_000546.6(TP53):c.470T>G (p.Val157Gly);GRCh37,NC_000017.10:g.7578460A>C GRCh38,NC_000017.11:g.7675142A>C;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;1
871293;NM_000546.6(TP53):c.402T>A (p.Phe134Leu);GRCh37,NC_000017.10:g.7578528A>T GRCh38,NC_000017.11:g.7675210A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
864652;NM_000546.6(TP53):c.215C>T (p.Pro72Leu);GRCh37,NC_000017.10:g.7579472G>A GRCh38,NC_000017.11:g.7676154G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
864520;NM_000546.6(TP53):c.425C>T (p.Pro142Leu);GRCh37,NC_000017.10:g.7578505G>A GRCh38,NC_000017.11:g.7675187G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
864154;NM_000546.6(TP53):c.129G>T (p.Leu43Phe);GRCh37,NC_000017.10:g.7579558C>A GRCh38,NC_000017.11:g.7676240C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
863522;NM_000546.6(TP53):c.122A>G (p.Asp41Gly);GRCh37,NC_000017.10:g.7579565T>C GRCh38,NC_000017.11:g.7676247T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
863153;NM_000546.6(TP53):c.691A>G (p.Thr231Ala);GRCh37,NC_000017.10:g.7577590T>C GRCh38,NC_000017.11:g.7674272T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
861772;NM_000546.6(TP53):c.7G>C (p.Glu3Gln);GRCh37,NC_000017.10:g.7579906C>G GRCh38,NC_000017.11:g.7676588C>G;TP53;Uncertain significance;Li-Fraumeni syndrome,Lung adenocarcinoma,not specified;2
860528;NM_000546.6(TP53):c.1145A>C (p.Lys382Thr);GRCh37,NC_000017.10:g.7572964T>G GRCh38,NC_000017.11:g.7669646T>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
859912;NM_000546.6(TP53):c.813G>T (p.Glu271Asp);GRCh38,NC_000017.11:g.7673807C>A GRCh37,NC_000017.10:g.7577125C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
859320;NM_000546.6(TP53):c.184G>A (p.Glu62Lys);GRCh37,NC_000017.10:g.7579503C>T GRCh38,NC_000017.11:g.7676185C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
858889;NM_000546.6(TP53):c.767C>T (p.Thr256Ile);GRCh37,NC_000017.10:g.7577514G>A GRCh38,NC_000017.11:g.7674196G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
858737;NM_000546.6(TP53):c.1100G>C (p.Ser367Thr);GRCh38,NC_000017.11:g.7670609C>G GRCh37,NC_000017.10:g.7573927C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
858236;NM_000546.6(TP53):c.7G>A (p.Glu3Lys);GRCh37,NC_000017.10:g.7579906C>T GRCh38,NC_000017.11:g.7676588C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
856299;NM_000546.6(TP53):c.761T>A (p.Ile254Asn);GRCh37,NC_000017.10:g.7577520A>T GRCh38,NC_000017.11:g.7674202A>T;TP53;Pathogenic/Likely pathogenic;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
856171;NM_000546.6(TP53):c.472C>G (p.Arg158Gly);GRCh37,NC_000017.10:g.7578458G>C GRCh38,NC_000017.11:g.7675140G>C;TP53;Pathogenic;Li-Fraumeni syndrome;1
855943;NM_000546.6(TP53):c.950A>T (p.Gln317Leu);GRCh37,NC_000017.10:g.7576896T>A GRCh38,NC_000017.11:g.7673578T>A;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome;2
854451;NM_000546.6(TP53):c.361T>C (p.Ser121Pro);GRCh37,NC_000017.10:g.7579326A>G GRCh38,NC_000017.11:g.7676008A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;2
854234;NM_000546.6(TP53):c.1048C>G (p.Leu350Val);GRCh37,NC_000017.10:g.7573979G>C GRCh38,NC_000017.11:g.7670661G>C;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
853530;NM_000546.6(TP53):c.572C>A (p.Pro191His);GRCh37,NC_000017.10:g.7578277G>T GRCh38,NC_000017.11:g.7674959G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
852206;NM_000546.6(TP53):c.800G>T (p.Arg267Leu);GRCh37,NC_000017.10:g.7577138C>A GRCh38,NC_000017.11:g.7673820C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
850916;NM_000546.6(TP53):c.674T>A (p.Val225Asp);GRCh37,NC_000017.10:g.7577607A>T GRCh38,NC_000017.11:g.7674289A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
850781;NM_000546.6(TP53):c.151G>A (p.Glu51Lys);GRCh38,NC_000017.11:g.7676218C>T GRCh37,NC_000017.10:g.7579536C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
850008;NM_000546.6(TP53):c.695T>A (p.Ile232Asn);GRCh38,NC_000017.11:g.7674268A>T GRCh37,NC_000017.10:g.7577586A>T;TP53;Pathogenic/Likely pathogenic;Li-Fraumeni syndrome;2
848951;NM_000546.6(TP53):c.1090G>T (p.Ala364Ser);GRCh37,NC_000017.10:g.7573937C>A GRCh38,NC_000017.11:g.7670619C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
848797;NM_000546.6(TP53):c.232G>T (p.Ala78Ser);GRCh38,NC_000017.11:g.7676137C>A GRCh37,NC_000017.10:g.7579455C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
848532;NM_000546.6(TP53):c.941C>G (p.Ser314Cys);GRCh38,NC_000017.11:g.7673587G>C GRCh37,NC_000017.10:g.7576905G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
845798;NM_000546.6(TP53):c.271T>C (p.Trp91Arg);GRCh38,NC_000017.11:g.7676098A>G GRCh37,NC_000017.10:g.7579416A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
844926;NM_000546.6(TP53):c.505A>G (p.Met169Val);GRCh38,NC_000017.11:g.7675107T>C GRCh37,NC_000017.10:g.7578425T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
842812;NM_000546.6(TP53):c.440T>C (p.Val147Ala);GRCh37,NC_000017.10:g.7578490A>G GRCh38,NC_000017.11:g.7675172A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
842527;NM_000546.6(TP53):c.86A>C (p.Asn29Thr);GRCh37,NC_000017.10:g.7579710T>G GRCh38,NC_000017.11:g.7676392T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
840626;NM_000546.6(TP53):c.1004G>C (p.Arg335Pro);GRCh37,NC_000017.10:g.7574023C>G GRCh38,NC_000017.11:g.7670705C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
840505;NM_000546.6(TP53):c.729G>A (p.Met243Ile);GRCh37,NC_000017.10:g.7577552C>T GRCh38,NC_000017.11:g.7674234C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
840399;NM_000546.6(TP53):c.559G>A (p.Gly187Ser);GRCh37,NC_000017.10:g.7578371C>T GRCh38,NC_000017.11:g.7675053C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
839717;NM_000546.6(TP53):c.1045G>A (p.Glu349Lys);GRCh37,NC_000017.10:g.7573982C>T GRCh38,NC_000017.11:g.7670664C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
839498;NM_000546.6(TP53):c.1119G>T (p.Lys373Asn);GRCh37,NC_000017.10:g.7572990C>A GRCh38,NC_000017.11:g.7669672C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
837688;NM_000546.6(TP53):c.758C>T (p.Thr253Ile);GRCh37,NC_000017.10:g.7577523G>A GRCh38,NC_000017.11:g.7674205G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
837018;NM_000546.6(TP53):c.350G>T (p.Gly117Val);GRCh37,NC_000017.10:g.7579337C>A GRCh38,NC_000017.11:g.7676019C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
836766;NM_000546.6(TP53):c.224C>T (p.Pro75Leu);GRCh37,NC_000017.10:g.7579463G>A GRCh38,NC_000017.11:g.7676145G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
836761;NM_000546.6(TP53):c.515T>A (p.Val172Asp);GRCh37,NC_000017.10:g.7578415A>T GRCh38,NC_000017.11:g.7675097A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder;1
836750;NM_000546.6(TP53):c.331C>A (p.Leu111Met);GRCh37,NC_000017.10:g.7579356G>T GRCh38,NC_000017.11:g.7676038G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
835228;NM_000546.6(TP53):c.199C>T (p.Pro67Ser);GRCh37,NC_000017.10:g.7579488G>A GRCh38,NC_000017.11:g.7676170G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
835067;NM_000546.6(TP53):c.47A>G (p.Gln16Arg);GRCh38,NC_000017.11:g.7676548T>C GRCh37,NC_000017.10:g.7579866T>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome;2
827547;NM_000546.6(TP53):c.826G>A (p.Ala276Thr);GRCh37,NC_000017.10:g.7577112C>T GRCh38,NC_000017.11:g.7673794C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
827405;NM_000546.6(TP53):c.802A>T (p.Asn268Tyr);GRCh37,NC_000017.10:g.7577136T>A GRCh38,NC_000017.11:g.7673818T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
827313;NM_000546.6(TP53):c.788A>G (p.Asn263Ser);GRCh37,NC_000017.10:g.7577150T>C GRCh38,NC_000017.11:g.7673832T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
827201;NM_000546.6(TP53):c.769C>G (p.Leu257Val);GRCh37,NC_000017.10:g.7577512G>C GRCh38,NC_000017.11:g.7674194G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
827132;NM_000546.6(TP53):c.757A>G (p.Thr253Ala);GRCh37,NC_000017.10:g.7577524T>C GRCh38,NC_000017.11:g.7674206T>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
826894;NM_000546.6(TP53):c.718A>C (p.Ser240Arg);GRCh37,NC_000017.10:g.7577563T>G GRCh38,NC_000017.11:g.7674245T>G;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome;1
826574;NM_000546.6(TP53):c.671A>G (p.Glu224Gly);GRCh37,NC_000017.10:g.7578178T>C GRCh38,NC_000017.11:g.7674860T>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome;2
826488;NM_000546.6(TP53):c.656C>T (p.Pro219Leu);GRCh37,NC_000017.10:g.7578193G>A GRCh38,NC_000017.11:g.7674875G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
826261;NM_000546.6(TP53):c.622G>C (p.Asp208His);GRCh37,NC_000017.10:g.7578227C>G GRCh38,NC_000017.11:g.7674909C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
826165;NM_000546.6(TP53):c.605G>C (p.Arg202Pro);GRCh37,NC_000017.10:g.7578244C>G GRCh38,NC_000017.11:g.7674926C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
826109;NM_000546.6(TP53):c.59C>T (p.Ser20Leu);GRCh37,NC_000017.10:g.7579854G>A GRCh38,NC_000017.11:g.7676536G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
826051;NM_000546.6(TP53):c.590T>G (p.Val197Gly);GRCh37,NC_000017.10:g.7578259A>C GRCh38,NC_000017.11:g.7674941A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
825975;NM_000546.6(TP53):c.579T>A (p.His193Gln);GRCh37,NC_000017.10:g.7578270A>T GRCh38,NC_000017.11:g.7674952A>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome;1
825729;NM_000546.6(TP53):c.542G>C (p.Arg181Pro);GRCh37,NC_000017.10:g.7578388C>G GRCh38,NC_000017.11:g.7675070C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
825481;NM_000546.6(TP53):c.514G>A (p.Val172Ile);GRCh37,NC_000017.10:g.7578416C>T GRCh38,NC_000017.11:g.7675098C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
824998;NM_000546.6(TP53):c.455C>G (p.Pro152Arg);GRCh37,NC_000017.10:g.7578475G>C GRCh38,NC_000017.11:g.7675157G>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
824855;NM_000546.6(TP53):c.438G>T (p.Trp146Cys);GRCh37,NC_000017.10:g.7578492C>A GRCh38,NC_000017.11:g.7675174C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
824720;NM_000546.6(TP53):c.424C>T (p.Pro142Ser);GRCh37,NC_000017.10:g.7578506G>A GRCh38,NC_000017.11:g.7675188G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
824351;NM_000546.6(TP53):c.389T>A (p.Leu130His);GRCh37,NC_000017.10:g.7578541A>T GRCh38,NC_000017.11:g.7675223A>T;TP53;Pathogenic;Hereditary cancer-predisposing syndrome;1
824314;NM_000546.6(TP53):c.385G>T (p.Ala129Ser);GRCh37,NC_000017.10:g.7578545C>A GRCh38,NC_000017.11:g.7675227C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
824286;NM_000546.6(TP53):c.383C>T (p.Pro128Leu);GRCh37,NC_000017.10:g.7578547G>A GRCh38,NC_000017.11:g.7675229G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
824232;NM_000546.6(TP53):c.379T>A (p.Ser127Thr);GRCh37,NC_000017.10:g.7578551A>T GRCh38,NC_000017.11:g.7675233A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
823709;NM_000546.6(TP53):c.338T>C (p.Phe113Ser);GRCh37,NC_000017.10:g.7579349A>G GRCh38,NC_000017.11:g.7676031A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
823553;NM_000546.6(TP53):c.991C>A (p.Gln331Lys);GRCh37,NC_000017.10:g.7576855G>T GRCh38,NC_000017.11:g.7673537G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
823452;NM_000546.6(TP53):c.328C>G (p.Arg110Gly);GRCh37,NC_000017.10:g.7579359G>C GRCh38,NC_000017.11:g.7676041G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
823403;NM_000546.6(TP53):c.968T>C (p.Leu323Pro);GRCh37,NC_000017.10:g.7576878A>G GRCh38,NC_000017.11:g.7673560A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
823268;NM_000546.6(TP53):c.946C>T (p.Pro316Ser);GRCh37,NC_000017.10:g.7576900G>A GRCh38,NC_000017.11:g.7673582G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
822635;NM_000546.6(TP53):c.865C>T (p.Leu289Phe);GRCh37,NC_000017.10:g.7577073G>A GRCh38,NC_000017.11:g.7673755G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
822586;NM_000546.6(TP53):c.85A>G (p.Asn29Asp);GRCh37,NC_000017.10:g.7579711T>C GRCh38,NC_000017.11:g.7676393T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
822501;NM_000546.6(TP53):c.29T>G (p.Val10Gly);GRCh37,NC_000017.10:g.7579884A>C GRCh38,NC_000017.11:g.7676566A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
822279;NM_000546.6(TP53):c.292C>T (p.Pro98Ser);GRCh37,NC_000017.10:g.7579395G>A GRCh38,NC_000017.11:g.7676077G>A;TP53;Uncertain significance;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome;2
822222;NM_000546.6(TP53):c.1130C>T (p.Thr377Ile);GRCh37,NC_000017.10:g.7572979G>A GRCh38,NC_000017.11:g.7669661G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
822085;NM_000546.6(TP53):c.1053G>T (p.Lys351Asn);GRCh37,NC_000017.10:g.7573974C>A GRCh38,NC_000017.11:g.7670656C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
822016;NM_000546.6(TP53):c.1016A>G (p.Glu339Gly);GRCh37,NC_000017.10:g.7574011T>C GRCh38,NC_000017.11:g.7670693T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
821828;NM_000546.6(TP53):c.27C>A (p.Ser9Arg);GRCh37,NC_000017.10:g.7579886G>T GRCh38,NC_000017.11:g.7676568G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
821636;NM_000546.6(TP53):c.265C>A (p.Pro89Thr);GRCh37,NC_000017.10:g.7579422G>T GRCh38,NC_000017.11:g.7676104G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
820372;NM_000546.6(TP53):c.193A>G (p.Arg65Gly);GRCh37,NC_000017.10:g.7579494T>C GRCh38,NC_000017.11:g.7676176T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
820144;NM_000546.6(TP53):c.183T>A (p.Asp61Glu);GRCh37,NC_000017.10:g.7579504A>T GRCh38,NC_000017.11:g.7676186A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
820098;NM_000546.6(TP53):c.179C>T (p.Pro60Leu);GRCh37,NC_000017.10:g.7579508G>A GRCh38,NC_000017.11:g.7676190G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
820048;NM_000546.6(TP53):c.176G>A (p.Gly59Asp);GRCh37,NC_000017.10:g.7579511C>T GRCh38,NC_000017.11:g.7676193C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Malignant tumor of breast;1
819145;NM_000546.6(TP53):c.140C>G (p.Pro47Arg);GRCh37,NC_000017.10:g.7579547G>C GRCh38,NC_000017.11:g.7676229G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
818502;NM_000546.6(TP53):c.1177G>C (p.Asp393His);GRCh37,NC_000017.10:g.7572932C>G GRCh38,NC_000017.11:g.7669614C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
818485;NM_000546.6(TP53):c.1168C>A (p.Pro390Thr);GRCh37,NC_000017.10:g.7572941G>T GRCh38,NC_000017.11:g.7669623G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
818446;NM_000546.6(TP53):c.1157A>G (p.Lys386Arg);GRCh37,NC_000017.10:g.7572952T>C GRCh38,NC_000017.11:g.7669634T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
818331;NM_000546.6(TP53):c.107C>T (p.Pro36Leu);GRCh37,NC_000017.10:g.7579580G>A GRCh38,NC_000017.11:g.7676262G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
818276;NM_000546.6(TP53):c.101C>T (p.Pro34Leu);GRCh37,NC_000017.10:g.7579586G>A GRCh38,NC_000017.11:g.7676268G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
818264;NM_000546.6(TP53):c.1019T>A (p.Met340Lys);GRCh37,NC_000017.10:g.7574008A>T GRCh38,NC_000017.11:g.7670690A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
804214;NM_000546.6(TP53):c.428T>C (p.Val143Ala);GRCh38,NC_000017.11:g.7675184A>G GRCh37,NC_000017.10:g.7578502A>G;TP53;Likely pathogenic;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
666137;NM_000546.6(TP53):c.920C>T (p.Ala307Val);GRCh37,NC_000017.10:g.7576926G>A GRCh38,NC_000017.11:g.7673608G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
665996;NM_000546.6(TP53):c.1120G>T (p.Gly374Cys);GRCh37,NC_000017.10:g.7572989C>A GRCh38,NC_000017.11:g.7669671C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
664710;NM_000546.6(TP53):c.22C>A (p.Pro8Thr);GRCh37,NC_000017.10:g.7579891G>T GRCh38,NC_000017.11:g.7676573G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
664352;NM_000546.6(TP53):c.80C>G (p.Pro27Arg);GRCh37,NC_000017.10:g.7579716G>C GRCh38,NC_000017.11:g.7676398G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
663876;NM_000546.6(TP53):c.35C>G (p.Pro12Arg);GRCh37,NC_000017.10:g.7579878G>C GRCh38,NC_000017.11:g.7676560G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
663719;NM_000546.6(TP53):c.127T>A (p.Leu43Met);GRCh37,NC_000017.10:g.7579560A>T GRCh38,NC_000017.11:g.7676242A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
662690;NM_000546.6(TP53):c.1039G>A (p.Ala347Thr);GRCh37,NC_000017.10:g.7573988C>T GRCh38,NC_000017.11:g.7670670C>T;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of urinary bladder,not provided;1
660046;NM_000546.6(TP53):c.891C>A (p.His297Gln);GRCh37,NC_000017.10:g.7577047G>T GRCh38,NC_000017.11:g.7673729G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
659842;NM_000546.6(TP53):c.133C>G (p.Leu45Val);GRCh37,NC_000017.10:g.7579554G>C GRCh38,NC_000017.11:g.7676236G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
659626;NM_000546.6(TP53):c.137C>A (p.Ser46Tyr);GRCh37,NC_000017.10:g.7579550G>T GRCh38,NC_000017.11:g.7676232G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
659457;NM_000546.6(TP53):c.761T>G (p.Ile254Ser);GRCh38,NC_000017.11:g.7674202A>C GRCh37,NC_000017.10:g.7577520A>C;TP53;Uncertain significance;Li-Fraumeni syndrome,Lung sarcomatoid carcinoma;1
658923;NM_000546.6(TP53):c.415A>G (p.Lys139Glu);GRCh38,NC_000017.11:g.7675197T>C GRCh37,NC_000017.10:g.7578515T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
657729;NM_000546.6(TP53):c.1045G>C (p.Glu349Gln);GRCh37,NC_000017.10:g.7573982C>G GRCh38,NC_000017.11:g.7670664C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
657014;NM_000546.6(TP53):c.1104C>A (p.His368Gln);GRCh37,NC_000017.10:g.7573005G>T GRCh38,NC_000017.11:g.7669687G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
656751;NM_000546.6(TP53):c.380C>A (p.Ser127Tyr);GRCh38,NC_000017.11:g.7675232G>T GRCh37,NC_000017.10:g.7578550G>T;TP53;Pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
655556;NM_000546.6(TP53):c.830G>C (p.Cys277Ser);GRCh37,NC_000017.10:g.7577108C>G GRCh38,NC_000017.11:g.7673790C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
655254;NM_000546.6(TP53):c.236C>G (p.Ala79Gly);GRCh37,NC_000017.10:g.7579451G>C GRCh38,NC_000017.11:g.7676133G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
654187;NM_000546.6(TP53):c.257C>T (p.Ala86Val);GRCh37,NC_000017.10:g.7579430G>A GRCh38,NC_000017.11:g.7676112G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
653104;NM_000546.6(TP53):c.500A>G (p.Gln167Arg);GRCh37,NC_000017.10:g.7578430T>C GRCh38,NC_000017.11:g.7675112T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
652718;NM_000546.6(TP53):c.986C>T (p.Thr329Ile);GRCh37,NC_000017.10:g.7576860G>A GRCh38,NC_000017.11:g.7673542G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;1
651769;NM_000546.6(TP53):c.461G>T (p.Gly154Val);GRCh37,NC_000017.10:g.7578469C>A GRCh38,NC_000017.11:g.7675151C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
651580;NM_000546.6(TP53):c.989T>C (p.Leu330Pro);GRCh37,NC_000017.10:g.7576857A>G GRCh38,NC_000017.11:g.7673539A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
651517;NM_000546.6(TP53):c.928A>G (p.Asn310Asp);GRCh37,NC_000017.10:g.7576918T>C GRCh38,NC_000017.11:g.7673600T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
649861;NM_000546.6(TP53):c.98C>T (p.Ser33Phe);GRCh37,NC_000017.10:g.7579589G>A GRCh38,NC_000017.11:g.7676271G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
649735;NM_000546.6(TP53):c.301A>C (p.Lys101Gln);GRCh37,NC_000017.10:g.7579386T>G GRCh38,NC_000017.11:g.7676068T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
649358;NM_000546.6(TP53):c.346T>G (p.Ser116Ala);GRCh37,NC_000017.10:g.7579341A>C GRCh38,NC_000017.11:g.7676023A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
648339;NM_000546.6(TP53):c.983T>C (p.Phe328Ser);GRCh37,NC_000017.10:g.7576863A>G GRCh38,NC_000017.11:g.7673545A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
648028;NM_000546.6(TP53):c.676G>A (p.Gly226Ser);GRCh37,NC_000017.10:g.7577605C>T GRCh38,NC_000017.11:g.7674287C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
647334;NM_000546.6(TP53):c.725G>C (p.Cys242Ser);GRCh37,NC_000017.10:g.7577556C>G GRCh38,NC_000017.11:g.7674238C>G;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
647256;NM_000546.6(TP53):c.805A>C (p.Ser269Arg);GRCh37,NC_000017.10:g.7577133T>G GRCh38,NC_000017.11:g.7673815T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
646925;NM_000546.6(TP53):c.1036G>A (p.Glu346Lys);GRCh37,NC_000017.10:g.7573991C>T GRCh38,NC_000017.11:g.7670673C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
646725;NM_000546.6(TP53):c.568C>T (p.Pro190Ser);GRCh37,NC_000017.10:g.7578281G>A GRCh38,NC_000017.11:g.7674963G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
646495;NM_000546.6(TP53):c.529C>T (p.Pro177Ser);GRCh37,NC_000017.10:g.7578401G>A GRCh38,NC_000017.11:g.7675083G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
645432;NM_000546.6(TP53):c.458C>T (p.Pro153Leu);GRCh37,NC_000017.10:g.7578472G>A GRCh38,NC_000017.11:g.7675154G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
644883;NM_000546.6(TP53):c.608T>A (p.Val203Glu);GRCh37,NC_000017.10:g.7578241A>T GRCh38,NC_000017.11:g.7674923A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
644101;NM_000546.6(TP53):c.418A>G (p.Thr140Ala);GRCh37,NC_000017.10:g.7578512T>C GRCh38,NC_000017.11:g.7675194T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
643576;NM_000546.6(TP53):c.118A>G (p.Met40Val);GRCh37,NC_000017.10:g.7579569T>C GRCh38,NC_000017.11:g.7676251T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;1
643078;NM_000546.6(TP53):c.641A>C (p.His214Pro);GRCh37,NC_000017.10:g.7578208T>G GRCh38,NC_000017.11:g.7674890T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
642623;NM_000546.6(TP53):c.48G>C (p.Gln16His);GRCh37,NC_000017.10:g.7579865C>G GRCh38,NC_000017.11:g.7676547C>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
641482;NM_000546.6(TP53):c.319T>G (p.Tyr107Asp);GRCh37,NC_000017.10:g.7579368A>C GRCh38,NC_000017.11:g.7676050A>C;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
640121;NM_000546.6(TP53):c.790C>A (p.Leu264Ile);GRCh37,NC_000017.10:g.7577148G>T GRCh38,NC_000017.11:g.7673830G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
639734;NM_000546.6(TP53):c.1152G>A (p.Met384Ile);GRCh37,NC_000017.10:g.7572957C>T GRCh38,NC_000017.11:g.7669639C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
638927;NM_000546.6(TP53):c.87C>G (p.Asn29Lys);GRCh37,NC_000017.10:g.7579709G>C GRCh38,NC_000017.11:g.7676391G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
635392;NM_000546.6(TP53):c.559G>C (p.Gly187Arg);GRCh37,NC_000017.10:g.7578371C>G GRCh38,NC_000017.11:g.7675053C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
635390;NM_000546.6(TP53):c.672G>T (p.Glu224Asp);GRCh37,NC_000017.10:g.7578177C>A GRCh38,NC_000017.11:g.7674859C>A;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;1
634784;NM_000546.6(TP53):c.326T>G (p.Phe109Cys);GRCh37,NC_000017.10:g.7579361A>C GRCh38,NC_000017.11:g.7676043A>C;TP53;Likely pathogenic;Li-Fraumeni syndrome 1,Neoplasm of ovary;1
634778;NM_000546.6(TP53):c.808T>C (p.Phe270Leu);GRCh37,NC_000017.10:g.7577130A>G GRCh38,NC_000017.11:g.7673812A>G;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;1
634773;NM_000546.6(TP53):c.396G>T (p.Lys132Asn);GRCh37,NC_000017.10:g.7578534C>A GRCh38,NC_000017.11:g.7675216C>A;TP53;Pathogenic/Likely pathogenic;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
634770;NM_000546.6(TP53):c.711G>T (p.Met237Ile);GRCh37,NC_000017.10:g.7577570C>A GRCh38,NC_000017.11:g.7674252C>A;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of urinary bladder,Neoplasm of ovary;2
634768;NM_000546.6(TP53):c.467G>C (p.Arg156Pro);GRCh37,NC_000017.10:g.7578463C>G GRCh38,NC_000017.11:g.7675145C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary;1
634757;NM_000546.6(TP53):c.590T>A (p.Val197Glu);GRCh37,NC_000017.10:g.7578259A>T GRCh38,NC_000017.11:g.7674941A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary;2
634756;NM_000546.6(TP53):c.695T>G (p.Ile232Ser);GRCh37,NC_000017.10:g.7577586A>C GRCh38,NC_000017.11:g.7674268A>C;TP53;Pathogenic;Hereditary cancer-predisposing syndrome,Neoplasm of ovary;1
634747;NM_000546.6(TP53):c.840A>C (p.Arg280Ser);GRCh37,NC_000017.10:g.7577098T>G GRCh38,NC_000017.11:g.7673780T>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;2
634708;NM_000546.6(TP53):c.314G>T (p.Gly105Val);GRCh37,NC_000017.10:g.7579373C>A GRCh38,NC_000017.11:g.7676055C>A;TP53;Likely pathogenic;Lung adenocarcinoma,Neoplasm of ovary;1
634690;NM_000546.6(TP53):c.338T>G (p.Phe113Cys);GRCh37,NC_000017.10:g.7579349A>C GRCh38,NC_000017.11:g.7676031A>C;TP53;Uncertain significance;Li-Fraumeni syndrome,Neoplasm of ovary;1
634682;NM_000546.6(TP53):c.817C>G (p.Arg273Gly);GRCh37,NC_000017.10:g.7577121G>C GRCh38,NC_000017.11:g.7673803G>C;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;2
634680;NM_000546.6(TP53):c.775G>T (p.Asp259Tyr);GRCh37,NC_000017.10:g.7577506C>A GRCh38,NC_000017.11:g.7674188C>A;TP53;Uncertain significance;Li-Fraumeni syndrome,Neoplasm of ovary;1
633445;NM_000546.6(TP53):c.869G>T (p.Arg290Leu);GRCh37,NC_000017.10:g.7577069C>A GRCh38,NC_000017.11:g.7673751C>A;TP53;Conflicting classifications of pathogenicity;Bone marrow failure syndrome 5,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not specified;1
630832;NM_000546.6(TP53):c.970G>T (p.Asp324Tyr);GRCh37,NC_000017.10:g.7576876C>A GRCh38,NC_000017.11:g.7673558C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
630031;NM_000546.6(TP53):c.209C>T (p.Ala70Val);GRCh37,NC_000017.10:g.7579478G>A GRCh38,NC_000017.11:g.7676160G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
629930;NM_000546.6(TP53):c.873G>C (p.Lys291Asn);GRCh37,NC_000017.10:g.7577065C>G GRCh38,NC_000017.11:g.7673747C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
629928;NM_000546.6(TP53):c.1061A>G (p.Gln354Arg);GRCh37,NC_000017.10:g.7573966T>C GRCh38,NC_000017.11:g.7670648T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
629791;NM_000546.6(TP53):c.317G>T (p.Ser106Ile);GRCh37,NC_000017.10:g.7579370C>A GRCh38,NC_000017.11:g.7676052C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
629276;NM_000546.6(TP53):c.262G>C (p.Ala88Pro);GRCh37,NC_000017.10:g.7579425C>G GRCh38,NC_000017.11:g.7676107C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
629063;NM_000546.6(TP53):c.1173C>G (p.Asp391Glu);GRCh37,NC_000017.10:g.7572936G>C GRCh38,NC_000017.11:g.7669618G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
628970;NM_000546.6(TP53):c.868C>G (p.Arg290Gly);GRCh37,NC_000017.10:g.7577070G>C GRCh38,NC_000017.11:g.7673752G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
628478;NM_000546.6(TP53):c.101C>G (p.Pro34Arg);GRCh37,NC_000017.10:g.7579586G>C GRCh38,NC_000017.11:g.7676268G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
628432;NM_000546.6(TP53):c.1013T>G (p.Phe338Cys);GRCh37,NC_000017.10:g.7574014A>C GRCh38,NC_000017.11:g.7670696A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
627819;NM_000546.6(TP53):c.625A>G (p.Arg209Gly);GRCh37,NC_000017.10:g.7578224T>C GRCh38,NC_000017.11:g.7674906T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
619733;NM_000546.6(TP53):c.1147C>T (p.Leu383Phe);GRCh37,NC_000017.10:g.7572962G>A GRCh38,NC_000017.11:g.7669644G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,not provided;1
584923;NM_000546.6(TP53):c.417G>T (p.Lys139Asn);GRCh37,NC_000017.10:g.7578513C>A GRCh38,NC_000017.11:g.7675195C>A;TP53;Uncertain significance;Li-Fraumeni syndrome;2
584922;NM_000546.6(TP53):c.623A>G (p.Asp208Gly);GRCh37,NC_000017.10:g.7578226T>C GRCh38,NC_000017.11:g.7674908T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
584921;NM_000546.6(TP53):c.718A>G (p.Ser240Gly);GRCh37,NC_000017.10:g.7577563T>C GRCh38,NC_000017.11:g.7674245T>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck;2
584919;NM_000546.6(TP53):c.1069A>G (p.Lys357Glu);GRCh37,NC_000017.10:g.7573958T>C GRCh38,NC_000017.11:g.7670640T>C;TP53;Uncertain significance;Squamous cell carcinoma of the head and neck;1
583101;NM_000546.6(TP53):c.242C>T (p.Thr81Ile);GRCh37,NC_000017.10:g.7579445G>A GRCh38,NC_000017.11:g.7676127G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
582302;NM_000546.6(TP53):c.686G>C (p.Cys229Ser);GRCh37,NC_000017.10:g.7577595C>G GRCh38,NC_000017.11:g.7674277C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
582257;NM_000546.6(TP53):c.596G>A (p.Gly199Glu);GRCh37,NC_000017.10:g.7578253C>T GRCh38,NC_000017.11:g.7674935C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
582041;NM_000546.6(TP53):c.304A>T (p.Thr102Ser);GRCh37,NC_000017.10:g.7579383T>A GRCh38,NC_000017.11:g.7676065T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
581024;NM_000546.6(TP53):c.950A>G (p.Gln317Arg);GRCh37,NC_000017.10:g.7576896T>C GRCh38,NC_000017.11:g.7673578T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,TP53-related disorder;1
580807;NM_000546.6(TP53):c.407A>C (p.Gln136Pro);GRCh37,NC_000017.10:g.7578523T>G GRCh38,NC_000017.11:g.7675205T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
580186;NM_000546.6(TP53):c.847C>G (p.Arg283Gly);GRCh37,NC_000017.10:g.7577091G>C GRCh38,NC_000017.11:g.7673773G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
579376;NM_000546.6(TP53):c.296C>T (p.Ser99Phe);GRCh37,NC_000017.10:g.7579391G>A GRCh38,NC_000017.11:g.7676073G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
578235;NM_000546.6(TP53):c.35C>A (p.Pro12His);GRCh37,NC_000017.10:g.7579878G>T GRCh38,NC_000017.11:g.7676560G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
577888;NM_000546.6(TP53):c.152A>G (p.Glu51Gly);GRCh37,NC_000017.10:g.7579535T>C GRCh38,NC_000017.11:g.7676217T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
577458;NM_000546.6(TP53):c.1118A>G (p.Lys373Arg);GRCh37,NC_000017.10:g.7572991T>C GRCh38,NC_000017.11:g.7669673T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
577431;NM_000546.6(TP53):c.211C>G (p.Pro71Ala);GRCh37,NC_000017.10:g.7579476G>C GRCh38,NC_000017.11:g.7676158G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
577290;NM_000546.6(TP53):c.40C>G (p.Leu14Val);GRCh37,NC_000017.10:g.7579873G>C GRCh38,NC_000017.11:g.7676555G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
575773;NM_000546.6(TP53):c.205G>A (p.Ala69Thr);GRCh37,NC_000017.10:g.7579482C>T GRCh38,NC_000017.11:g.7676164C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
575702;NM_000546.6(TP53):c.534C>A (p.His178Gln);GRCh37,NC_000017.10:g.7578396G>T GRCh38,NC_000017.11:g.7675078G>T;TP53;Pathogenic/Likely pathogenic;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
574679;NM_000546.6(TP53):c.814G>C (p.Val272Leu);GRCh37,NC_000017.10:g.7577124C>G GRCh38,NC_000017.11:g.7673806C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
573679;NM_000546.6(TP53):c.662A>C (p.Glu221Ala);GRCh37,NC_000017.10:g.7578187T>G GRCh38,NC_000017.11:g.7674869T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
572378;NM_000546.6(TP53):c.211C>T (p.Pro71Ser);GRCh37,NC_000017.10:g.7579476G>A GRCh38,NC_000017.11:g.7676158G>A;TP53;Uncertain significance;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
569629;NM_000546.6(TP53):c.116C>T (p.Ala39Val);GRCh37,NC_000017.10:g.7579571G>A GRCh38,NC_000017.11:g.7676253G>A;TP53;Conflicting classifications of pathogenicity;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
569094;NM_000546.6(TP53):c.1129A>G (p.Thr377Ala);GRCh37,NC_000017.10:g.7572980T>C GRCh38,NC_000017.11:g.7669662T>C;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;2
568955;NM_000546.6(TP53):c.1091C>T (p.Ala364Val);GRCh37,NC_000017.10:g.7573936G>A GRCh38,NC_000017.11:g.7670618G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
568736;NM_000546.6(TP53):c.506T>G (p.Met169Arg);GRCh37,NC_000017.10:g.7578424A>C GRCh38,NC_000017.11:g.7675106A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
568069;NM_000546.6(TP53):c.442G>A (p.Asp148Asn);GRCh37,NC_000017.10:g.7578488C>T GRCh38,NC_000017.11:g.7675170C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
567972;NM_000546.6(TP53):c.110C>T (p.Ser37Phe);GRCh37,NC_000017.10:g.7579577G>A GRCh38,NC_000017.11:g.7676259G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
566954;NM_000546.6(TP53):c.296C>G (p.Ser99Cys);GRCh37,NC_000017.10:g.7579391G>C GRCh38,NC_000017.11:g.7676073G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
565884;NM_000546.6(TP53):c.815T>C (p.Val272Ala);GRCh38,NC_000017.11:g.7673805A>G GRCh37,NC_000017.10:g.7577123A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528273;NM_000546.6(TP53):c.947C>T (p.Pro316Leu);GRCh37,NC_000017.10:g.7576899G>A GRCh38,NC_000017.11:g.7673581G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528271;NM_000546.6(TP53):c.79C>T (p.Pro27Ser);GRCh37,NC_000017.10:g.7579717G>A GRCh38,NC_000017.11:g.7676399G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;2
528270;NM_000546.6(TP53):c.413C>A (p.Ala138Asp);GRCh37,NC_000017.10:g.7578517G>T GRCh38,NC_000017.11:g.7675199G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528269;NM_000546.6(TP53):c.766A>C (p.Thr256Pro);GRCh37,NC_000017.10:g.7577515T>G GRCh38,NC_000017.11:g.7674197T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528268;NM_000546.6(TP53):c.269C>T (p.Ser90Phe);GRCh37,NC_000017.10:g.7579418G>A GRCh38,NC_000017.11:g.7676100G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
528266;NM_000546.6(TP53):c.229C>T (p.Pro77Ser);GRCh37,NC_000017.10:g.7579458G>A GRCh38,NC_000017.11:g.7676140G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528264;NM_000546.6(TP53):c.200C>A (p.Pro67Gln);GRCh37,NC_000017.10:g.7579487G>T GRCh38,NC_000017.11:g.7676169G>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528262;NM_000546.6(TP53):c.565G>T (p.Ala189Ser);GRCh37,NC_000017.10:g.7578284C>A GRCh38,NC_000017.11:g.7674966C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
528260;NM_000546.6(TP53):c.206C>T (p.Ala69Val);GRCh37,NC_000017.10:g.7579481G>A GRCh38,NC_000017.11:g.7676163G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
528258;NM_000546.6(TP53):c.35C>T (p.Pro12Leu);GRCh37,NC_000017.10:g.7579878G>A GRCh38,NC_000017.11:g.7676560G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528255;NM_000546.6(TP53):c.439G>A (p.Val147Ile);GRCh37,NC_000017.10:g.7578491C>T GRCh38,NC_000017.11:g.7675173C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528254;NM_000546.6(TP53):c.752T>A (p.Ile251Asn);GRCh37,NC_000017.10:g.7577529A>T GRCh38,NC_000017.11:g.7674211A>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528252;NM_000546.6(TP53):c.1096T>C (p.Ser366Pro);GRCh37,NC_000017.10:g.7573931A>G GRCh38,NC_000017.11:g.7670613A>G;TP53;Uncertain significance;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
528251;NM_000546.6(TP53):c.787A>C (p.Asn263His);GRCh37,NC_000017.10:g.7577151T>G GRCh38,NC_000017.11:g.7673833T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528249;NM_000546.6(TP53):c.653T>G (p.Val218Gly);GRCh37,NC_000017.10:g.7578196A>C GRCh38,NC_000017.11:g.7674878A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528248;NM_000546.6(TP53):c.473G>T (p.Arg158Leu);GRCh37,NC_000017.10:g.7578457C>A GRCh38,NC_000017.11:g.7675139C>A;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
528246;NM_000546.6(TP53):c.397A>G (p.Met133Val);GRCh38,NC_000017.11:g.7675215T>C GRCh37,NC_000017.10:g.7578533T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528245;NM_000546.6(TP53):c.515T>C (p.Val172Ala);GRCh37,NC_000017.10:g.7578415A>G GRCh38,NC_000017.11:g.7675097A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528241;NM_000546.6(TP53):c.1064C>T (p.Ala355Val);GRCh37,NC_000017.10:g.7573963G>A GRCh38,NC_000017.11:g.7670645G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
528240;NM_000546.6(TP53):c.931A>C (p.Asn311His);GRCh37,NC_000017.10:g.7576915T>G GRCh38,NC_000017.11:g.7673597T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
528239;NM_000546.6(TP53):c.497C>T (p.Ser166Leu);GRCh37,NC_000017.10:g.7578433G>A GRCh38,NC_000017.11:g.7675115G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528238;NM_000546.6(TP53):c.25A>C (p.Ser9Arg);GRCh37,NC_000017.10:g.7579888T>G GRCh38,NC_000017.11:g.7676570T>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
528236;NM_000546.6(TP53):c.293C>T (p.Pro98Leu);GRCh37,NC_000017.10:g.7579394G>A GRCh38,NC_000017.11:g.7676076G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;2
528235;NM_000546.6(TP53):c.631A>C (p.Thr211Pro);GRCh37,NC_000017.10:g.7578218T>G GRCh38,NC_000017.11:g.7674900T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
505571;NM_000546.6(TP53):c.758C>A (p.Thr253Asn);GRCh37,NC_000017.10:g.7577523G>T GRCh38,NC_000017.11:g.7674205G>T;TP53;Uncertain significance;Li-Fraumeni syndrome,not specified;2
496049;NM_000546.6(TP53):c.865C>G (p.Leu289Val);GRCh37,NC_000017.10:g.7577073G>C GRCh38,NC_000017.11:g.7673755G>C;TP53;Uncertain significance;not provided;1
496047;NM_000546.6(TP53):c.27C>G (p.Ser9Arg);GRCh37,NC_000017.10:g.7579886G>C GRCh38,NC_000017.11:g.7676568G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,not provided;1
492752;NM_000546.6(TP53):c.318C>G (p.Ser106Arg);GRCh37,NC_000017.10:g.7579369G>C GRCh38,NC_000017.11:g.7676051G>C;TP53;Likely pathogenic;Li-Fraumeni syndrome,not specified;1
492627;NM_000546.6(TP53):c.953C>T (p.Pro318Leu);GRCh37,NC_000017.10:g.7576893G>A GRCh38,NC_000017.11:g.7673575G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
492575;NM_000546.6(TP53):c.334G>A (p.Gly112Ser);GRCh37,NC_000017.10:g.7579353C>T GRCh38,NC_000017.11:g.7676035C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
492574;NM_000546.6(TP53):c.1177G>A (p.Asp393Asn);GRCh37,NC_000017.10:g.7572932C>T GRCh38,NC_000017.11:g.7669614C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
492573;NM_000546.6(TP53):c.1127C>T (p.Ser376Phe);GRCh37,NC_000017.10:g.7572982G>A GRCh38,NC_000017.11:g.7669664G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
490174;NM_000546.6(TP53):c.509C>G (p.Thr170Arg);GRCh37,NC_000017.10:g.7578421G>C GRCh38,NC_000017.11:g.7675103G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;2
490173;NM_000546.6(TP53):c.500A>C (p.Gln167Pro);GRCh37,NC_000017.10:g.7578430T>G GRCh38,NC_000017.11:g.7675112T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
490172;NM_000546.6(TP53):c.4G>A (p.Glu2Lys);GRCh37,NC_000017.10:g.7579909C>T GRCh38,NC_000017.11:g.7676591C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
490170;NM_000546.6(TP53):c.202G>C (p.Glu68Gln);GRCh37,NC_000017.10:g.7579485C>G GRCh38,NC_000017.11:g.7676167C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
486559;NM_000546.6(TP53):c.446C>T (p.Ser149Phe);GRCh37,NC_000017.10:g.7578484G>A GRCh38,NC_000017.11:g.7675166G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
486556;NM_000546.6(TP53):c.428T>G (p.Val143Gly);GRCh37,NC_000017.10:g.7578502A>C GRCh38,NC_000017.11:g.7675184A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
486555;NM_000546.6(TP53):c.848G>C (p.Arg283Pro);GRCh37,NC_000017.10:g.7577090C>G GRCh38,NC_000017.11:g.7673772C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;1
485050;NM_000546.6(TP53):c.1160C>G (p.Thr387Arg);GRCh37,NC_000017.10:g.7572949G>C GRCh38,NC_000017.11:g.7669631G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
485049;NM_000546.6(TP53):c.21T>G (p.Asp7Glu);GRCh37,NC_000017.10:g.7579892A>C GRCh38,NC_000017.11:g.7676574A>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
485048;NM_000546.6(TP53):c.1085G>T (p.Ser362Ile);GRCh37,NC_000017.10:g.7573942C>A GRCh38,NC_000017.11:g.7670624C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
485047;NM_000546.6(TP53):c.789T>A (p.Asn263Lys);GRCh37,NC_000017.10:g.7577149A>T GRCh38,NC_000017.11:g.7673831A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
485046;NM_000546.6(TP53):c.753C>G (p.Ile251Met);GRCh37,NC_000017.10:g.7577528G>C GRCh38,NC_000017.11:g.7674210G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
485045;NM_000546.6(TP53):c.232G>A (p.Ala78Thr);GRCh37,NC_000017.10:g.7579455C>T GRCh38,NC_000017.11:g.7676137C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
485044;NM_000546.6(TP53):c.825T>G (p.Cys275Trp);GRCh37,NC_000017.10:g.7577113A>C GRCh38,NC_000017.11:g.7673795A>C;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Neoplasm of ovary;1
485040;NM_000546.6(TP53):c.121G>A (p.Asp41Asn);GRCh37,NC_000017.10:g.7579566C>T GRCh38,NC_000017.11:g.7676248C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
485039;NM_000546.6(TP53):c.712T>A (p.Cys238Ser);GRCh37,NC_000017.10:g.7577569A>T GRCh38,NC_000017.11:g.7674251A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
485038;NM_000546.6(TP53):c.1104C>G (p.His368Gln);GRCh37,NC_000017.10:g.7573005G>C GRCh38,NC_000017.11:g.7669687G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
485034;NM_000546.6(TP53):c.776A>T (p.Asp259Val);GRCh37,NC_000017.10:g.7577505T>A GRCh38,NC_000017.11:g.7674187T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
485032;NM_000546.6(TP53):c.443A>C (p.Asp148Ala);GRCh37,NC_000017.10:g.7578487T>G GRCh38,NC_000017.11:g.7675169T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
485030;NM_000546.6(TP53):c.533A>C (p.His178Pro);GRCh37,NC_000017.10:g.7578397T>G GRCh38,NC_000017.11:g.7675079T>G;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
485029;NM_000546.6(TP53):c.1153T>C (p.Phe385Leu);GRCh37,NC_000017.10:g.7572956A>G GRCh38,NC_000017.11:g.7669638A>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
485028;NM_000546.6(TP53):c.38C>G (p.Pro13Arg);GRCh37,NC_000017.10:g.7579875G>C GRCh38,NC_000017.11:g.7676557G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
485027;NM_000546.6(TP53):c.920C>G (p.Ala307Gly);GRCh37,NC_000017.10:g.7576926G>C GRCh38,NC_000017.11:g.7673608G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
485023;NM_000546.6(TP53):c.214C>T (p.Pro72Ser);GRCh37,NC_000017.10:g.7579473G>A GRCh38,NC_000017.11:g.7676155G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
482235;NM_000546.6(TP53):c.607G>C (p.Val203Leu);GRCh37,NC_000017.10:g.7578242C>G GRCh38,NC_000017.11:g.7674924C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
482232;NM_000546.6(TP53):c.493C>A (p.Gln165Lys);GRCh37,NC_000017.10:g.7578437G>T GRCh38,NC_000017.11:g.7675119G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
482231;NM_000546.6(TP53):c.470T>A (p.Val157Asp);GRCh37,NC_000017.10:g.7578460A>T GRCh38,NC_000017.11:g.7675142A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
482230;NM_000546.6(TP53):c.454C>T (p.Pro152Ser);GRCh37,NC_000017.10:g.7578476G>A GRCh38,NC_000017.11:g.7675158G>A;TP53;Conflicting classifications of pathogenicity;Glioma susceptibility 1,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
482229;NM_000546.6(TP53):c.460G>C (p.Gly154Arg);GRCh37,NC_000017.10:g.7578470C>G GRCh38,NC_000017.11:g.7675152C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
482226;NM_000546.6(TP53):c.1014C>G (p.Phe338Leu);GRCh37,NC_000017.10:g.7574013G>C GRCh38,NC_000017.11:g.7670695G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
482223;NM_000546.6(TP53):c.532C>G (p.His178Asp);GRCh37,NC_000017.10:g.7578398G>C GRCh38,NC_000017.11:g.7675080G>C;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
482220;NM_000546.6(TP53):c.529C>A (p.Pro177Thr);GRCh37,NC_000017.10:g.7578401G>T GRCh38,NC_000017.11:g.7675083G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
482218;NM_000546.6(TP53):c.607G>T (p.Val203Leu);GRCh37,NC_000017.10:g.7578242C>A GRCh38,NC_000017.11:g.7674924C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
482217;NM_000546.6(TP53):c.385G>A (p.Ala129Thr);GRCh37,NC_000017.10:g.7578545C>T GRCh38,NC_000017.11:g.7675227C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
482216;NM_000546.6(TP53):c.244C>G (p.Pro82Ala);GRCh37,NC_000017.10:g.7579443G>C GRCh38,NC_000017.11:g.7676125G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
482214;NM_000546.6(TP53):c.694A>C (p.Ile232Leu);GRCh37,NC_000017.10:g.7577587T>G GRCh38,NC_000017.11:g.7674269T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
482213;NM_000546.6(TP53):c.408A>T (p.Gln136His);GRCh37,NC_000017.10:g.7578522T>A GRCh38,NC_000017.11:g.7675204T>A;TP53;Uncertain significance;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome;2
482211;NM_000546.6(TP53):c.98C>A (p.Ser33Tyr);GRCh37,NC_000017.10:g.7579589G>T GRCh38,NC_000017.11:g.7676271G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
481176;NM_000546.6(TP53):c.80C>T (p.Pro27Leu);GRCh37,NC_000017.10:g.7579716G>A GRCh38,NC_000017.11:g.7676398G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
481148;NM_000546.6(TP53):c.1054G>T (p.Asp352Tyr);GRCh37,NC_000017.10:g.7573973C>A GRCh38,NC_000017.11:g.7670655C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
481098;NM_000546.6(TP53):c.160T>C (p.Phe54Leu);GRCh37,NC_000017.10:g.7579527A>G GRCh38,NC_000017.11:g.7676209A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
481073;NM_000546.6(TP53):c.355G>C (p.Ala119Pro);GRCh37,NC_000017.10:g.7579332C>G GRCh38,NC_000017.11:g.7676014C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
481069;NM_000546.6(TP53):c.710T>C (p.Met237Thr);GRCh37,NC_000017.10:g.7577571A>G GRCh38,NC_000017.11:g.7674253A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
481049;NM_000546.6(TP53):c.902C>T (p.Pro301Leu);GRCh37,NC_000017.10:g.7577036G>A GRCh38,NC_000017.11:g.7673718G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
481022;NM_000546.6(TP53):c.1048C>T (p.Leu350Phe);GRCh37,NC_000017.10:g.7573979G>A GRCh38,NC_000017.11:g.7670661G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
480961;NM_000546.6(TP53):c.738G>A (p.Met246Ile);GRCh37,NC_000017.10:g.7577543C>T GRCh38,NC_000017.11:g.7674225C>T;TP53;Pathogenic/Likely pathogenic;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
480953;NM_000546.6(TP53):c.400T>A (p.Phe134Ile);GRCh37,NC_000017.10:g.7578530A>T GRCh38,NC_000017.11:g.7675212A>T;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
480952;NM_000546.6(TP53):c.974G>A (p.Gly325Glu);GRCh37,NC_000017.10:g.7576872C>T GRCh38,NC_000017.11:g.7673554C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
480951;NM_000546.6(TP53):c.871A>G (p.Lys291Glu);GRCh37,NC_000017.10:g.7577067T>C GRCh38,NC_000017.11:g.7673749T>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480767;NM_000546.6(TP53):c.670G>A (p.Glu224Lys);GRCh37,NC_000017.10:g.7578179C>T GRCh38,NC_000017.11:g.7674861C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480766;NM_000546.6(TP53):c.589G>C (p.Val197Leu);GRCh37,NC_000017.10:g.7578260C>G GRCh38,NC_000017.11:g.7674942C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
480764;NM_000546.6(TP53):c.737T>A (p.Met246Lys);GRCh37,NC_000017.10:g.7577544A>T GRCh38,NC_000017.11:g.7674226A>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480761;NM_000546.6(TP53):c.1081G>C (p.Gly361Arg);GRCh37,NC_000017.10:g.7573946C>G GRCh38,NC_000017.11:g.7670628C>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480760;NM_000546.6(TP53):c.434T>A (p.Leu145Gln);GRCh37,NC_000017.10:g.7578496A>T GRCh38,NC_000017.11:g.7675178A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;1
480759;NM_000546.6(TP53):c.791T>C (p.Leu264Pro);GRCh37,NC_000017.10:g.7577147A>G GRCh38,NC_000017.11:g.7673829A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480758;NM_000546.6(TP53):c.349G>A (p.Gly117Arg);GRCh37,NC_000017.10:g.7579338C>T GRCh38,NC_000017.11:g.7676020C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;2
480755;NM_000546.6(TP53):c.1038G>C (p.Glu346Asp);GRCh37,NC_000017.10:g.7573989C>G GRCh38,NC_000017.11:g.7670671C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
480753;NM_000546.6(TP53):c.1078G>T (p.Gly360Trp);GRCh37,NC_000017.10:g.7573949C>A GRCh38,NC_000017.11:g.7670631C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
480751;NM_000546.6(TP53):c.406C>G (p.Gln136Glu);GRCh37,NC_000017.10:g.7578524G>C GRCh38,NC_000017.11:g.7675206G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480749;NM_000546.6(TP53):c.1133C>G (p.Ser378Cys);GRCh37,NC_000017.10:g.7572976G>C GRCh38,NC_000017.11:g.7669658G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480745;NM_000546.6(TP53):c.198G>A (p.Met66Ile);GRCh37,NC_000017.10:g.7579489C>T GRCh38,NC_000017.11:g.7676171C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480743;NM_000546.6(TP53):c.382C>A (p.Pro128Thr);GRCh37,NC_000017.10:g.7578548G>T GRCh38,NC_000017.11:g.7675230G>T;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480741;NM_000546.6(TP53):c.343C>A (p.His115Asn);GRCh37,NC_000017.10:g.7579344G>T GRCh38,NC_000017.11:g.7676026G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480740;NM_000546.6(TP53):c.973G>A (p.Gly325Arg);GRCh37,NC_000017.10:g.7576873C>T GRCh38,NC_000017.11:g.7673555C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,not specified;1
480738;NM_000546.6(TP53):c.1004G>A (p.Arg335His);GRCh37,NC_000017.10:g.7574023C>T GRCh38,NC_000017.11:g.7670705C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
480737;NM_000546.6(TP53):c.368C>T (p.Thr123Ile);GRCh37,NC_000017.10:g.7579319G>A GRCh38,NC_000017.11:g.7676001G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
480736;NM_000546.6(TP53):c.673G>A (p.Val225Ile);GRCh37,NC_000017.10:g.7577608C>T GRCh38,NC_000017.11:g.7674290C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480735;NM_000546.6(TP53):c.548C>T (p.Ser183Leu);GRCh37,NC_000017.10:g.7578382G>A GRCh38,NC_000017.11:g.7675064G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480734;NM_000546.6(TP53):c.263C>T (p.Ala88Val);GRCh37,NC_000017.10:g.7579424G>A GRCh38,NC_000017.11:g.7676106G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
480733;NM_000546.6(TP53):c.275C>T (p.Pro92Leu);GRCh37,NC_000017.10:g.7579412G>A GRCh38,NC_000017.11:g.7676094G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458583;NM_000546.6(TP53):c.996C>G (p.Ile332Met);GRCh37,NC_000017.10:g.7574031G>C GRCh38,NC_000017.11:g.7670713G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458575;NM_000546.6(TP53):c.925C>T (p.Pro309Ser);GRCh37,NC_000017.10:g.7576921G>A GRCh38,NC_000017.11:g.7673603G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458574;NM_000546.6(TP53):c.917G>A (p.Arg306Gln);GRCh37,NC_000017.10:g.7577021C>T GRCh38,NC_000017.11:g.7673703C>T;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Squamous cell carcinoma of the head and neck,not provided,not specified;1
458572;NM_000546.6(TP53):c.869G>C (p.Arg290Pro);GRCh37,NC_000017.10:g.7577069C>G GRCh38,NC_000017.11:g.7673751C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458571;NM_000546.6(TP53):c.850A>T (p.Thr284Ser);GRCh38,NC_000017.11:g.7673770T>A GRCh37,NC_000017.10:g.7577088T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
458568;NM_000546.6(TP53):c.835G>A (p.Gly279Arg);GRCh37,NC_000017.10:g.7577103C>T GRCh38,NC_000017.11:g.7673785C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458567;NM_000546.6(TP53):c.830G>T (p.Cys277Phe);GRCh37,NC_000017.10:g.7577108C>A GRCh38,NC_000017.11:g.7673790C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder;1
458566;NM_000546.6(TP53):c.796G>A (p.Gly266Arg);GRCh37,NC_000017.10:g.7577142C>T GRCh38,NC_000017.11:g.7673824C>T;TP53;Pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;2
458563;NM_000546.6(TP53):c.773A>C (p.Glu258Ala);GRCh37,NC_000017.10:g.7577508T>G GRCh38,NC_000017.11:g.7674190T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;2
458562;NM_000546.6(TP53):c.770T>C (p.Leu257Pro);GRCh37,NC_000017.10:g.7577511A>G GRCh38,NC_000017.11:g.7674193A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458560;NM_000546.6(TP53):c.731G>C (p.Gly244Ala);GRCh37,NC_000017.10:g.7577550C>G GRCh38,NC_000017.11:g.7674232C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma;2
458559;NM_000546.6(TP53):c.720T>G (p.Ser240Arg);GRCh37,NC_000017.10:g.7577561A>C GRCh38,NC_000017.11:g.7674243A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458557;NM_000546.6(TP53):c.692C>T (p.Thr231Ile);GRCh37,NC_000017.10:g.7577589G>A GRCh38,NC_000017.11:g.7674271G>A;TP53;Uncertain significance;Li-Fraumeni syndrome;2
458556;NM_000546.6(TP53):c.677G>T (p.Gly226Val);GRCh37,NC_000017.10:g.7577604C>A GRCh38,NC_000017.11:g.7674286C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
458547;NM_000546.6(TP53):c.530C>G (p.Pro177Arg);GRCh37,NC_000017.10:g.7578400G>C GRCh38,NC_000017.11:g.7675082G>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
458545;NM_000546.6(TP53):c.476C>T (p.Ala159Val);GRCh37,NC_000017.10:g.7578454G>A GRCh38,NC_000017.11:g.7675136G>A;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
458544;NM_000546.6(TP53):c.463A>G (p.Thr155Ala);GRCh37,NC_000017.10:g.7578467T>C GRCh38,NC_000017.11:g.7675149T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
458543;NM_000546.6(TP53):c.388C>G (p.Leu130Val);GRCh37,NC_000017.10:g.7578542G>C GRCh38,NC_000017.11:g.7675224G>C;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
458542;NM_000546.6(TP53):c.386C>G (p.Ala129Gly);GRCh37,NC_000017.10:g.7578544G>C GRCh38,NC_000017.11:g.7675226G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458541;NM_000546.6(TP53):c.377A>G (p.Tyr126Cys);GRCh37,NC_000017.10:g.7578553T>C GRCh38,NC_000017.11:g.7675235T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;1
458536;NM_000546.6(TP53):c.341T>C (p.Leu114Ser);GRCh37,NC_000017.10:g.7579346A>G GRCh38,NC_000017.11:g.7676028A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;1
458535;NM_000546.6(TP53):c.322G>C (p.Gly108Arg);GRCh37,NC_000017.10:g.7579365C>G GRCh38,NC_000017.11:g.7676047C>G;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
458532;NM_000546.6(TP53):c.289G>T (p.Val97Phe);GRCh37,NC_000017.10:g.7579398C>A GRCh38,NC_000017.11:g.7676080C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458531;NM_000546.6(TP53):c.26G>A (p.Ser9Asn);GRCh38,NC_000017.11:g.7676569C>T GRCh37,NC_000017.10:g.7579887C>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458530;NM_000546.6(TP53):c.245C>G (p.Pro82Arg);GRCh37,NC_000017.10:g.7579442G>C GRCh38,NC_000017.11:g.7676124G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458528;NM_000546.6(TP53):c.229C>A (p.Pro77Thr);GRCh37,NC_000017.10:g.7579458G>T GRCh38,NC_000017.11:g.7676140G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
458522;NM_000546.6(TP53):c.1165G>A (p.Gly389Arg);GRCh37,NC_000017.10:g.7572944C>T GRCh38,NC_000017.11:g.7669626C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
458521;NM_000546.6(TP53):c.1151T>G (p.Met384Arg);GRCh37,NC_000017.10:g.7572958A>C GRCh38,NC_000017.11:g.7669640A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458516;NM_000546.6(TP53):c.1085G>A (p.Ser362Asn);GRCh37,NC_000017.10:g.7573942C>T GRCh38,NC_000017.11:g.7670624C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
458515;NM_000546.6(TP53):c.1084A>T (p.Ser362Cys);GRCh38,NC_000017.11:g.7670625T>A GRCh37,NC_000017.10:g.7573943T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
458513;NM_000546.6(TP53):c.1052A>G (p.Lys351Arg);GRCh37,NC_000017.10:g.7573975T>C GRCh38,NC_000017.11:g.7670657T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
451799;NM_000546.6(TP53):c.596G>T (p.Gly199Val);GRCh37,NC_000017.10:g.7578253C>A GRCh38,NC_000017.11:g.7674935C>A;TP53;Likely pathogenic;not provided;1
449512;NM_000546.6(TP53):c.724T>C (p.Cys242Arg);GRCh37,NC_000017.10:g.7577557A>G GRCh38,NC_000017.11:g.7674239A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
444396;NM_000546.6(TP53):c.478A>G (p.Met160Val);GRCh37,NC_000017.10:g.7578452T>C GRCh38,NC_000017.11:g.7675134T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
439320;NM_000546.6(TP53):c.752T>C (p.Ile251Thr);GRCh37,NC_000017.10:g.7577529A>G GRCh38,NC_000017.11:g.7674211A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;1
439319;NM_000546.6(TP53):c.617T>C (p.Leu206Ser);GRCh37,NC_000017.10:g.7578232A>G GRCh38,NC_000017.11:g.7674914A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not specified;1
439315;NM_000546.6(TP53):c.1115A>C (p.Lys372Thr);GRCh37,NC_000017.10:g.7572994T>G GRCh38,NC_000017.11:g.7669676T>G;TP53;Uncertain significance;not specified;1
428909;NM_000546.6(TP53):c.514G>T (p.Val172Phe);GRCh37,NC_000017.10:g.7578416C>A GRCh38,NC_000017.11:g.7675098C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
428902;NM_000546.6(TP53):c.392A>T (p.Asn131Ile);GRCh37,NC_000017.10:g.7578538T>A GRCh38,NC_000017.11:g.7675220T>A;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428899;NM_000546.6(TP53):c.492G>C (p.Lys164Asn);GRCh37,NC_000017.10:g.7578438C>G GRCh38,NC_000017.11:g.7675120C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
428895;NM_000546.6(TP53):c.643A>C (p.Ser215Arg);GRCh37,NC_000017.10:g.7578206T>G GRCh38,NC_000017.11:g.7674888T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
428893;NM_000546.6(TP53):c.826G>C (p.Ala276Pro);GRCh37,NC_000017.10:g.7577112C>G GRCh38,NC_000017.11:g.7673794C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary;1
428892;NM_000546.6(TP53):c.671A>C (p.Glu224Ala);GRCh37,NC_000017.10:g.7578178T>G GRCh38,NC_000017.11:g.7674860T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428889;NM_000546.6(TP53):c.785G>T (p.Gly262Val);GRCh37,NC_000017.10:g.7577153C>A GRCh38,NC_000017.11:g.7673835C>A;TP53;Uncertain significance;Atypical endometrial hyperplasia,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428887;NM_000546.6(TP53):c.470T>C (p.Val157Ala);GRCh37,NC_000017.10:g.7578460A>G GRCh38,NC_000017.11:g.7675142A>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
428886;NM_000546.6(TP53):c.737T>C (p.Met246Thr);GRCh37,NC_000017.10:g.7577544A>G GRCh38,NC_000017.11:g.7674226A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;1
428884;NM_000546.6(TP53):c.313G>A (p.Gly105Ser);GRCh37,NC_000017.10:g.7579374C>T GRCh38,NC_000017.11:g.7676056C>T;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428883;NM_000546.6(TP53):c.515T>G (p.Val172Gly);GRCh37,NC_000017.10:g.7578415A>C GRCh38,NC_000017.11:g.7675097A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
428879;NM_000546.6(TP53):c.930C>G (p.Asn310Lys);GRCh37,NC_000017.10:g.7576916G>C GRCh38,NC_000017.11:g.7673598G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
428876;NM_000546.6(TP53):c.1000G>T (p.Gly334Trp);GRCh37,NC_000017.10:g.7574027C>A GRCh38,NC_000017.11:g.7670709C>A;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
428873;NM_000546.6(TP53):c.389T>C (p.Leu130Pro);GRCh37,NC_000017.10:g.7578541A>G GRCh38,NC_000017.11:g.7675223A>G;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome;2
428871;NM_000546.6(TP53):c.376T>A (p.Tyr126Asn);GRCh37,NC_000017.10:g.7578554A>T GRCh38,NC_000017.11:g.7675236A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428867;NM_000546.6(TP53):c.800G>C (p.Arg267Pro);GRCh37,NC_000017.10:g.7577138C>G GRCh38,NC_000017.11:g.7673820C>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
428866;NM_000546.6(TP53):c.503A>G (p.His168Arg);GRCh37,NC_000017.10:g.7578427T>C GRCh38,NC_000017.11:g.7675109T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
428863;NM_000546.6(TP53):c.442G>T (p.Asp148Tyr);GRCh37,NC_000017.10:g.7578488C>A GRCh38,NC_000017.11:g.7675170C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
428862;NM_000546.6(TP53):c.883C>T (p.Pro295Ser);GRCh37,NC_000017.10:g.7577055G>A GRCh38,NC_000017.11:g.7673737G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;3
423970;NM_000546.6(TP53):c.326T>C (p.Phe109Ser);GRCh37,NC_000017.10:g.7579361A>G GRCh38,NC_000017.11:g.7676043A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;2
423887;NM_000546.6(TP53):c.521G>A (p.Arg174Lys);GRCh37,NC_000017.10:g.7578409C>T GRCh38,NC_000017.11:g.7675091C>T;TP53;Likely benign;not provided;1
423398;NM_000546.6(TP53):c.1013T>C (p.Phe338Ser);GRCh37,NC_000017.10:g.7574014A>G GRCh38,NC_000017.11:g.7670696A>G;TP53;Uncertain significance;Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
423255;NM_000546.6(TP53):c.358A>C (p.Lys120Gln);GRCh37,NC_000017.10:g.7579329T>G GRCh38,NC_000017.11:g.7676011T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided;2
423137;NM_000546.6(TP53):c.546C>G (p.Cys182Trp);GRCh37,NC_000017.10:g.7578384G>C GRCh38,NC_000017.11:g.7675066G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided;2
422725;NM_000546.6(TP53):c.1040C>T (p.Ala347Val);GRCh37,NC_000017.10:g.7573987G>A GRCh38,NC_000017.11:g.7670669G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,not provided;2
422563;NM_000546.6(TP53):c.457C>T (p.Pro153Ser);GRCh37,NC_000017.10:g.7578473G>A GRCh38,NC_000017.11:g.7675155G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
422532;NM_000546.6(TP53):c.560G>A (p.Gly187Asp);GRCh37,NC_000017.10:g.7578289C>T GRCh38,NC_000017.11:g.7674971C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
422414;NM_000546.6(TP53):c.634T>A (p.Phe212Ile);GRCh37,NC_000017.10:g.7578215A>T GRCh38,NC_000017.11:g.7674897A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
422295;NM_000546.6(TP53):c.482C>A (p.Ala161Asp);GRCh37,NC_000017.10:g.7578448G>T GRCh38,NC_000017.11:g.7675130G>T;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
422130;NM_000546.6(TP53):c.861G>C (p.Glu287Asp);GRCh37,NC_000017.10:g.7577077C>G GRCh38,NC_000017.11:g.7673759C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
421804;NM_000546.6(TP53):c.829T>C (p.Cys277Arg);GRCh37,NC_000017.10:g.7577109A>G GRCh38,NC_000017.11:g.7673791A>G;TP53;Conflicting classifications of pathogenicity;Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
421546;NM_000546.6(TP53):c.532C>A (p.His178Asn);GRCh37,NC_000017.10:g.7578398G>T GRCh38,NC_000017.11:g.7675080G>T;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;2
421437;NM_000546.6(TP53):c.399G>A (p.Met133Ile);GRCh37,NC_000017.10:g.7578531C>T GRCh38,NC_000017.11:g.7675213C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
421319;NM_000546.6(TP53):c.992A>G (p.Gln331Arg);GRCh37,NC_000017.10:g.7576854T>C GRCh38,NC_000017.11:g.7673536T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
420974;NM_000546.6(TP53):c.884C>T (p.Pro295Leu);GRCh37,NC_000017.10:g.7577054G>A GRCh38,NC_000017.11:g.7673736G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
420950;NM_000546.6(TP53):c.970G>C (p.Asp324His);GRCh37,NC_000017.10:g.7576876C>G GRCh38,NC_000017.11:g.7673558C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
420137;NM_000546.6(TP53):c.685T>C (p.Cys229Arg);GRCh37,NC_000017.10:g.7577596A>G GRCh38,NC_000017.11:g.7674278A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
420136;NM_000546.6(TP53):c.749C>T (p.Pro250Leu);GRCh37,NC_000017.10:g.7577532G>A GRCh38,NC_000017.11:g.7674214G>A;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;2
420133;NM_000546.6(TP53):c.853G>A (p.Glu285Lys);GRCh37,NC_000017.10:g.7577085C>T GRCh38,NC_000017.11:g.7673767C>T;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Poly (ADP-Ribose) polymerase inhibitor response,not provided;2
419837;NM_000546.6(TP53):c.353C>T (p.Thr118Ile);GRCh37,NC_000017.10:g.7579334G>A GRCh38,NC_000017.11:g.7676016G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
419524;NM_000546.6(TP53):c.710T>G (p.Met237Arg);GRCh37,NC_000017.10:g.7577571A>C GRCh38,NC_000017.11:g.7674253A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;2
419454;NM_000546.6(TP53):c.836G>A (p.Gly279Glu);GRCh37,NC_000017.10:g.7577102C>T GRCh38,NC_000017.11:g.7673784C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,Squamous cell carcinoma of the head and neck,not provided,not specified;1
419040;NM_000546.6(TP53):c.686G>A (p.Cys229Tyr);GRCh37,NC_000017.10:g.7577595C>T GRCh38,NC_000017.11:g.7674277C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
418693;NM_000546.6(TP53):c.31G>A (p.Glu11Lys);GRCh37,NC_000017.10:g.7579882C>T GRCh38,NC_000017.11:g.7676564C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
418517;NM_000546.6(TP53):c.569C>T (p.Pro190Leu);GRCh37,NC_000017.10:g.7578280G>A GRCh38,NC_000017.11:g.7674962G>A;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
406609;NM_000546.6(TP53):c.103T>A (p.Leu35Met);GRCh37,NC_000017.10:g.7579584A>T GRCh38,NC_000017.11:g.7676266A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406608;NM_000546.6(TP53):c.139C>A (p.Pro47Thr);GRCh37,NC_000017.10:g.7579548G>T GRCh38,NC_000017.11:g.7676230G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406607;NM_000546.6(TP53):c.194G>C (p.Arg65Thr);GRCh37,NC_000017.10:g.7579493C>G GRCh38,NC_000017.11:g.7676175C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406606;NM_000546.6(TP53):c.551A>G (p.Asp184Gly);GRCh37,NC_000017.10:g.7578379T>C GRCh38,NC_000017.11:g.7675061T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406605;NM_000546.6(TP53):c.760A>G (p.Ile254Val);GRCh37,NC_000017.10:g.7577521T>C GRCh38,NC_000017.11:g.7674203T>C;TP53;Likely benign;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
406604;NM_000546.6(TP53):c.37C>T (p.Pro13Ser);GRCh37,NC_000017.10:g.7579876G>A GRCh38,NC_000017.11:g.7676558G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
406601;NM_000546.6(TP53):c.556G>A (p.Asp186Asn);GRCh38,NC_000017.11:g.7675056C>T GRCh37,NC_000017.10:g.7578374C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
406600;NM_000546.6(TP53):c.79C>A (p.Pro27Thr);GRCh37,NC_000017.10:g.7579717G>T GRCh38,NC_000017.11:g.7676399G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
406598;NM_000546.6(TP53):c.747G>C (p.Arg249Ser);GRCh37,NC_000017.10:g.7577534C>G GRCh38,NC_000017.11:g.7674216C>G;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406597;NM_000546.6(TP53):c.329G>T (p.Arg110Leu);GRCh37,NC_000017.10:g.7579358C>A GRCh38,NC_000017.11:g.7676040C>A;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;2
406596;NM_000546.6(TP53):c.646G>C (p.Val216Leu);GRCh37,NC_000017.10:g.7578203C>G GRCh38,NC_000017.11:g.7674885C>G;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Squamous cell carcinoma of the head and neck;1
406595;NM_000546.6(TP53):c.740A>G (p.Asn247Ser);GRCh37,NC_000017.10:g.7577541T>C GRCh38,NC_000017.11:g.7674223T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
406593;NM_000546.6(TP53):c.238C>T (p.Pro80Ser);GRCh37,NC_000017.10:g.7579449G>A GRCh38,NC_000017.11:g.7676131G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
406592;NM_000546.6(TP53):c.664C>T (p.Pro222Ser);GRCh37,NC_000017.10:g.7578185G>A GRCh38,NC_000017.11:g.7674867G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
406591;NM_000546.6(TP53):c.905G>A (p.Gly302Glu);GRCh37,NC_000017.10:g.7577033C>T GRCh38,NC_000017.11:g.7673715C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406590;NM_000546.6(TP53):c.773A>G (p.Glu258Gly);GRCh37,NC_000017.10:g.7577508T>C GRCh38,NC_000017.11:g.7674190T>C;TP53;Conflicting classifications of pathogenicity;Bone osteosarcoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406589;NM_000546.6(TP53):c.932A>G (p.Asn311Ser);GRCh37,NC_000017.10:g.7576914T>C GRCh38,NC_000017.11:g.7673596T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406588;NM_000546.6(TP53):c.628A>T (p.Asn210Tyr);GRCh37,NC_000017.10:g.7578221T>A GRCh38,NC_000017.11:g.7674903T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406587;NM_000546.6(TP53):c.941C>T (p.Ser314Phe);GRCh37,NC_000017.10:g.7576905G>A GRCh38,NC_000017.11:g.7673587G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406586;NM_000546.6(TP53):c.736A>T (p.Met246Leu);GRCh37,NC_000017.10:g.7577545T>A GRCh38,NC_000017.11:g.7674227T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406585;NM_000546.6(TP53):c.951G>T (p.Gln317His);GRCh37,NC_000017.10:g.7576895C>A GRCh38,NC_000017.11:g.7673577C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
406583;NM_000546.6(TP53):c.530C>T (p.Pro177Leu);GRCh37,NC_000017.10:g.7578400G>A GRCh38,NC_000017.11:g.7675082G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
406582;NM_000546.6(TP53):c.11C>G (p.Pro4Arg);GRCh37,NC_000017.10:g.7579902G>C GRCh38,NC_000017.11:g.7676584G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406581;NM_000546.6(TP53):c.631A>G (p.Thr211Ala);GRCh37,NC_000017.10:g.7578218T>C GRCh38,NC_000017.11:g.7674900T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
406578;NM_000546.6(TP53):c.537T>A (p.His179Gln);GRCh37,NC_000017.10:g.7578393A>T GRCh38,NC_000017.11:g.7675075A>T;TP53;Pathogenic;Acute myeloid leukemia,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary;3
406577;NM_000546.6(TP53):c.875A>G (p.Lys292Arg);GRCh38,NC_000017.11:g.7673745T>C GRCh37,NC_000017.10:g.7577063T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
406575;NM_000546.6(TP53):c.1151T>C (p.Met384Thr);GRCh37,NC_000017.10:g.7572958A>G GRCh38,NC_000017.11:g.7669640A>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
406574;NM_000546.6(TP53):c.313G>C (p.Gly105Arg);GRCh38,NC_000017.11:g.7676056C>G GRCh37,NC_000017.10:g.7579374C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
406572;NM_000546.6(TP53):c.319T>A (p.Tyr107Asn);GRCh37,NC_000017.10:g.7579368A>T GRCh38,NC_000017.11:g.7676050A>T;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406571;NM_000546.6(TP53):c.1042T>G (p.Leu348Val);GRCh37,NC_000017.10:g.7573985A>C GRCh38,NC_000017.11:g.7670667A>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
406568;NM_000546.6(TP53):c.843C>A (p.Asp281Glu);GRCh37,NC_000017.10:g.7577095G>T GRCh38,NC_000017.11:g.7673777G>T;TP53;Likely pathogenic;Carcinoma of colon,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary,not provided;2
406567;NM_000546.6(TP53):c.727A>G (p.Met243Val);GRCh37,NC_000017.10:g.7577554T>C GRCh38,NC_000017.11:g.7674236T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
406566;NM_000546.6(TP53):c.811G>A (p.Glu271Lys);GRCh37,NC_000017.10:g.7577127C>T GRCh38,NC_000017.11:g.7673809C>T;TP53;Conflicting classifications of pathogenicity;Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
406565;NM_000546.6(TP53):c.132G>A (p.Met44Ile);GRCh37,NC_000017.10:g.7579555C>T GRCh38,NC_000017.11:g.7676237C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
406564;NM_000546.6(TP53):c.464C>A (p.Thr155Asn);GRCh37,NC_000017.10:g.7578466G>T GRCh38,NC_000017.11:g.7675148G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;1
389644;NM_000546.6(TP53):c.325T>G (p.Phe109Val);GRCh37,NC_000017.10:g.7579362A>C GRCh38,NC_000017.11:g.7676044A>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,not provided;2
385614;NM_000546.6(TP53):c.717C>G (p.Asn239Lys);GRCh37,NC_000017.10:g.7577564G>C GRCh38,NC_000017.11:g.7674246G>C;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
376694;NM_000546.6(TP53):c.706T>A (p.Tyr236Asn);GRCh37,NC_000017.10:g.7577575A>T GRCh38,NC_000017.11:g.7674257A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;1
376693;NM_000546.6(TP53):c.707A>G (p.Tyr236Cys);GRCh37,NC_000017.10:g.7577574T>C GRCh38,NC_000017.11:g.7674256T>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;1
376692;NM_000546.6(TP53):c.700T>A (p.Tyr234Asn);GRCh37,NC_000017.10:g.7577581A>T GRCh38,NC_000017.11:g.7674263A>T;TP53;Pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376691;NM_000546.6(TP53):c.700T>C (p.Tyr234His);GRCh37,NC_000017.10:g.7577581A>G GRCh38,NC_000017.11:g.7674263A>G;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376690;NM_000546.6(TP53):c.701A>C (p.Tyr234Ser);GRCh37,NC_000017.10:g.7577580T>G GRCh38,NC_000017.11:g.7674262T>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376689;NM_000546.6(TP53):c.658T>G (p.Tyr220Asp);GRCh37,NC_000017.10:g.7578191A>C GRCh38,NC_000017.11:g.7674873A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376688;NM_000546.6(TP53):c.658T>A (p.Tyr220Asn);GRCh37,NC_000017.10:g.7578191A>T GRCh38,NC_000017.11:g.7674873A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;1
376687;NM_000546.6(TP53):c.658T>C (p.Tyr220His);GRCh37,NC_000017.10:g.7578191A>G GRCh38,NC_000017.11:g.7674873A>G;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376686;NM_000546.6(TP53):c.613T>G (p.Tyr205Asp);GRCh37,NC_000017.10:g.7578236A>C GRCh38,NC_000017.11:g.7674918A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376685;NM_000546.6(TP53):c.613T>C (p.Tyr205His);GRCh37,NC_000017.10:g.7578236A>G GRCh38,NC_000017.11:g.7674918A>G;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;2
376684;NM_000546.6(TP53):c.613T>A (p.Tyr205Asn);GRCh37,NC_000017.10:g.7578236A>T GRCh38,NC_000017.11:g.7674918A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376683;NM_000546.6(TP53):c.614A>C (p.Tyr205Ser);GRCh37,NC_000017.10:g.7578235T>G GRCh38,NC_000017.11:g.7674917T>G;TP53;Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;0
376682;NM_000546.6(TP53):c.614A>T (p.Tyr205Phe);GRCh37,NC_000017.10:g.7578235T>A GRCh38,NC_000017.11:g.7674917T>A;TP53;Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;0
376681;NM_000546.6(TP53):c.614A>G (p.Tyr205Cys);GRCh37,NC_000017.10:g.7578235T>C GRCh38,NC_000017.11:g.7674917T>C;TP53;Pathogenic;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;2
376680;NM_000546.6(TP53):c.487T>C (p.Tyr163His);GRCh37,NC_000017.10:g.7578443A>G GRCh38,NC_000017.11:g.7675125A>G;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376679;NM_000546.6(TP53):c.487T>A (p.Tyr163Asn);GRCh37,NC_000017.10:g.7578443A>T GRCh38,NC_000017.11:g.7675125A>T;TP53;Conflicting classifications of pathogenicity;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376678;NM_000546.6(TP53):c.820G>C (p.Val274Leu);GRCh37,NC_000017.10:g.7577118C>G GRCh38,NC_000017.11:g.7673800C>G;TP53;Uncertain significance;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma;1
376677;NM_000546.6(TP53):c.821T>C (p.Val274Ala);GRCh37,NC_000017.10:g.7577117A>G GRCh38,NC_000017.11:g.7673799A>G;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma;1
376676;NM_000546.6(TP53):c.821T>G (p.Val274Gly);GRCh37,NC_000017.10:g.7577117A>C GRCh38,NC_000017.11:g.7673799A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma;1
376675;NM_000546.6(TP53):c.821T>A (p.Val274Asp);GRCh37,NC_000017.10:g.7577117A>T GRCh38,NC_000017.11:g.7673799A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma;1
376674;NM_000546.6(TP53):c.820G>T (p.Val274Phe);GRCh37,NC_000017.10:g.7577118C>A GRCh38,NC_000017.11:g.7673800C>A;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma;1
376673;NM_000546.6(TP53):c.815T>A (p.Val272Glu);GRCh37,NC_000017.10:g.7577123A>T GRCh38,NC_000017.11:g.7673805A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
376672;NM_000546.6(TP53):c.647T>A (p.Val216Glu);GRCh37,NC_000017.10:g.7578202A>T GRCh38,NC_000017.11:g.7674884A>T;TP53;Uncertain significance;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hereditary cancer-predisposing syndrome,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376671;NM_000546.6(TP53):c.647T>G (p.Val216Gly);GRCh37,NC_000017.10:g.7578202A>C GRCh38,NC_000017.11:g.7674884A>C;TP53;Uncertain significance;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376670;NM_000546.6(TP53):c.646G>T (p.Val216Leu);GRCh37,NC_000017.10:g.7578203C>A GRCh38,NC_000017.11:g.7674885C>A;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376669;NM_000546.6(TP53):c.518T>A (p.Val173Glu);GRCh37,NC_000017.10:g.7578412A>T GRCh38,NC_000017.11:g.7675094A>T;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,not specified;1
376668;NM_000546.6(TP53):c.517G>T (p.Val173Leu);GRCh37,NC_000017.10:g.7578413C>A GRCh38,NC_000017.11:g.7675095C>A;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,not provided;2
376667;NM_000546.6(TP53):c.374C>G (p.Thr125Arg);GRCh37,NC_000017.10:g.7579313G>C GRCh38,NC_000017.11:g.7675995G>C;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376666;NM_000546.6(TP53):c.373A>C (p.Thr125Pro);GRCh37,NC_000017.10:g.7579314T>G GRCh38,NC_000017.11:g.7675996T>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376665;NM_000546.6(TP53):c.721T>G (p.Ser241Ala);GRCh37,NC_000017.10:g.7577560A>C GRCh38,NC_000017.11:g.7674242A>C;TP53;Conflicting classifications of pathogenicity;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376664;NM_000546.6(TP53):c.721T>C (p.Ser241Pro);GRCh37,NC_000017.10:g.7577560A>G GRCh38,NC_000017.11:g.7674242A>G;TP53;Uncertain significance;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Glioblastoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376663;NM_000546.6(TP53):c.722C>A (p.Ser241Tyr);GRCh37,NC_000017.10:g.7577559G>T GRCh38,NC_000017.11:g.7674241G>T;TP53;Pathogenic/Likely pathogenic;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
376662;NM_000546.6(TP53):c.644G>A (p.Ser215Asn);GRCh37,NC_000017.10:g.7578205C>T GRCh38,NC_000017.11:g.7674887C>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma;1
376661;NM_000546.6(TP53):c.645T>G (p.Ser215Arg);GRCh37,NC_000017.10:g.7578204A>C GRCh38,NC_000017.11:g.7674886A>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma;1
376660;NM_000546.6(TP53):c.644G>T (p.Ser215Ile);GRCh37,NC_000017.10:g.7578205C>A GRCh38,NC_000017.11:g.7674887C>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma;1
376659;NM_000546.6(TP53):c.845G>C (p.Arg282Pro);GRCh37,NC_000017.10:g.7577093C>G GRCh38,NC_000017.11:g.7673775C>G;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Nasopharyngeal carcinoma,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376658;NM_000546.6(TP53):c.838A>G (p.Arg280Gly);GRCh37,NC_000017.10:g.7577100T>C GRCh38,NC_000017.11:g.7673782T>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376657;NM_000546.6(TP53):c.839G>A (p.Arg280Lys);GRCh37,NC_000017.10:g.7577099C>T GRCh38,NC_000017.11:g.7673781C>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376656;NM_000546.6(TP53):c.817C>A (p.Arg273Ser);GRCh37,NC_000017.10:g.7577121G>T GRCh38,NC_000017.11:g.7673803G>T;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376655;NM_000546.6(TP53):c.818G>T (p.Arg273Leu);GRCh37,NC_000017.10:g.7577120C>A GRCh38,NC_000017.11:g.7673802C>A;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Metastatic pancreatic neuroendocrine tumours,Multiple myeloma,Nasopharyngeal carcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
376654;NM_000546.6(TP53):c.745A>G (p.Arg249Gly);GRCh37,NC_000017.10:g.7577536T>C GRCh38,NC_000017.11:g.7674218T>C;TP53;Conflicting classifications of pathogenicity;Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376653;NM_000546.6(TP53):c.746G>T (p.Arg249Met);GRCh37,NC_000017.10:g.7577535C>A GRCh38,NC_000017.11:g.7674217C>A;TP53;Conflicting classifications of pathogenicity;Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376652;NM_000546.6(TP53):c.742C>G (p.Arg248Gly);GRCh37,NC_000017.10:g.7577539G>C GRCh38,NC_000017.11:g.7674221G>C;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of colon,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Myelodysplastic syndrome,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376651;NM_000546.6(TP53):c.637C>G (p.Arg213Gly);GRCh37,NC_000017.10:g.7578212G>C GRCh38,NC_000017.11:g.7674894G>C;TP53;Conflicting classifications of pathogenicity;Adenoid cystic carcinoma,Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376650;NM_000546.6(TP53):c.638G>T (p.Arg213Leu);GRCh37,NC_000017.10:g.7578211C>A GRCh38,NC_000017.11:g.7674893C>A;TP53;Conflicting classifications of pathogenicity;Adenoid cystic carcinoma,Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376649;NM_000546.6(TP53):c.523C>G (p.Arg175Gly);GRCh37,NC_000017.10:g.7578407G>C GRCh38,NC_000017.11:g.7675089G>C;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
376648;NM_000546.6(TP53):c.432G>T (p.Gln144His);GRCh37,NC_000017.10:g.7578498C>A GRCh38,NC_000017.11:g.7675180C>A;TP53;Uncertain significance;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,not provided;1
376647;NM_000546.6(TP53):c.431A>T (p.Gln144Leu);GRCh38,NC_000017.11:g.7675181T>A GRCh37,NC_000017.10:g.7578499T>A;TP53;Uncertain significance;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;3
376646;NM_000546.6(TP53):c.833C>A (p.Pro278His);GRCh37,NC_000017.10:g.7577105G>T GRCh38,NC_000017.11:g.7673787G>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;1
376645;NM_000546.6(TP53):c.832C>G (p.Pro278Ala);GRCh37,NC_000017.10:g.7577106G>C GRCh38,NC_000017.11:g.7673788G>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;1
376644;NM_000546.6(TP53):c.833C>G (p.Pro278Arg);GRCh37,NC_000017.10:g.7577105G>C GRCh38,NC_000017.11:g.7673787G>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;1
376643;NM_000546.6(TP53):c.832C>A (p.Pro278Thr);GRCh37,NC_000017.10:g.7577106G>T GRCh38,NC_000017.11:g.7673788G>T;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Poly (ADP-Ribose) polymerase inhibitor response,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;2
376642;NM_000546.6(TP53):c.832C>T (p.Pro278Ser);GRCh37,NC_000017.10:g.7577106G>A GRCh38,NC_000017.11:g.7673788G>A;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;2
376641;NM_000546.6(TP53):c.451C>G (p.Pro151Ala);GRCh37,NC_000017.10:g.7578479G>C GRCh38,NC_000017.11:g.7675161G>C;TP53;Pathogenic;Adenoid cystic carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376640;NM_000546.6(TP53):c.452C>G (p.Pro151Arg);GRCh37,NC_000017.10:g.7578478G>C GRCh38,NC_000017.11:g.7675160G>C;TP53;Pathogenic/Likely pathogenic;Adenoid cystic carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376639;NM_000546.6(TP53):c.452C>A (p.Pro151His);GRCh37,NC_000017.10:g.7578478G>T GRCh38,NC_000017.11:g.7675160G>T;TP53;Uncertain significance;Adenoid cystic carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376638;NM_000546.6(TP53):c.716A>C (p.Asn239Thr);GRCh37,NC_000017.10:g.7577565T>G GRCh38,NC_000017.11:g.7674247T>G;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Uterine carcinosarcoma;1
376637;NM_000546.6(TP53):c.716A>G (p.Asn239Ser);GRCh37,NC_000017.10:g.7577565T>C GRCh38,NC_000017.11:g.7674247T>C;TP53;Likely pathogenic;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Uterine carcinosarcoma,not provided;2
376636;NM_000546.6(TP53):c.710T>A (p.Met237Lys);GRCh37,NC_000017.10:g.7577571A>T GRCh38,NC_000017.11:g.7674253A>T;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;2
376635;NM_000546.6(TP53):c.581T>C (p.Leu194Pro);GRCh37,NC_000017.10:g.7578268A>G GRCh38,NC_000017.11:g.7674950A>G;TP53;Uncertain significance;Breast neoplasm,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376634;NM_000546.6(TP53):c.581T>A (p.Leu194His);GRCh37,NC_000017.10:g.7578268A>T GRCh38,NC_000017.11:g.7674950A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376633;NM_000546.6(TP53):c.581T>G (p.Leu194Arg);GRCh37,NC_000017.10:g.7578268A>C GRCh38,NC_000017.11:g.7674950A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Colorectal cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376632;NM_000546.6(TP53):c.332T>A (p.Leu111Gln);GRCh37,NC_000017.10:g.7579355A>T GRCh38,NC_000017.11:g.7676037A>T;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant melanoma of skin,Squamous cell lung carcinoma;1
376631;NM_000546.6(TP53):c.332T>G (p.Leu111Arg);GRCh37,NC_000017.10:g.7579355A>C GRCh38,NC_000017.11:g.7676037A>C;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Malignant melanoma of skin,Squamous cell lung carcinoma;1
376630;NM_000546.6(TP53):c.332T>C (p.Leu111Pro);GRCh37,NC_000017.10:g.7579355A>G GRCh38,NC_000017.11:g.7676037A>G;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant melanoma of skin,Neoplasm of ovary,Squamous cell lung carcinoma,not provided;1
376629;NM_000546.6(TP53):c.395A>T (p.Lys132Met);GRCh37,NC_000017.10:g.7578535T>A GRCh38,NC_000017.11:g.7675217T>A;TP53;Uncertain significance;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376628;NM_000546.6(TP53):c.394A>C (p.Lys132Gln);GRCh37,NC_000017.10:g.7578536T>G GRCh38,NC_000017.11:g.7675218T>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376627;NM_000546.6(TP53):c.395A>C (p.Lys132Thr);GRCh37,NC_000017.10:g.7578535T>G GRCh38,NC_000017.11:g.7675217T>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376626;NM_000546.6(TP53):c.394A>G (p.Lys132Glu);GRCh37,NC_000017.10:g.7578536T>C GRCh38,NC_000017.11:g.7675218T>C;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;1
376625;NM_000546.6(TP53):c.395A>G (p.Lys132Arg);GRCh37,NC_000017.10:g.7578535T>C GRCh38,NC_000017.11:g.7675217T>C;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376624;NM_000546.6(TP53):c.396G>C (p.Lys132Asn);GRCh37,NC_000017.10:g.7578534C>G GRCh38,NC_000017.11:g.7675216C>G;TP53;Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;3
376623;NM_000546.6(TP53):c.764T>C (p.Ile255Thr);GRCh37,NC_000017.10:g.7577517A>G GRCh38,NC_000017.11:g.7674199A>G;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Pancreatic adenocarcinoma;1
376622;NM_000546.6(TP53):c.764T>G (p.Ile255Ser);GRCh37,NC_000017.10:g.7577517A>C GRCh38,NC_000017.11:g.7674199A>C;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Pancreatic adenocarcinoma;1
376621;NM_000546.6(TP53):c.763A>T (p.Ile255Phe);GRCh37,NC_000017.10:g.7577518T>A GRCh38,NC_000017.11:g.7674200T>A;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Pancreatic adenocarcinoma;1
376620;NM_000546.6(TP53):c.585C>G (p.Ile195Met);GRCh37,NC_000017.10:g.7578264G>C GRCh38,NC_000017.11:g.7674946G>C;TP53;Uncertain significance;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;2
376619;NM_000546.6(TP53):c.584T>G (p.Ile195Ser);GRCh37,NC_000017.10:g.7578265A>C GRCh38,NC_000017.11:g.7674947A>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376618;NM_000546.6(TP53):c.584T>A (p.Ile195Asn);GRCh37,NC_000017.10:g.7578265A>T GRCh38,NC_000017.11:g.7674947A>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376617;NM_000546.6(TP53):c.583A>T (p.Ile195Phe);GRCh37,NC_000017.10:g.7578266T>A GRCh38,NC_000017.11:g.7674948T>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant tumor of esophagus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376616;NM_000546.6(TP53):c.641A>T (p.His214Leu);GRCh37,NC_000017.10:g.7578208T>A GRCh38,NC_000017.11:g.7674890T>A;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376615;NM_000546.6(TP53):c.641A>G (p.His214Arg);GRCh37,NC_000017.10:g.7578208T>C GRCh38,NC_000017.11:g.7674890T>C;TP53;Likely pathogenic;B-cell chronic lymphocytic leukemia,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;3
376614;NM_000546.6(TP53):c.577C>A (p.His193Asn);GRCh37,NC_000017.10:g.7578272G>T GRCh38,NC_000017.11:g.7674954G>T;TP53;Likely pathogenic;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;0
376613;NM_000546.6(TP53):c.577C>G (p.His193Asp);GRCh37,NC_000017.10:g.7578272G>C GRCh38,NC_000017.11:g.7674954G>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376612;NM_000546.6(TP53):c.578A>C (p.His193Pro);GRCh38,NC_000017.11:g.7674953T>G GRCh37,NC_000017.10:g.7578271T>G;TP53;Pathogenic;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;3
376611;NM_000546.6(TP53):c.536A>C (p.His179Pro);GRCh37,NC_000017.10:g.7578394T>G GRCh38,NC_000017.11:g.7675076T>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376610;NM_000546.6(TP53):c.535C>G (p.His179Asp);GRCh37,NC_000017.10:g.7578395G>C GRCh38,NC_000017.11:g.7675077G>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not specified;1
376609;NM_000546.6(TP53):c.535C>A (p.His179Asn);GRCh37,NC_000017.10:g.7578395G>T GRCh38,NC_000017.11:g.7675077G>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376608;NM_000546.6(TP53):c.536A>T (p.His179Leu);GRCh37,NC_000017.10:g.7578394T>A GRCh38,NC_000017.11:g.7675076T>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376607;NM_000546.6(TP53):c.537T>G (p.His179Gln);GRCh37,NC_000017.10:g.7578393A>C GRCh38,NC_000017.11:g.7675075A>C;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;2
376606;NM_000546.6(TP53):c.536A>G (p.His179Arg);GRCh37,NC_000017.10:g.7578394T>C GRCh38,NC_000017.11:g.7675076T>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,TP53-related disorder,Uterine carcinosarcoma,not provided;1
376605;NM_000546.6(TP53):c.796G>C (p.Gly266Arg);GRCh37,NC_000017.10:g.7577142C>G GRCh38,NC_000017.11:g.7673824C>G;TP53;Pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376604;NM_000546.6(TP53):c.733G>C (p.Gly245Arg);GRCh37,NC_000017.10:g.7577548C>G GRCh38,NC_000017.11:g.7674230C>G;TP53;Conflicting classifications of pathogenicity;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376603;NM_000546.6(TP53):c.734G>T (p.Gly245Val);GRCh37,NC_000017.10:g.7577547C>A GRCh38,NC_000017.11:g.7674229C>A;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
376602;NM_000546.6(TP53):c.730G>C (p.Gly244Arg);GRCh37,NC_000017.10:g.7577551C>G GRCh38,NC_000017.11:g.7674233C>G;TP53;Likely pathogenic;Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;0
376601;NM_000546.6(TP53):c.731G>T (p.Gly244Val);GRCh37,NC_000017.10:g.7577550C>A GRCh38,NC_000017.11:g.7674232C>A;TP53;Likely pathogenic;Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
376600;NM_000546.6(TP53):c.730G>A (p.Gly244Ser);GRCh37,NC_000017.10:g.7577551C>T GRCh38,NC_000017.11:g.7674233C>T;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Carcinoma of esophagus,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Malignant tumor of urinary bladder,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Rhabdomyosarcoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;2
376599;NM_000546.6(TP53):c.730G>T (p.Gly244Cys);GRCh37,NC_000017.10:g.7577551C>A GRCh38,NC_000017.11:g.7674233C>A;TP53;Conflicting classifications of pathogenicity;Carcinoma of esophagus,Familial cancer of breast,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
376598;NM_000546.6(TP53):c.808T>G (p.Phe270Val);GRCh37,NC_000017.10:g.7577130A>C GRCh38,NC_000017.11:g.7673812A>C;TP53;Pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;1
376597;NM_000546.6(TP53):c.809T>G (p.Phe270Cys);GRCh37,NC_000017.10:g.7577129A>C GRCh38,NC_000017.11:g.7673811A>C;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;1
376596;NM_000546.6(TP53):c.808T>A (p.Phe270Ile);GRCh37,NC_000017.10:g.7577130A>T GRCh38,NC_000017.11:g.7673812A>T;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;1
376595;NM_000546.6(TP53):c.810T>G (p.Phe270Leu);GRCh37,NC_000017.10:g.7577128A>C GRCh38,NC_000017.11:g.7673810A>C;TP53;Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;0
376594;NM_000546.6(TP53):c.809T>C (p.Phe270Ser);GRCh37,NC_000017.10:g.7577129A>G GRCh38,NC_000017.11:g.7673811A>G;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;2
376593;NM_000546.6(TP53):c.857A>C (p.Glu286Ala);GRCh37,NC_000017.10:g.7577081T>G GRCh38,NC_000017.11:g.7673763T>G;TP53;Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
376592;NM_000546.6(TP53):c.857A>T (p.Glu286Val);GRCh37,NC_000017.10:g.7577081T>A GRCh38,NC_000017.11:g.7673763T>A;TP53;Uncertain significance;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
376591;NM_000546.6(TP53):c.856G>C (p.Glu286Gln);GRCh37,NC_000017.10:g.7577082C>G GRCh38,NC_000017.11:g.7673764C>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
376590;NM_000546.6(TP53):c.857A>G (p.Glu286Gly);GRCh37,NC_000017.10:g.7577081T>C GRCh38,NC_000017.11:g.7673763T>C;TP53;Uncertain significance;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
376589;NM_000546.6(TP53):c.842A>C (p.Asp281Ala);GRCh37,NC_000017.10:g.7577096T>G GRCh38,NC_000017.11:g.7673778T>G;TP53;Likely pathogenic;Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376588;NM_000546.6(TP53):c.841G>C (p.Asp281His);GRCh37,NC_000017.10:g.7577097C>G GRCh38,NC_000017.11:g.7673779C>G;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gallbladder cancer,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376587;NM_000546.6(TP53):c.843C>G (p.Asp281Glu);GRCh37,NC_000017.10:g.7577095G>C GRCh38,NC_000017.11:g.7673777G>C;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of ovary,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376586;NM_000546.6(TP53):c.841G>A (p.Asp281Asn);GRCh37,NC_000017.10:g.7577097C>T GRCh38,NC_000017.11:g.7673779C>T;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of ovary,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376585;NM_000546.6(TP53):c.841G>T (p.Asp281Tyr);GRCh37,NC_000017.10:g.7577097C>A GRCh38,NC_000017.11:g.7673779C>A;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376584;NM_000546.6(TP53):c.823T>C (p.Cys275Arg);GRCh37,NC_000017.10:g.7577115A>G GRCh38,NC_000017.11:g.7673797A>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376583;NM_000546.6(TP53):c.824G>C (p.Cys275Ser);GRCh37,NC_000017.10:g.7577114C>G GRCh38,NC_000017.11:g.7673796C>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376582;NM_000546.6(TP53):c.824G>T (p.Cys275Phe);GRCh37,NC_000017.10:g.7577114C>A GRCh38,NC_000017.11:g.7673796C>A;TP53;Pathogenic;Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
376581;NM_000546.6(TP53):c.724T>G (p.Cys242Gly);GRCh37,NC_000017.10:g.7577557A>C GRCh38,NC_000017.11:g.7674239A>C;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376580;NM_000546.6(TP53):c.726C>G (p.Cys242Trp);GRCh37,NC_000017.10:g.7577555G>C GRCh38,NC_000017.11:g.7674237G>C;TP53;Pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376579;NM_000546.6(TP53):c.724T>A (p.Cys242Ser);GRCh37,NC_000017.10:g.7577557A>T GRCh38,NC_000017.11:g.7674239A>T;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376578;NM_000546.6(TP53):c.725G>T (p.Cys242Phe);GRCh37,NC_000017.10:g.7577556C>A GRCh38,NC_000017.11:g.7674238C>A;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of ovary,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
376577;NM_000546.6(TP53):c.712T>G (p.Cys238Gly);GRCh37,NC_000017.10:g.7577569A>C GRCh38,NC_000017.11:g.7674251A>C;TP53;Pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376576;NM_000546.6(TP53):c.712T>C (p.Cys238Arg);GRCh37,NC_000017.10:g.7577569A>G GRCh38,NC_000017.11:g.7674251A>G;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376575;NM_000546.6(TP53):c.713G>C (p.Cys238Ser);GRCh37,NC_000017.10:g.7577568C>G GRCh38,NC_000017.11:g.7674250C>G;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
376574;NM_000546.6(TP53):c.713G>T (p.Cys238Phe);GRCh37,NC_000017.10:g.7577568C>A GRCh38,NC_000017.11:g.7674250C>A;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
376573;NM_000546.6(TP53):c.526T>C (p.Cys176Arg);GRCh37,NC_000017.10:g.7578404A>G GRCh38,NC_000017.11:g.7675086A>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376572;NM_000546.6(TP53):c.528C>G (p.Cys176Trp);GRCh37,NC_000017.10:g.7578402G>C GRCh38,NC_000017.11:g.7675084G>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,TP53-related disorder,Transitional cell carcinoma of the bladder;1
376571;NM_000546.6(TP53):c.526T>G (p.Cys176Gly);GRCh37,NC_000017.10:g.7578404A>C GRCh38,NC_000017.11:g.7675086A>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376570;NM_000546.6(TP53):c.526T>A (p.Cys176Ser);GRCh37,NC_000017.10:g.7578404A>T GRCh38,NC_000017.11:g.7675086A>T;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;1
376569;NM_000546.6(TP53):c.527G>T (p.Cys176Phe);GRCh37,NC_000017.10:g.7578403C>A GRCh38,NC_000017.11:g.7675085C>A;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376568;NM_000546.6(TP53):c.422G>T (p.Cys141Phe);GRCh37,NC_000017.10:g.7578508C>A GRCh38,NC_000017.11:g.7675190C>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;1
376567;NM_000546.6(TP53):c.421T>A (p.Cys141Ser);GRCh37,NC_000017.10:g.7578509A>T GRCh38,NC_000017.11:g.7675191A>T;TP53;Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;0
376566;NM_000546.6(TP53):c.421T>G (p.Cys141Gly);GRCh37,NC_000017.10:g.7578509A>C GRCh38,NC_000017.11:g.7675191A>C;TP53;Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;0
376565;NM_000546.6(TP53):c.421T>C (p.Cys141Arg);GRCh37,NC_000017.10:g.7578509A>G GRCh38,NC_000017.11:g.7675191A>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;1
376564;NM_000546.6(TP53):c.423C>G (p.Cys141Trp);GRCh37,NC_000017.10:g.7578507G>C GRCh38,NC_000017.11:g.7675189G>C;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma;2
376563;NM_000546.6(TP53):c.403T>G (p.Cys135Gly);GRCh38,NC_000017.11:g.7675209A>C GRCh37,NC_000017.10:g.7578527A>C;TP53;Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;3
376562;NM_000546.6(TP53):c.403T>A (p.Cys135Ser);GRCh37,NC_000017.10:g.7578527A>T GRCh38,NC_000017.11:g.7675209A>T;TP53;Uncertain significance;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;1
376561;NM_000546.6(TP53):c.405C>G (p.Cys135Trp);GRCh37,NC_000017.10:g.7578525G>C GRCh38,NC_000017.11:g.7675207G>C;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;1
376560;NM_000546.6(TP53):c.403T>C (p.Cys135Arg);GRCh37,NC_000017.10:g.7578527A>G GRCh38,NC_000017.11:g.7675209A>G;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376559;NM_000546.6(TP53):c.404G>T (p.Cys135Phe);GRCh37,NC_000017.10:g.7578526C>A GRCh38,NC_000017.11:g.7675208C>A;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
376017;NM_000546.6(TP53):c.518T>C (p.Val173Ala);GRCh37,NC_000017.10:g.7578412A>G GRCh38,NC_000017.11:g.7675094A>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck;2
376016;NM_000546.6(TP53):c.518T>G (p.Val173Gly);GRCh37,NC_000017.10:g.7578412A>C GRCh38,NC_000017.11:g.7675094A>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck;1
376015;NM_000546.6(TP53):c.746G>C (p.Arg249Thr);GRCh37,NC_000017.10:g.7577535C>G GRCh38,NC_000017.11:g.7674217C>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;2
372785;NM_000546.6(TP53):c.731G>A (p.Gly244Asp);GRCh37,NC_000017.10:g.7577550C>T GRCh38,NC_000017.11:g.7674232C>T;TP53;Pathogenic/Likely pathogenic;Carcinoma of esophagus,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;2
265357;NM_000546.6(TP53):c.734G>C (p.Gly245Ala);GRCh37,NC_000017.10:g.7577547C>G GRCh38,NC_000017.11:g.7674229C>G;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;1
265337;NM_000546.6(TP53):c.643A>G (p.Ser215Gly);GRCh37,NC_000017.10:g.7578206T>C GRCh38,NC_000017.11:g.7674888T>C;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,not provided,not specified;1
265333;NM_000546.6(TP53):c.376T>G (p.Tyr126Asp);GRCh37,NC_000017.10:g.7578554A>C GRCh38,NC_000017.11:g.7675236A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;1
246429;NM_000546.6(TP53):c.393C>A (p.Asn131Lys);GRCh38,NC_000017.11:g.7675219G>T GRCh37,NC_000017.10:g.7578537G>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;3
246416;NM_000546.6(TP53):c.490A>G (p.Lys164Glu);GRCh37,NC_000017.10:g.7578440T>C GRCh38,NC_000017.11:g.7675122T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
246388;NM_000546.6(TP53):c.698A>G (p.His233Arg);GRCh37,NC_000017.10:g.7577583T>C GRCh38,NC_000017.11:g.7674265T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
246221;NM_000546.6(TP53):c.1136G>A (p.Arg379His);GRCh37,NC_000017.10:g.7572973C>T GRCh38,NC_000017.11:g.7669655C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
246118;NM_000546.6(TP53):c.473G>C (p.Arg158Pro);GRCh37,NC_000017.10:g.7578457C>G GRCh38,NC_000017.11:g.7675139C>G;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,not provided;2
246049;NM_000546.6(TP53):c.134T>C (p.Leu45Pro);GRCh37,NC_000017.10:g.7579553A>G GRCh38,NC_000017.11:g.7676235A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
245851;NM_000546.6(TP53):c.523C>T (p.Arg175Cys);GRCh38,NC_000017.11:g.7675089G>A GRCh37,NC_000017.10:g.7578407G>A;TP53;Uncertain significance;B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided,not specified;3
245777;NM_000546.6(TP53):c.794T>C (p.Leu265Pro);GRCh37,NC_000017.10:g.7577144A>G GRCh38,NC_000017.11:g.7673826A>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Rhabdomyosarcoma,not provided;2
245711;NM_000546.6(TP53):c.538G>A (p.Glu180Lys);GRCh37,NC_000017.10:g.7578392C>T GRCh38,NC_000017.11:g.7675074C>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;3
245673;NM_000546.6(TP53):c.655C>T (p.Pro219Ser);GRCh37,NC_000017.10:g.7578194G>A GRCh38,NC_000017.11:g.7674876G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
237956;NM_000546.6(TP53):c.845G>A (p.Arg282Gln);GRCh37,NC_000017.10:g.7577093C>T GRCh38,NC_000017.11:g.7673775C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Malignant tumor of breast,Neoplasm of brain,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided,not specified;1
237954;NM_000546.6(TP53):c.743G>C (p.Arg248Pro);GRCh37,NC_000017.10:g.7577538C>G GRCh38,NC_000017.11:g.7674220C>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Myelodysplastic syndrome,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
237952;NM_000546.6(TP53):c.652G>A (p.Val218Met);GRCh37,NC_000017.10:g.7578197C>T GRCh38,NC_000017.11:g.7674879C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
237950;NM_000546.6(TP53):c.461G>A (p.Gly154Asp);GRCh37,NC_000017.10:g.7578469C>T GRCh38,NC_000017.11:g.7675151C>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of urinary bladder,not provided;3
237949;NM_000546.6(TP53):c.38C>T (p.Pro13Leu);GRCh37,NC_000017.10:g.7579875G>A GRCh38,NC_000017.11:g.7676557G>A;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
237947;NM_000546.6(TP53):c.303A>T (p.Lys101Asn);GRCh37,NC_000017.10:g.7579384T>A GRCh38,NC_000017.11:g.7676066T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
237943;NM_000546.6(TP53):c.212C>G (p.Pro71Arg);GRCh37,NC_000017.10:g.7579475G>C GRCh38,NC_000017.11:g.7676157G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
237942;NM_000546.6(TP53):c.155A>G (p.Gln52Arg);GRCh37,NC_000017.10:g.7579532T>C GRCh38,NC_000017.11:g.7676214T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
237941;NM_000546.6(TP53):c.11C>T (p.Pro4Leu);GRCh37,NC_000017.10:g.7579902G>A GRCh38,NC_000017.11:g.7676584G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
237938;NM_000546.6(TP53):c.1009C>G (p.Arg337Gly);GRCh37,NC_000017.10:g.7574018G>C GRCh38,NC_000017.11:g.7670700G>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
234214;NM_000546.6(TP53):c.668C>T (p.Pro223Leu);GRCh37,NC_000017.10:g.7578181G>A GRCh38,NC_000017.11:g.7674863G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
234067;NM_000546.6(TP53):c.930C>A (p.Asn310Lys);GRCh37,NC_000017.10:g.7576916G>T GRCh38,NC_000017.11:g.7673598G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
234061;NM_000546.6(TP53):c.569C>G (p.Pro190Arg);GRCh37,NC_000017.10:g.7578280G>C GRCh38,NC_000017.11:g.7674962G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
234059;NM_000546.6(TP53):c.1066G>C (p.Gly356Arg);GRCh37,NC_000017.10:g.7573961C>G GRCh38,NC_000017.11:g.7670643C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
234036;NM_000546.6(TP53):c.715A>G (p.Asn239Asp);GRCh37,NC_000017.10:g.7577566T>C GRCh38,NC_000017.11:g.7674248T>C;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Malignant tumor of breast,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Uterine carcinosarcoma,not provided;1
233951;NM_000546.6(TP53):c.517G>A (p.Val173Met);GRCh37,NC_000017.10:g.7578413C>T GRCh38,NC_000017.11:g.7675095C>T;TP53;Pathogenic;Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,not provided;3
233852;NM_000546.6(TP53):c.91G>T (p.Val31Phe);GRCh37,NC_000017.10:g.7579705C>A GRCh38,NC_000017.11:g.7676387C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
233627;NM_000546.6(TP53):c.329G>C (p.Arg110Pro);GRCh37,NC_000017.10:g.7579358C>G GRCh38,NC_000017.11:g.7676040C>G;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
233323;NM_000546.6(TP53):c.815T>G (p.Val272Gly);GRCh37,NC_000017.10:g.7577123A>C GRCh38,NC_000017.11:g.7673805A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;1
233303;NM_000546.6(TP53):c.797G>T (p.Gly266Val);GRCh37,NC_000017.10:g.7577141C>A GRCh38,NC_000017.11:g.7673823C>A;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
233248;NM_000546.6(TP53):c.14A>G (p.Gln5Arg);GRCh37,NC_000017.10:g.7579899T>C GRCh38,NC_000017.11:g.7676581T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
233244;NM_000546.6(TP53):c.1088G>A (p.Arg363Lys);GRCh37,NC_000017.10:g.7573939C>T GRCh38,NC_000017.11:g.7670621C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
233197;NM_000546.6(TP53):c.568C>A (p.Pro190Thr);GRCh37,NC_000017.10:g.7578281G>T GRCh38,NC_000017.11:g.7674963G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
233136;NM_000546.6(TP53):c.1025G>A (p.Arg342Gln);GRCh37,NC_000017.10:g.7574002C>T GRCh38,NC_000017.11:g.7670684C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
232750;NM_000546.6(TP53):c.214C>A (p.Pro72Thr);GRCh37,NC_000017.10:g.7579473G>T GRCh38,NC_000017.11:g.7676155G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
232683;NM_000546.6(TP53):c.827C>A (p.Ala276Asp);GRCh37,NC_000017.10:g.7577111G>T GRCh38,NC_000017.11:g.7673793G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
232673;NM_000546.6(TP53):c.58T>C (p.Ser20Pro);GRCh37,NC_000017.10:g.7579855A>G GRCh38,NC_000017.11:g.7676537A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
232497;NM_000546.6(TP53):c.833C>T (p.Pro278Leu);GRCh37,NC_000017.10:g.7577105G>A GRCh38,NC_000017.11:g.7673787G>A;TP53;Pathogenic;Breast neoplasm,Carcinoma of esophagus,Gallbladder cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,not provided;2
232344;NM_000546.6(TP53):c.586C>G (p.Arg196Gly);GRCh37,NC_000017.10:g.7578263G>C GRCh38,NC_000017.11:g.7674945G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
232289;NM_000546.6(TP53):c.764T>A (p.Ile255Asn);GRCh37,NC_000017.10:g.7577517A>T GRCh38,NC_000017.11:g.7674199A>T;TP53;Conflicting classifications of pathogenicity;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Pancreatic adenocarcinoma;1
232223;NM_000546.6(TP53):c.136T>C (p.Ser46Pro);GRCh37,NC_000017.10:g.7579551A>G GRCh38,NC_000017.11:g.7676233A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
231990;NM_000546.6(TP53):c.890A>G (p.His297Arg);GRCh37,NC_000017.10:g.7577048T>C GRCh38,NC_000017.11:g.7673730T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
231953;NM_000546.6(TP53):c.1099A>G (p.Ser367Gly);GRCh37,NC_000017.10:g.7573928T>C GRCh38,NC_000017.11:g.7670610T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
231868;NM_000546.6(TP53):c.23C>T (p.Pro8Leu);GRCh37,NC_000017.10:g.7579890G>A GRCh38,NC_000017.11:g.7676572G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
231661;NM_000546.6(TP53):c.604C>G (p.Arg202Gly);GRCh37,NC_000017.10:g.7578245G>C GRCh38,NC_000017.11:g.7674927G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
231553;NM_000546.6(TP53):c.964C>A (p.Pro322Thr);GRCh37,NC_000017.10:g.7576882G>T GRCh38,NC_000017.11:g.7673564G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
231485;NM_000546.6(TP53):c.1060C>A (p.Gln354Lys);GRCh37,NC_000017.10:g.7573967G>T GRCh38,NC_000017.11:g.7670649G>T;TP53;Likely benign;Colonic neoplasm,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;3
231387;NM_000546.6(TP53):c.28G>C (p.Val10Leu);GRCh37,NC_000017.10:g.7579885C>G GRCh38,NC_000017.11:g.7676567C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
231214;NM_000546.6(TP53):c.638G>C (p.Arg213Pro);GRCh37,NC_000017.10:g.7578211C>G GRCh38,NC_000017.11:g.7674893C>G;TP53;Pathogenic/Likely pathogenic;Adenoid cystic carcinoma,Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not specified;2
231165;NM_000546.6(TP53):c.587G>C (p.Arg196Pro);GRCh37,NC_000017.10:g.7578262C>G GRCh38,NC_000017.11:g.7674944C>G;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;2
231133;NM_000546.6(TP53):c.146A>G (p.Asp49Gly);GRCh37,NC_000017.10:g.7579541T>C GRCh38,NC_000017.11:g.7676223T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
231060;NM_000546.6(TP53):c.818G>C (p.Arg273Pro);GRCh37,NC_000017.10:g.7577120C>G GRCh38,NC_000017.11:g.7673802C>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
231033;NM_000546.6(TP53):c.779C>A (p.Ser260Tyr);GRCh38,NC_000017.11:g.7674184G>T GRCh37,NC_000017.10:g.7577502G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
231015;NM_000546.6(TP53):c.187G>A (p.Ala63Thr);GRCh37,NC_000017.10:g.7579500C>T GRCh38,NC_000017.11:g.7676182C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome;1
231008;NM_000546.6(TP53):c.949C>A (p.Gln317Lys);GRCh37,NC_000017.10:g.7576897G>T GRCh38,NC_000017.11:g.7673579G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided;3
230970;NM_000546.6(TP53):c.1115A>G (p.Lys372Arg);GRCh37,NC_000017.10:g.7572994T>C GRCh38,NC_000017.11:g.7669676T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,TP53-related disorder;1
230764;NM_000546.6(TP53):c.541C>A (p.Arg181Ser);GRCh38,NC_000017.11:g.7675071G>T GRCh37,NC_000017.10:g.7578389G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;3
230758;NM_000546.6(TP53):c.480G>A (p.Met160Ile);GRCh37,NC_000017.10:g.7578450C>T GRCh38,NC_000017.11:g.7675132C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
230695;NM_000546.6(TP53):c.908G>A (p.Ser303Asn);GRCh37,NC_000017.10:g.7577030C>T GRCh38,NC_000017.11:g.7673712C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
230661;NM_000546.6(TP53):c.370T>G (p.Cys124Gly);GRCh37,NC_000017.10:g.7579317A>C GRCh38,NC_000017.11:g.7675999A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
230534;NM_000546.6(TP53):c.1073A>T (p.Glu358Val);GRCh37,NC_000017.10:g.7573954T>A GRCh38,NC_000017.11:g.7670636T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;1
230477;NM_000546.6(TP53):c.401T>G (p.Phe134Cys);GRCh37,NC_000017.10:g.7578529A>C GRCh38,NC_000017.11:g.7675211A>C;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,not provided;1
230382;NM_000546.6(TP53):c.946C>A (p.Pro316Thr);GRCh37,NC_000017.10:g.7576900G>T GRCh38,NC_000017.11:g.7673582G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
230368;NM_000546.6(TP53):c.233C>G (p.Ala78Gly);GRCh37,NC_000017.10:g.7579454G>C GRCh38,NC_000017.11:g.7676136G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
230306;NM_000546.6(TP53):c.1079G>A (p.Gly360Glu);GRCh37,NC_000017.10:g.7573948C>T GRCh38,NC_000017.11:g.7670630C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
230269;NM_000546.6(TP53):c.1120G>C (p.Gly374Arg);GRCh37,NC_000017.10:g.7572989C>G GRCh38,NC_000017.11:g.7669671C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,TP53-related disorder,not provided;3
230256;NM_000546.6(TP53):c.577C>T (p.His193Tyr);GRCh37,NC_000017.10:g.7578272G>A GRCh38,NC_000017.11:g.7674954G>A;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Malignant tumor of urinary bladder,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
230254;NM_000546.6(TP53):c.640C>A (p.His214Asn);GRCh37,NC_000017.10:g.7578209G>T GRCh38,NC_000017.11:g.7674891G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
230253;NM_000546.6(TP53):c.743G>T (p.Arg248Leu);GRCh37,NC_000017.10:g.7577538C>A GRCh38,NC_000017.11:g.7674220C>A;TP53;Pathogenic;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Myelodysplastic syndrome,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;3
230208;NM_000546.6(TP53):c.877G>A (p.Gly293Arg);GRCh37,NC_000017.10:g.7577061C>T GRCh38,NC_000017.11:g.7673743C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
230112;NM_000546.6(TP53):c.206C>G (p.Ala69Gly);GRCh38,NC_000017.11:g.7676163G>C GRCh37,NC_000017.10:g.7579481G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;3
230006;NM_000546.6(TP53):c.558T>A (p.Asp186Glu);GRCh37,NC_000017.10:g.7578372A>T GRCh38,NC_000017.11:g.7675054A>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
229693;NM_000546.6(TP53):c.188C>G (p.Ala63Gly);GRCh37,NC_000017.10:g.7579499G>C GRCh38,NC_000017.11:g.7676181G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
219969;NM_000546.6(TP53):c.932A>C (p.Asn311Thr);GRCh37,NC_000017.10:g.7576914T>G GRCh38,NC_000017.11:g.7673596T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
219759;NM_000546.6(TP53):c.700T>G (p.Tyr234Asp);GRCh37,NC_000017.10:g.7577581A>C GRCh38,NC_000017.11:g.7674263A>C;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
219532;NM_000546.6(TP53):c.380C>G (p.Ser127Cys);GRCh37,NC_000017.10:g.7578550G>C GRCh38,NC_000017.11:g.7675232G>C;TP53;Pathogenic;Li-Fraumeni syndrome;1
219487;NM_000546.6(TP53):c.520A>G (p.Arg174Gly);GRCh37,NC_000017.10:g.7578410T>C GRCh38,NC_000017.11:g.7675092T>C;TP53;Uncertain significance;Li-Fraumeni syndrome;1
216475;NM_000546.6(TP53):c.964C>T (p.Pro322Ser);GRCh37,NC_000017.10:g.7576882G>A GRCh38,NC_000017.11:g.7673564G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
216473;NM_000546.6(TP53):c.904G>C (p.Gly302Arg);GRCh37,NC_000017.10:g.7577034C>G GRCh38,NC_000017.11:g.7673716C>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
216472;NM_000546.6(TP53):c.868C>T (p.Arg290Cys);GRCh37,NC_000017.10:g.7577070G>A GRCh38,NC_000017.11:g.7673752G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
216471;NM_000546.6(TP53):c.851C>T (p.Thr284Ile);GRCh37,NC_000017.10:g.7577087G>A GRCh38,NC_000017.11:g.7673769G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
216469;NM_000546.6(TP53):c.706T>C (p.Tyr236His);GRCh37,NC_000017.10:g.7577575A>G GRCh38,NC_000017.11:g.7674257A>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
216468;NM_000546.6(TP53):c.589G>T (p.Val197Leu);GRCh37,NC_000017.10:g.7578260C>A GRCh38,NC_000017.11:g.7674942C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
216467;NM_000546.6(TP53):c.587G>A (p.Arg196Gln);GRCh37,NC_000017.10:g.7578262C>T GRCh38,NC_000017.11:g.7674944C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;2
216466;NM_000546.6(TP53):c.388C>T (p.Leu130Phe);GRCh37,NC_000017.10:g.7578542G>A GRCh38,NC_000017.11:g.7675224G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;1
216465;NM_000546.6(TP53):c.374C>A (p.Thr125Lys);GRCh37,NC_000017.10:g.7579313G>T GRCh38,NC_000017.11:g.7675995G>T;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
216464;NM_000546.6(TP53):c.149T>C (p.Ile50Thr);GRCh37,NC_000017.10:g.7579538A>G GRCh38,NC_000017.11:g.7676220A>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
216463;NM_000546.6(TP53):c.1136G>T (p.Arg379Leu);GRCh37,NC_000017.10:g.7572973C>A GRCh38,NC_000017.11:g.7669655C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
216077;NM_000546.6(TP53):c.584T>C (p.Ile195Thr);GRCh37,NC_000017.10:g.7578265A>G GRCh38,NC_000017.11:g.7674947A>G;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
215997;NM_000546.6(TP53):c.824G>A (p.Cys275Tyr);GRCh37,NC_000017.10:g.7577114C>T GRCh38,NC_000017.11:g.7673796C>T;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Breast carcinoma,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,not provided;2
215996;NM_000546.6(TP53):c.1025G>C (p.Arg342Pro);GRCh37,NC_000017.10:g.7574002C>G GRCh38,NC_000017.11:g.7670684C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
188349;NM_000546.6(TP53):c.776A>G (p.Asp259Gly);GRCh37,NC_000017.10:g.7577505T>C GRCh38,NC_000017.11:g.7674187T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;2
188342;NM_000546.6(TP53):c.1102C>T (p.His368Tyr);GRCh37,NC_000017.10:g.7573007G>A GRCh38,NC_000017.11:g.7669689G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
188206;NM_000546.6(TP53):c.703A>T (p.Asn235Tyr);GRCh37,NC_000017.10:g.7577578T>A GRCh38,NC_000017.11:g.7674260T>A;TP53;Uncertain significance;Li-Fraumeni syndrome;1
188151;NM_000546.6(TP53):c.1087A>G (p.Arg363Gly);GRCh37,NC_000017.10:g.7573940T>C GRCh38,NC_000017.11:g.7670622T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
188060;NM_000546.6(TP53):c.589G>A (p.Val197Met);GRCh37,NC_000017.10:g.7578260C>T GRCh38,NC_000017.11:g.7674942C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
187706;NM_000546.6(TP53):c.8A>G (p.Glu3Gly);GRCh37,NC_000017.10:g.7579905T>C GRCh38,NC_000017.11:g.7676587T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
187302;NM_000546.6(TP53):c.149T>A (p.Ile50Asn);GRCh37,NC_000017.10:g.7579538A>T GRCh38,NC_000017.11:g.7676220A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
187052;NM_000546.6(TP53):c.487T>G (p.Tyr163Asp);GRCh37,NC_000017.10:g.7578443A>C GRCh38,NC_000017.11:g.7675125A>C;TP53;Conflicting classifications of pathogenicity;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma;1
187005;NM_000546.6(TP53):c.782G>C (p.Ser261Thr);GRCh37,NC_000017.10:g.7577499C>G GRCh38,NC_000017.11:g.7674181C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,not provided;1
186887;NM_000546.6(TP53):c.1078G>A (p.Gly360Arg);GRCh37,NC_000017.10:g.7573949C>T GRCh38,NC_000017.11:g.7670631C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,TP53-related disorder,not provided,not specified;1
186762;NM_000546.6(TP53):c.1135C>A (p.Arg379Ser);GRCh37,NC_000017.10:g.7572974G>T GRCh38,NC_000017.11:g.7669656G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
186737;NM_000546.6(TP53):c.736A>C (p.Met246Leu);GRCh37,NC_000017.10:g.7577545T>G GRCh38,NC_000017.11:g.7674227T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
186653;NM_000546.6(TP53):c.727A>C (p.Met243Leu);GRCh37,NC_000017.10:g.7577554T>G GRCh38,NC_000017.11:g.7674236T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
186611;NM_000546.6(TP53):c.1135C>T (p.Arg379Cys);GRCh37,NC_000017.10:g.7572974G>A GRCh38,NC_000017.11:g.7669656G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
186594;NM_000546.6(TP53):c.431A>C (p.Gln144Pro);GRCh37,NC_000017.10:g.7578499T>G GRCh38,NC_000017.11:g.7675181T>G;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder;1
186587;NM_000546.6(TP53):c.436T>G (p.Trp146Gly);GRCh38,NC_000017.11:g.7675176A>C GRCh37,NC_000017.10:g.7578494A>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;3
186451;NM_000546.6(TP53):c.527G>A (p.Cys176Tyr);GRCh37,NC_000017.10:g.7578403C>T GRCh38,NC_000017.11:g.7675085C>T;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Familial ovarian cancer,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,TP53-related disorder,Transitional cell carcinoma of the bladder,not provided;2
186363;NM_000546.6(TP53):c.145G>A (p.Asp49Asn);GRCh37,NC_000017.10:g.7579542C>T GRCh38,NC_000017.11:g.7676224C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
186313;NM_000546.6(TP53):c.100C>G (p.Pro34Ala);GRCh37,NC_000017.10:g.7579587G>C GRCh38,NC_000017.11:g.7676269G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
186301;NM_000546.6(TP53):c.408A>C (p.Gln136His);GRCh37,NC_000017.10:g.7578522T>G GRCh38,NC_000017.11:g.7675204T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
186179;NM_000546.6(TP53):c.464C>G (p.Thr155Ser);GRCh37,NC_000017.10:g.7578466G>C GRCh38,NC_000017.11:g.7675148G>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;1
186132;NM_000546.6(TP53):c.305C>T (p.Thr102Ile);GRCh37,NC_000017.10:g.7579382G>A GRCh38,NC_000017.11:g.7676064G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
186086;NM_000546.6(TP53):c.1000G>A (p.Gly334Arg);GRCh37,NC_000017.10:g.7574027C>T GRCh38,NC_000017.11:g.7670709C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
185918;NM_000546.6(TP53):c.419C>A (p.Thr140Asn);GRCh37,NC_000017.10:g.7578511G>T GRCh38,NC_000017.11:g.7675193G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;2
185822;NM_000546.6(TP53):c.578A>T (p.His193Leu);GRCh37,NC_000017.10:g.7578271T>A GRCh38,NC_000017.11:g.7674953T>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
185814;NM_000546.6(TP53):c.814G>A (p.Val272Met);GRCh37,NC_000017.10:g.7577124C>T GRCh38,NC_000017.11:g.7673806C>T;TP53;Pathogenic;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,not provided;3
185729;NM_000546.6(TP53):c.427G>T (p.Val143Leu);GRCh37,NC_000017.10:g.7578503C>A GRCh38,NC_000017.11:g.7675185C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
185722;NM_000546.6(TP53):c.830G>A (p.Cys277Tyr);GRCh37,NC_000017.10:g.7577108C>T GRCh38,NC_000017.11:g.7673790C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of breast,not provided;1
185581;NM_000546.6(TP53):c.83A>T (p.Glu28Val);GRCh37,NC_000017.10:g.7579713T>A GRCh38,NC_000017.11:g.7676395T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
185404;NM_000546.6(TP53):c.469G>A (p.Val157Ile);GRCh37,NC_000017.10:g.7578461C>T GRCh38,NC_000017.11:g.7675143C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
185319;NM_000546.6(TP53):c.827C>G (p.Ala276Gly);GRCh37,NC_000017.10:g.7577111G>C GRCh38,NC_000017.11:g.7673793G>C;TP53;Pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
185212;NM_000546.6(TP53):c.943T>A (p.Ser315Thr);GRCh37,NC_000017.10:g.7576903A>T GRCh38,NC_000017.11:g.7673585A>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,TP53-related disorder,not specified;3
185157;NM_000546.6(TP53):c.100C>A (p.Pro34Thr);GRCh37,NC_000017.10:g.7579587G>T GRCh38,NC_000017.11:g.7676269G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
185120;NM_000546.6(TP53):c.215C>A (p.Pro72His);GRCh37,NC_000017.10:g.7579472G>T GRCh38,NC_000017.11:g.7676154G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
184979;NM_000546.6(TP53):c.578A>G (p.His193Arg);GRCh37,NC_000017.10:g.7578271T>C GRCh38,NC_000017.11:g.7674953T>C;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
184882;NM_000546.6(TP53):c.740A>T (p.Asn247Ile);GRCh37,NC_000017.10:g.7577541T>A GRCh38,NC_000017.11:g.7674223T>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Neoplasm of ovary;1
184863;NM_000546.6(TP53):c.413C>T (p.Ala138Val);GRCh37,NC_000017.10:g.7578517G>A GRCh38,NC_000017.11:g.7675199G>A;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
184745;NM_000546.6(TP53):c.997C>T (p.Arg333Cys);GRCh37,NC_000017.10:g.7574030G>A GRCh38,NC_000017.11:g.7670712G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided,not specified;3
184647;NM_000546.6(TP53):c.661G>A (p.Glu221Lys);GRCh37,NC_000017.10:g.7578188C>T GRCh38,NC_000017.11:g.7674870C>T;TP53;Uncertain significance;Familial melanoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
184014;NM_000546.6(TP53):c.509C>T (p.Thr170Met);GRCh37,NC_000017.10:g.7578421G>A GRCh38,NC_000017.11:g.7675103G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
183752;NM_000546.6(TP53):c.856G>A (p.Glu286Lys);GRCh37,NC_000017.10:g.7577082C>T GRCh38,NC_000017.11:g.7673764C>T;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Vulvar adenocarcinoma of mammary gland type,not provided;2
183748;NM_000546.6(TP53):c.374C>T (p.Thr125Met);GRCh37,NC_000017.10:g.7579313G>A GRCh38,NC_000017.11:g.7675995G>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;1
183071;NM_000546.6(TP53):c.649G>A (p.Val217Met);GRCh37,NC_000017.10:g.7578200C>T GRCh38,NC_000017.11:g.7674882C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
182969;NM_000546.6(TP53):c.1000G>C (p.Gly334Arg);GRCh37,NC_000017.10:g.7574027C>G GRCh38,NC_000017.11:g.7670709C>G;TP53;Uncertain significance;Colorectal cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
182968;NM_000546.6(TP53):c.842A>T (p.Asp281Val);GRCh37,NC_000017.10:g.7577096T>A GRCh38,NC_000017.11:g.7673778T>A;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
182967;NM_000546.6(TP53):c.752T>G (p.Ile251Ser);GRCh37,NC_000017.10:g.7577529A>C GRCh38,NC_000017.11:g.7674211A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
182966;NM_000546.6(TP53):c.707A>C (p.Tyr236Ser);GRCh37,NC_000017.10:g.7577574T>G GRCh38,NC_000017.11:g.7674256T>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
182965;NM_000546.6(TP53):c.646G>A (p.Val216Met);GRCh37,NC_000017.10:g.7578203C>T GRCh38,NC_000017.11:g.7674885C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided,not specified;2
182963;NM_000546.6(TP53):c.524G>T (p.Arg175Leu);GRCh37,NC_000017.10:g.7578406C>A GRCh38,NC_000017.11:g.7675088C>A;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
182962;NM_000546.6(TP53):c.289G>C (p.Val97Leu);GRCh37,NC_000017.10:g.7579398C>G GRCh38,NC_000017.11:g.7676080C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
182946;NM_000546.6(TP53):c.245C>T (p.Pro82Leu);GRCh37,NC_000017.10:g.7579442G>A GRCh38,NC_000017.11:g.7676124G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided;3
182939;NM_000546.6(TP53):c.1150A>G (p.Met384Val);GRCh37,NC_000017.10:g.7572959T>C GRCh38,NC_000017.11:g.7669641T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
182938;NM_000546.6(TP53):c.845G>T (p.Arg282Leu);GRCh37,NC_000017.10:g.7577093C>A GRCh38,NC_000017.11:g.7673775C>A;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
182937;NM_000546.6(TP53):c.751A>C (p.Ile251Leu);GRCh37,NC_000017.10:g.7577530T>G GRCh38,NC_000017.11:g.7674212T>G;TP53;Pathogenic/Likely pathogenic;Gastric cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
182936;NM_000546.6(TP53):c.728T>C (p.Met243Thr);GRCh37,NC_000017.10:g.7577553A>G GRCh38,NC_000017.11:g.7674235A>G;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
182935;NM_000546.6(TP53):c.713G>A (p.Cys238Tyr);GRCh37,NC_000017.10:g.7577568C>T GRCh38,NC_000017.11:g.7674250C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Gallbladder cancer,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
182934;NM_000546.6(TP53):c.709A>G (p.Met237Val);GRCh37,NC_000017.10:g.7577572T>C GRCh38,NC_000017.11:g.7674254T>C;TP53;Conflicting classifications of pathogenicity;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,not specified;1
182933;NM_000546.6(TP53):c.607G>A (p.Val203Met);GRCh37,NC_000017.10:g.7578242C>T GRCh38,NC_000017.11:g.7674924C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
182932;NM_000546.6(TP53):c.605G>T (p.Arg202Leu);GRCh37,NC_000017.10:g.7578244C>A GRCh38,NC_000017.11:g.7674926C>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
182931;NM_000546.6(TP53):c.575A>G (p.Gln192Arg);GRCh37,NC_000017.10:g.7578274T>C GRCh38,NC_000017.11:g.7674956T>C;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
182929;NM_000546.6(TP53):c.475G>C (p.Ala159Pro);GRCh37,NC_000017.10:g.7578455C>G GRCh38,NC_000017.11:g.7675137C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not specified;2
182928;NM_000546.6(TP53):c.380C>T (p.Ser127Phe);GRCh37,NC_000017.10:g.7578550G>A GRCh38,NC_000017.11:g.7675232G>A;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided,not specified;1
182926;NM_000546.6(TP53):c.370T>A (p.Cys124Ser);GRCh37,NC_000017.10:g.7579317A>T GRCh38,NC_000017.11:g.7675999A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
182925;NM_000546.6(TP53):c.344A>G (p.His115Arg);GRCh37,NC_000017.10:g.7579343T>C GRCh38,NC_000017.11:g.7676025T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
182924;NM_000546.6(TP53):c.290T>A (p.Val97Asp);GRCh37,NC_000017.10:g.7579397A>T GRCh38,NC_000017.11:g.7676079A>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,not provided;2
182923;NM_000546.6(TP53):c.266C>T (p.Pro89Leu);GRCh37,NC_000017.10:g.7579421G>A GRCh38,NC_000017.11:g.7676103G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
182922;NM_000546.6(TP53):c.188C>T (p.Ala63Val);GRCh37,NC_000017.10:g.7579499G>A GRCh38,NC_000017.11:g.7676181G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
182921;NM_000546.6(TP53):c.106C>T (p.Pro36Ser);GRCh37,NC_000017.10:g.7579581G>A GRCh38,NC_000017.11:g.7676263G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
177879;NM_000546.6(TP53):c.1010G>C (p.Arg337Pro);GRCh37,NC_000017.10:g.7574017C>G GRCh38,NC_000017.11:g.7670699C>G;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
177791;NM_000546.6(TP53):c.722C>G (p.Ser241Cys);GRCh37,NC_000017.10:g.7577559G>C GRCh38,NC_000017.11:g.7674241G>C;TP53;Pathogenic/Likely pathogenic;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Glioblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
161518;NM_000546.6(TP53):c.481G>A (p.Ala161Thr);GRCh37,NC_000017.10:g.7578449C>T GRCh38,NC_000017.11:g.7675131C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of prostate,Neoplasm of ovary,not provided;2
161517;NM_000546.6(TP53):c.839G>T (p.Arg280Ile);GRCh37,NC_000017.10:g.7577099C>A GRCh38,NC_000017.11:g.7673781C>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant tumor of prostate,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;1
161516;NM_000546.6(TP53):c.797G>A (p.Gly266Glu);GRCh37,NC_000017.10:g.7577141C>T GRCh38,NC_000017.11:g.7673823C>T;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Malignant tumor of prostate,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
161515;NM_000546.6(TP53):c.714T>G (p.Cys238Trp);GRCh38,NC_000017.11:g.7674249A>C GRCh37,NC_000017.10:g.7577567A>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of prostate;2
161397;NM_000546.6(TP53):c.665C>T (p.Pro222Leu);GRCh37,NC_000017.10:g.7578184G>A GRCh38,NC_000017.11:g.7674866G>A;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided,not specified;1
156517;NM_000546.6(TP53):c.1165G>T (p.Gly389Trp);GRCh37,NC_000017.10:g.7572944C>A GRCh38,NC_000017.11:g.7669626C>A;TP53;Uncertain significance;Li-Fraumeni syndrome 1;0
142995;NM_000546.6(TP53):c.119T>C (p.Met40Thr);GRCh37,NC_000017.10:g.7579568A>G GRCh38,NC_000017.11:g.7676250A>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
142916;NM_000546.6(TP53):c.787A>G (p.Asn263Asp);GRCh37,NC_000017.10:g.7577151T>C GRCh38,NC_000017.11:g.7673833T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
142863;NM_000546.6(TP53):c.171C>A (p.Asp57Glu);GRCh37,NC_000017.10:g.7579516G>T GRCh38,NC_000017.11:g.7676198G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
142854;NM_000546.6(TP53):c.214C>G (p.Pro72Ala);GRCh38,NC_000017.11:g.7676155G>C GRCh37,NC_000017.10:g.7579473G>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
142846;NM_000546.6(TP53):c.1015G>A (p.Glu339Lys);GRCh37,NC_000017.10:g.7574012C>T GRCh38,NC_000017.11:g.7670694C>T;TP53;Conflicting classifications of pathogenicity;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not specified;1
142828;NM_000546.6(TP53):c.1010G>T (p.Arg337Leu);GRCh37,NC_000017.10:g.7574017C>A GRCh38,NC_000017.11:g.7670699C>A;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
142766;NM_000546.6(TP53):c.455C>T (p.Pro152Leu);GRCh38,NC_000017.11:g.7675157G>A GRCh37,NC_000017.10:g.7578475G>A;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Squamous cell carcinoma of the head and neck,not provided;3
142714;NM_000546.6(TP53):c.711G>A (p.Met237Ile);GRCh37,NC_000017.10:g.7577570C>T GRCh38,NC_000017.11:g.7674252C>T;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,not provided,not specified;3
142702;NM_000546.6(TP53):c.910A>G (p.Thr304Ala);GRCh37,NC_000017.10:g.7577028T>C GRCh38,NC_000017.11:g.7673710T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
142691;NM_000546.6(TP53):c.320A>G (p.Tyr107Cys);GRCh37,NC_000017.10:g.7579367T>C GRCh38,NC_000017.11:g.7676049T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
142689;NM_000546.6(TP53):c.19G>C (p.Asp7His);GRCh37,NC_000017.10:g.7579894C>G GRCh38,NC_000017.11:g.7676576C>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
142657;NM_000546.6(TP53):c.427G>A (p.Val143Met);GRCh37,NC_000017.10:g.7578503C>T GRCh38,NC_000017.11:g.7675185C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Breast neoplasm,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided;1
142624;NM_000546.6(TP53):c.541C>T (p.Arg181Cys);GRCh37,NC_000017.10:g.7578389G>A GRCh38,NC_000017.11:g.7675071G>A;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
142562;NM_000546.6(TP53):c.105G>C (p.Leu35Phe);GRCh37,NC_000017.10:g.7579582C>G GRCh38,NC_000017.11:g.7676264C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
142552;NM_000546.6(TP53):c.1079G>T (p.Gly360Val);GRCh37,NC_000017.10:g.7573948C>A GRCh38,NC_000017.11:g.7670630C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;1
142536;NM_000546.6(TP53):c.1009C>T (p.Arg337Cys);GRCh37,NC_000017.10:g.7574018G>A GRCh38,NC_000017.11:g.7670700G>A;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
142431;NM_000546.6(TP53):c.322G>A (p.Gly108Ser);GRCh37,NC_000017.10:g.7579365C>T GRCh38,NC_000017.11:g.7676047C>T;TP53;Likely benign;Adrenocortical carcinoma, hereditary,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
142414;NM_000546.6(TP53):c.320A>C (p.Tyr107Ser);GRCh37,NC_000017.10:g.7579367T>G GRCh38,NC_000017.11:g.7676049T>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome;1
142386;NM_000546.6(TP53):c.217G>A (p.Val73Met);GRCh37,NC_000017.10:g.7579470C>T GRCh38,NC_000017.11:g.7676152C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;3
142332;NM_000546.6(TP53):c.907A>G (p.Ser303Gly);GRCh37,NC_000017.10:g.7577031T>C GRCh38,NC_000017.11:g.7673713T>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
142324;NM_000546.6(TP53):c.848G>A (p.Arg283His);GRCh37,NC_000017.10:g.7577090C>T GRCh38,NC_000017.11:g.7673772C>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Astrocytoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;2
142320;NM_000546.6(TP53):c.542G>A (p.Arg181His);GRCh37,NC_000017.10:g.7578388C>T GRCh38,NC_000017.11:g.7675070C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Carcinoma of pancreas,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,not provided;1
142273;NM_000546.6(TP53):c.998G>A (p.Arg333His);GRCh37,NC_000017.10:g.7574029C>T GRCh38,NC_000017.11:g.7670711C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
142241;NM_000546.6(TP53):c.746G>A (p.Arg249Lys);GRCh37,NC_000017.10:g.7577535C>T GRCh38,NC_000017.11:g.7674217C>T;TP53;Conflicting classifications of pathogenicity;Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
142206;NM_000546.6(TP53):c.328C>T (p.Arg110Cys);GRCh37,NC_000017.10:g.7579359G>A GRCh38,NC_000017.11:g.7676041G>A;TP53;Uncertain significance;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided,not specified;2
142183;NM_000546.6(TP53):c.706T>G (p.Tyr236Asp);GRCh37,NC_000017.10:g.7577575A>C GRCh38,NC_000017.11:g.7674257A>C;TP53;Conflicting classifications of pathogenicity;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma;1
142134;NM_000546.6(TP53):c.770T>G (p.Leu257Arg);GRCh37,NC_000017.10:g.7577511A>C GRCh38,NC_000017.11:g.7674193A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
142105;NM_000546.6(TP53):c.1072G>A (p.Glu358Lys);GRCh37,NC_000017.10:g.7573955C>T GRCh38,NC_000017.11:g.7670637C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
142050;NM_000546.6(TP53):c.434T>C (p.Leu145Pro);GRCh37,NC_000017.10:g.7578496A>G GRCh38,NC_000017.11:g.7675178A>G;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary;1
142012;NM_000546.6(TP53):c.644G>C (p.Ser215Thr);GRCh37,NC_000017.10:g.7578205C>G GRCh38,NC_000017.11:g.7674887C>G;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
142003;NM_000546.6(TP53):c.1079G>C (p.Gly360Ala);GRCh37,NC_000017.10:g.7573948C>G GRCh38,NC_000017.11:g.7670630C>G;TP53;Likely benign;Breast and/or ovarian cancer,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
141988;NM_000546.6(TP53):c.391A>T (p.Asn131Tyr);GRCh37,NC_000017.10:g.7578539T>A GRCh38,NC_000017.11:g.7675221T>A;TP53;Pathogenic;Hereditary cancer-predisposing syndrome;1
141967;NM_000546.6(TP53):c.256G>A (p.Ala86Thr);GRCh37,NC_000017.10:g.7579431C>T GRCh38,NC_000017.11:g.7676113C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;1
141963;NM_000546.6(TP53):c.473G>A (p.Arg158His);GRCh37,NC_000017.10:g.7578457C>T GRCh38,NC_000017.11:g.7675139C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Rhabdomyosarcoma,not provided;2
141956;NM_000546.6(TP53):c.248C>A (p.Ala83Glu);GRCh37,NC_000017.10:g.7579439G>T GRCh38,NC_000017.11:g.7676121G>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
141893;NM_000546.6(TP53):c.1015G>C (p.Glu339Gln);GRCh37,NC_000017.10:g.7574012C>G GRCh38,NC_000017.11:g.7670694C>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;3
141881;NM_000546.6(TP53):c.745A>T (p.Arg249Trp);GRCh37,NC_000017.10:g.7577536T>A GRCh38,NC_000017.11:g.7674218T>A;TP53;Conflicting classifications of pathogenicity;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;1
141781;NM_000546.6(TP53):c.859G>A (p.Glu287Lys);GRCh37,NC_000017.10:g.7577079C>T GRCh38,NC_000017.11:g.7673761C>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
141764;NM_000546.6(TP53):c.799C>T (p.Arg267Trp);GRCh37,NC_000017.10:g.7577139G>A GRCh38,NC_000017.11:g.7673821G>A;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Breast and/or ovarian cancer,Carcinoma of pancreas,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,not provided;2
141762;NM_000546.6(TP53):c.404G>A (p.Cys135Tyr);GRCh37,NC_000017.10:g.7578526C>T GRCh38,NC_000017.11:g.7675208C>T;TP53;Conflicting classifications of pathogenicity;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;1
141597;NM_000546.6(TP53):c.107C>A (p.Pro36Gln);GRCh37,NC_000017.10:g.7579580G>T GRCh38,NC_000017.11:g.7676262G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
141583;NM_000546.6(TP53):c.1120G>A (p.Gly374Ser);GRCh37,NC_000017.10:g.7572989C>T GRCh38,NC_000017.11:g.7669671C>T;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;1
141566;NM_000546.6(TP53):c.511G>A (p.Glu171Lys);GRCh38,NC_000017.11:g.7675101C>T GRCh37,NC_000017.10:g.7578419C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
141547;NM_000546.6(TP53):c.221C>T (p.Ala74Val);GRCh38,NC_000017.11:g.7676148G>A GRCh37,NC_000017.10:g.7579466G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;3
141483;NM_000546.6(TP53):c.892G>A (p.Glu298Lys);GRCh37,NC_000017.10:g.7577046C>T GRCh38,NC_000017.11:g.7673728C>T;TP53;Likely benign;Carcinoma of colon,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided,not specified;3
141464;NM_000546.6(TP53):c.125A>G (p.Asp42Gly);GRCh37,NC_000017.10:g.7579562T>C GRCh38,NC_000017.11:g.7676244T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;1
141425;NM_000546.6(TP53):c.1163A>C (p.Glu388Ala);GRCh38,NC_000017.11:g.7669628T>G GRCh37,NC_000017.10:g.7572946T>G;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;3
141359;NM_000546.6(TP53):c.554G>A (p.Ser185Asn);GRCh37,NC_000017.10:g.7578376C>T GRCh38,NC_000017.11:g.7675058C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
141331;NM_000546.6(TP53):c.1082G>A (p.Gly361Glu);GRCh37,NC_000017.10:g.7573945C>T GRCh38,NC_000017.11:g.7670627C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;2
141302;NM_000546.6(TP53):c.337T>G (p.Phe113Val);GRCh37,NC_000017.10:g.7579350A>C GRCh38,NC_000017.11:g.7676032A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;1
141228;NM_000546.6(TP53):c.784G>A (p.Gly262Ser);GRCh37,NC_000017.10:g.7577154C>T GRCh38,NC_000017.11:g.7673836C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided;3
141224;NM_000546.6(TP53):c.695T>C (p.Ile232Thr);GRCh37,NC_000017.10:g.7577586A>G GRCh38,NC_000017.11:g.7674268A>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,not provided,not specified;2
141159;NM_000546.6(TP53):c.1003C>T (p.Arg335Cys);GRCh37,NC_000017.10:g.7574024G>A GRCh38,NC_000017.11:g.7670706G>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;3
141141;NM_000546.6(TP53):c.842A>G (p.Asp281Gly);GRCh37,NC_000017.10:g.7577096T>C GRCh38,NC_000017.11:g.7673778T>C;TP53;Pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neuroblastoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
141114;NM_000546.6(TP53):c.314G>A (p.Gly105Asp);GRCh37,NC_000017.10:g.7579373C>T GRCh38,NC_000017.11:g.7676055C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
141102;NM_000546.6(TP53):c.935C>G (p.Thr312Ser);GRCh38,NC_000017.11:g.7673593G>C GRCh37,NC_000017.10:g.7576911G>C;TP53;Benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
141101;NM_000546.6(TP53):c.364G>A (p.Val122Met);GRCh37,NC_000017.10:g.7579323C>T GRCh38,NC_000017.11:g.7676005C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;3
141098;NM_000546.6(TP53):c.358A>G (p.Lys120Glu);GRCh37,NC_000017.10:g.7579329T>C GRCh38,NC_000017.11:g.7676011T>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;1
141056;NM_000546.6(TP53):c.144C>A (p.Asp48Glu);GRCh37,NC_000017.10:g.7579543G>T GRCh38,NC_000017.11:g.7676225G>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;3
141011;NM_000546.6(TP53):c.766A>G (p.Thr256Ala);GRCh37,NC_000017.10:g.7577515T>C GRCh38,NC_000017.11:g.7674197T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
140943;NM_000546.6(TP53):c.642T>G (p.His214Gln);GRCh37,NC_000017.10:g.7578207A>C GRCh38,NC_000017.11:g.7674889A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;1
140921;NM_000546.6(TP53):c.328C>A (p.Arg110Ser);GRCh37,NC_000017.10:g.7579359G>T GRCh38,NC_000017.11:g.7676041G>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;2
140833;NM_000546.6(TP53):c.250G>A (p.Ala84Thr);GRCh37,NC_000017.10:g.7579437C>T GRCh38,NC_000017.11:g.7676119C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
140821;NM_000546.6(TP53):c.844C>G (p.Arg282Gly);GRCh37,NC_000017.10:g.7577094G>C GRCh38,NC_000017.11:g.7673776G>C;TP53;Pathogenic;Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder;2
140801;NM_000546.6(TP53):c.422G>A (p.Cys141Tyr);GRCh37,NC_000017.10:g.7578508C>T GRCh38,NC_000017.11:g.7675190C>T;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,not provided;2
140786;NM_000546.6(TP53):c.319T>C (p.Tyr107His);GRCh37,NC_000017.10:g.7579368A>G GRCh38,NC_000017.11:g.7676050A>G;TP53;Benign;Adrenocortical carcinoma, hereditary,Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
140782;NM_000546.6(TP53):c.21T>A (p.Asp7Glu);GRCh38,NC_000017.11:g.7676574A>T GRCh37,NC_000017.10:g.7579892A>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided,not specified;3
135949;NM_000546.6(TP53):c.508A>G (p.Thr170Ala);GRCh37,NC_000017.10:g.7578422T>C GRCh38,NC_000017.11:g.7675104T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome;2
135948;NM_000546.6(TP53):c.145G>C (p.Asp49His);GRCh37,NC_000017.10:g.7579542C>G GRCh38,NC_000017.11:g.7676224C>G;TP53;Likely benign;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not specified;3
135360;NM_000546.6(TP53):c.1096T>G (p.Ser366Ala);GRCh37,NC_000017.10:g.7573931A>C GRCh38,NC_000017.11:g.7670613A>C;TP53;Likely benign;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of breast,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided,not specified;3
135359;NM_000546.6(TP53):c.638G>A (p.Arg213Gln);GRCh37,NC_000017.10:g.7578211C>T GRCh38,NC_000017.11:g.7674893C>T;TP53;Pathogenic;Adenoid cystic carcinoma,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Poly (ADP-Ribose) polymerase inhibitor response,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided,not specified;2
135358;NM_000546.6(TP53):c.605G>A (p.Arg202His);GRCh37,NC_000017.10:g.7578244C>T GRCh38,NC_000017.11:g.7674926C>T;TP53;Conflicting classifications of pathogenicity;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Malignant tumor of breast,not specified;1
133284;NM_000546.6(TP53):c.460G>A (p.Gly154Ser);GRCh37,NC_000017.10:g.7578470C>T GRCh38,NC_000017.11:g.7675152C>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of urinary bladder,Sarcoma,TP53-related disorder,not provided,not specified;2
133280;NM_000546.6(TP53):c.386C>T (p.Ala129Val);GRCh37,NC_000017.10:g.7578544G>A GRCh38,NC_000017.11:g.7675226G>A;TP53;not provided;Familial cancer of breast;0
132973;NM_000546.6(TP53):c.886C>T (p.His296Tyr);GRCh38,NC_000017.11:g.7673734G>A GRCh37,NC_000017.10:g.7577052G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Sarcoma,not provided,not specified;3
127827;NM_000546.6(TP53):c.91G>A (p.Val31Ile);GRCh37,NC_000017.10:g.7579705C>T GRCh38,NC_000017.11:g.7676387C>T;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;1
127826;NM_000546.6(TP53):c.877G>T (p.Gly293Trp);GRCh38,NC_000017.11:g.7673743C>A GRCh37,NC_000017.10:g.7577061C>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;3
127825;NM_000546.6(TP53):c.869G>A (p.Arg290His);GRCh38,NC_000017.11:g.7673751C>T GRCh37,NC_000017.10:g.7577069C>T;TP53;Benign;Breast and/or ovarian cancer,Familial ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;3
127824;NM_000546.6(TP53):c.847C>T (p.Arg283Cys);GRCh38,NC_000017.11:g.7673773G>A GRCh37,NC_000017.10:g.7577091G>A;TP53;Likely benign;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,Neoplasm of stomach,not provided,not specified;3
127823;NM_000546.6(TP53):c.800G>A (p.Arg267Gln);GRCh38,NC_000017.11:g.7673820C>T GRCh37,NC_000017.10:g.7577138C>T;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided,not specified;3
127822;NM_000546.6(TP53):c.737T>G (p.Met246Arg);GRCh37,NC_000017.10:g.7577544A>C GRCh38,NC_000017.11:g.7674226A>C;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,not provided;1
127821;NM_000546.6(TP53):c.704A>G (p.Asn235Ser);GRCh37,NC_000017.10:g.7577577T>C GRCh38,NC_000017.11:g.7674259T>C;TP53;Benign;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Rhabdomyosarcoma,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided,not specified;3
127820;NM_000546.6(TP53):c.701A>G (p.Tyr234Cys);GRCh37,NC_000017.10:g.7577580T>C GRCh38,NC_000017.11:g.7674262T>C;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;2
127819;NM_000546.6(TP53):c.659A>G (p.Tyr220Cys);GRCh38,NC_000017.11:g.7674872T>C GRCh37,NC_000017.10:g.7578190T>C;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Breast carcinoma,Breast neoplasm,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,TP53-related disorder,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;3
127818;NM_000546.6(TP53):c.604C>T (p.Arg202Cys);GRCh37,NC_000017.10:g.7578245G>A GRCh38,NC_000017.11:g.7674927G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
127817;NM_000546.6(TP53):c.580C>T (p.Leu194Phe);GRCh37,NC_000017.10:g.7578269G>A GRCh38,NC_000017.11:g.7674951G>A;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Breast neoplasm,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Squamous cell carcinoma of the head and neck,Transitional cell carcinoma of the bladder,not provided;2
127816;NM_000546.6(TP53):c.572C>G (p.Pro191Arg);GRCh38,NC_000017.11:g.7674959G>C GRCh37,NC_000017.10:g.7578277G>C;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
127815;NM_000546.6(TP53):c.535C>T (p.His179Tyr);GRCh37,NC_000017.10:g.7578395G>A GRCh38,NC_000017.11:g.7675077G>A;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;2
127814;NM_000546.6(TP53):c.488A>G (p.Tyr163Cys);GRCh37,NC_000017.10:g.7578442T>C GRCh38,NC_000017.11:g.7675124T>C;TP53;Pathogenic;Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Uterine carcinosarcoma,not provided;3
127813;NM_000546.6(TP53):c.485T>G (p.Ile162Ser);GRCh37,NC_000017.10:g.7578445A>C GRCh38,NC_000017.11:g.7675127A>C;TP53;Uncertain significance;Li-Fraumeni syndrome,not provided;2
127812;NM_000546.6(TP53):c.472C>T (p.Arg158Cys);GRCh37,NC_000017.10:g.7578458G>A GRCh38,NC_000017.11:g.7675140G>A;TP53;Conflicting classifications of pathogenicity;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,not provided;1
127811;NM_000546.6(TP53):c.467G>A (p.Arg156His);GRCh37,NC_000017.10:g.7578463C>T GRCh38,NC_000017.11:g.7675145C>T;TP53;Uncertain significance;Adrenocortical carcinoma, hereditary,Familial cancer of breast,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,not provided,not specified;3
127810;NM_000546.6(TP53):c.466C>T (p.Arg156Cys);GRCh37,NC_000017.10:g.7578464G>A GRCh38,NC_000017.11:g.7675146G>A;TP53;Conflicting classifications of pathogenicity;Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Nasopharyngeal carcinoma,not provided,not specified;1
127808;NM_000546.6(TP53):c.329G>A (p.Arg110His);GRCh38,NC_000017.11:g.7676040C>T GRCh37,NC_000017.10:g.7579358C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided,not specified;3
127806;NM_000546.6(TP53):c.28G>A (p.Val10Ile);GRCh38,NC_000017.11:g.7676567C>T GRCh37,NC_000017.10:g.7579885C>T;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,TP53-related disorder,not provided,not specified;3
127805;NM_000546.6(TP53):c.248C>T (p.Ala83Val);GRCh37,NC_000017.10:g.7579439G>A GRCh38,NC_000017.11:g.7676121G>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;1
127804;NM_000546.6(TP53):c.173C>G (p.Pro58Arg);GRCh37,NC_000017.10:g.7579514G>C GRCh38,NC_000017.11:g.7676196G>C;TP53;Conflicting classifications of pathogenicity;Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;1
100816;NM_000546.6(TP53):c.887A>G (p.His296Arg);GRCh37,NC_000017.10:g.7577051T>C GRCh38,NC_000017.11:g.7673733T>C;TP53;Likely pathogenic;not provided;0
100815;NM_000546.6(TP53):c.736A>G (p.Met246Val);GRCh37,NC_000017.10:g.7577545T>C GRCh38,NC_000017.11:g.7674227T>C;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided;2
100814;NM_000546.6(TP53):c.587G>T (p.Arg196Leu);GRCh37,NC_000017.10:g.7578262C>A GRCh38,NC_000017.11:g.7674944C>A;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
80710;NM_000546.6(TP53):c.400T>C (p.Phe134Leu);GRCh37,NC_000017.10:g.7578530A>G GRCh38,NC_000017.11:g.7675212A>G;TP53;Uncertain significance;Li-Fraumeni syndrome;1
80708;NM_000546.6(TP53):c.1093C>T (p.His365Tyr);GRCh38,NC_000017.11:g.7670616G>A GRCh37,NC_000017.10:g.7573934G>A;TP53;Likely benign;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,TP53-related disorder;3
72340;NM_000546.6(TP53):c.1051A>G (p.Lys351Glu);GRCh37,NC_000017.10:g.7573976T>C GRCh38,NC_000017.11:g.7670658T>C;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
43594;NM_000546.6(TP53):c.817C>T (p.Arg273Cys);GRCh37,NC_000017.10:g.7577121G>A GRCh38,NC_000017.11:g.7673803G>A;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,Breast neoplasm,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of prostate,Neoplasm,Neoplasm of ovary,not provided;2
43588;NM_000546.6(TP53):c.139C>T (p.Pro47Ser);GRCh38,NC_000017.11:g.7676230G>A GRCh37,NC_000017.10:g.7579548G>A;TP53;Benign;Adrenocortical carcinoma, hereditary,Breast and/or ovarian cancer,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Malignant tumor of breast,not provided,not specified;3
43587;NM_000546.6(TP53):c.1040C>A (p.Ala347Asp);GRCh38,NC_000017.11:g.7670669G>T GRCh37,NC_000017.10:g.7573987G>T;TP53;Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;3
41723;NM_000546.6(TP53):c.31G>C (p.Glu11Gln);GRCh37,NC_000017.10:g.7579882C>G GRCh38,NC_000017.11:g.7676564C>G;TP53;Conflicting classifications of pathogenicity;Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,TP53-related disorder,not provided,not specified;1
39420;NM_000546.6(TP53):c.542G>T (p.Arg181Leu);GRCh37,NC_000017.10:g.7578388C>A GRCh38,NC_000017.11:g.7675070C>A;TP53;Uncertain significance;Glioma susceptibility 1,Li-Fraumeni syndrome;2
12384;NM_000546.6(TP53):c.854A>T (p.Glu285Val);GRCh37,NC_000017.10:g.7577084T>A GRCh38,NC_000017.11:g.7673766T>A;TP53;Pathogenic;Adrenocortical carcinoma, pediatric,Choroid plexus carcinoma,Li-Fraumeni syndrome;1
12383;NM_000546.6(TP53):c.659A>C (p.Tyr220Ser);GRCh37,NC_000017.10:g.7578190T>G GRCh38,NC_000017.11:g.7674872T>G;TP53;Pathogenic;Breast neoplasm,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
12382;NM_000546.6(TP53):c.566C>T (p.Ala189Val);GRCh37,NC_000017.10:g.7578283G>A GRCh38,NC_000017.11:g.7674965G>A;TP53;Conflicting classifications of pathogenicity;Familial colorectal cancer,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided,not specified;1
12379;NM_000546.6(TP53):c.1010G>A (p.Arg337His);GRCh37,NC_000017.10:g.7574017C>T GRCh38,NC_000017.11:g.7670699C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Adrenocortical carcinoma, pediatric,Bone marrow failure syndrome 5,Breast neoplasm,Gastric cancer,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,not provided;2
12378;NM_000546.6(TP53):c.875A>T (p.Lys292Ile);GRCh37,NC_000017.10:g.7577063T>A GRCh38,NC_000017.11:g.7673745T>A;TP53;Uncertain significance;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome 1;2
12376;NM_000546.6(TP53):c.412G>C (p.Ala138Pro);GRCh37,NC_000017.10:g.7578518C>G GRCh38,NC_000017.11:g.7675200C>G;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
12375;NM_000546.6(TP53):c.1031T>C (p.Leu344Pro);GRCh38,NC_000017.11:g.7670678A>G GRCh37,NC_000017.10:g.7573996A>G;TP53;Likely pathogenic;Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;3
12374;NM_000546.6(TP53):c.524G>A (p.Arg175His);GRCh37,NC_000017.10:g.7578406C>T GRCh38,NC_000017.11:g.7675088C>T;TP53;Pathogenic;Adrenocortical carcinoma, hereditary,Bone marrow failure syndrome 5,Breast neoplasm,Colorectal cancer,Familial cancer of breast,Gastric cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Malignant tumor of esophagus,Neoplasm,Neoplasm of ovary,Squamous cell carcinoma of the head and neck,not provided;2
12372;NM_000546.6(TP53):c.770T>A (p.Leu257Gln);GRCh37,NC_000017.10:g.7577511A>T GRCh38,NC_000017.11:g.7674193A>T;TP53;Conflicting classifications of pathogenicity;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-fraumeni-like syndrome,Neoplasm of ovary;1
12371;NM_000546.6(TP53):c.105G>T (p.Leu35Phe);GRCh37,NC_000017.10:g.7579582C>A GRCh38,NC_000017.11:g.7676264C>A;TP53;Pathogenic;Carcinoma of pancreas;0
12370;NM_000546.6(TP53):c.451C>T (p.Pro151Ser);GRCh37,NC_000017.10:g.7578479G>A GRCh38,NC_000017.11:g.7675161G>A;TP53;Pathogenic/Likely pathogenic;Adenoid cystic carcinoma,Breast adenocarcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Rhabdomyosarcoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12369;NM_000546.6(TP53):c.451C>A (p.Pro151Thr);GRCh37,NC_000017.10:g.7578479G>T GRCh38,NC_000017.11:g.7675161G>T;TP53;Pathogenic/Likely pathogenic;Adenoid cystic carcinoma,Breast adenocarcinoma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Multiple myeloma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Rhabdomyosarcoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12368;NM_000546.6(TP53):c.839G>C (p.Arg280Thr);GRCh37,NC_000017.10:g.7577099C>G GRCh38,NC_000017.11:g.7673781C>G;TP53;Pathogenic/Likely pathogenic;Acute myeloid leukemia,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant tumor of urinary bladder,Nasopharyngeal carcinoma,Nasopharyngeal neoplasm,Neoplasm of brain,Neoplasm of uterine cervix,Ovarian serous cystadenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma;2
12367;NM_000546.6(TP53):c.974G>T (p.Gly325Val);GRCh37,NC_000017.10:g.7576872C>A GRCh38,NC_000017.11:g.7673554C>A;TP53;Conflicting classifications of pathogenicity;Familial colorectal cancer,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Non-Hodgkin lymphoma,not provided;1
12366;NM_000546.6(TP53):c.818G>A (p.Arg273His);GRCh38,NC_000017.11:g.7673802C>T GRCh37,NC_000017.10:g.7577120C>T;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Bone marrow failure syndrome 5,Brainstem glioma,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Familial cancer of breast,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Malignant tumor of breast,Medulloblastoma,Multiple myeloma,Multiple myeloma,Neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Rhabdomyosarcoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Thyroid gland undifferentiated (anaplastic) carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;3
12365;NM_000546.6(TP53):c.733G>A (p.Gly245Ser);GRCh37,NC_000017.10:g.7577548C>T GRCh38,NC_000017.11:g.7674230C>T;TP53;Pathogenic;Adenocarcinoma,Adrenocortical carcinoma, hereditary,Astrocytoma, anaplastic,Atypical teratoid rhabdoid tumor,Bone marrow failure syndrome 5,Brainstem glioma,Breast carcinoma,Breast neoplasm,Carcinoma of esophagus,Colorectal cancer,Familial ovarian cancer,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Li-fraumeni-like syndrome,Lung adenocarcinoma,Malignant tumor of urinary bladder,Multiple acyl-CoA dehydrogenase deficiency,Neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,TP53-related disorder,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,Xeroderma pigmentosum,not provided;3
12364;NM_000546.6(TP53):c.844C>T (p.Arg282Trp);GRCh37,NC_000017.10:g.7577094G>A GRCh38,NC_000017.11:g.7673776G>A;TP53;Pathogenic/Likely pathogenic;Breast neoplasm,Carcinoma of esophagus,Colorectal cancer,Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Li-fraumeni-like syndrome,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Pleomorphic xanthoastrocytoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,not provided;2
12359;NM_000546.6(TP53):c.722C>T (p.Ser241Phe);GRCh37,NC_000017.10:g.7577559G>A GRCh38,NC_000017.11:g.7674241G>A;TP53;Pathogenic/Likely pathogenic;Basal cell carcinoma, susceptibility to, 7,Bone osteosarcoma,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gallbladder carcinoma,Glioblastoma,Hepatoblastoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Non-Hodgkin lymphoma,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Papillary renal cell carcinoma, sporadic,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12358;NM_000546.6(TP53):c.814G>T (p.Val272Leu);GRCh37,NC_000017.10:g.7577124C>A GRCh38,NC_000017.11:g.7673806C>A;TP53;Likely pathogenic;Breast neoplasm,Gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Papillary renal cell carcinoma type 1,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Transitional cell carcinoma of the bladder;2
12357;NM_000546.6(TP53):c.398T>C (p.Met133Thr);GRCh37,NC_000017.10:g.7578532A>G GRCh38,NC_000017.11:g.7675214A>G;TP53;Pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1;2
12356;NM_000546.6(TP53):c.743G>A (p.Arg248Gln);GRCh38,NC_000017.11:g.7674220C>T GRCh37,NC_000017.10:g.7577538C>T;TP53;Pathogenic;Acute myeloid leukemia,Adrenal cortex carcinoma,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast carcinoma,Breast neoplasm,Carcinoma of esophagus,Colorectal cancer,Ductal carcinoma in situ,Familial cancer of breast,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Lymphoma,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Malignant tumor of urinary bladder,Medulloblastoma,Multiple myeloma,Myelodysplastic syndrome,Neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Rhabdomyosarcoma,Sarcoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;3
12355;NM_000546.6(TP53):c.734G>A (p.Gly245Asp);GRCh37,NC_000017.10:g.7577547C>T GRCh38,NC_000017.11:g.7674229C>T;TP53;Pathogenic/Likely pathogenic;Adrenocortical carcinoma, hereditary,Brainstem glioma,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12354;NM_000546.6(TP53):c.725G>A (p.Cys242Tyr);GRCh37,NC_000017.10:g.7577556C>T GRCh38,NC_000017.11:g.7674238C>T;TP53;Pathogenic/Likely pathogenic;B-cell chronic lymphocytic leukemia,Breast neoplasm,Carcinoma of esophagus,Familial cancer of breast,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Li-fraumeni-like syndrome,Lung adenocarcinoma,Neoplasm of ovary,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12353;NM_000546.6(TP53):c.469G>T (p.Val157Phe);GRCh37,NC_000017.10:g.7578461C>A GRCh38,NC_000017.11:g.7675143C>A;TP53;Conflicting classifications of pathogenicity;Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,Squamous cell carcinoma;1
12352;NM_000546.6(TP53):c.747G>T (p.Arg249Ser);GRCh37,NC_000017.10:g.7577534C>A GRCh38,NC_000017.11:g.7674216C>A;TP53;Pathogenic/Likely pathogenic;Adrenal cortex carcinoma,Cervical cancer,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,Squamous cell carcinoma of the head and neck,not provided;2
12351;NM_000546.6(TP53):c.215C>G (p.Pro72Arg);GRCh37,NC_000017.10:g.7579472G>C GRCh38,NC_000017.11:g.7676154G>C;TP53;Benign;Acute myeloid leukemia,Bone marrow failure syndrome 5,CODON 72 POLYMORPHISM,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,not provided,not specified;2
12350;NM_000546.6(TP53):c.755T>C (p.Leu252Pro);GRCh37,NC_000017.10:g.7577526A>G GRCh38,NC_000017.11:g.7674208A>G;TP53;Conflicting classifications of pathogenicity;Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,not provided;1
12349;NM_000546.6(TP53):c.733G>T (p.Gly245Cys);GRCh37,NC_000017.10:g.7577548C>A GRCh38,NC_000017.11:g.7674230C>A;TP53;Pathogenic;Brainstem glioma,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Gastric adenocarcinoma,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lung adenocarcinoma,Neoplasm of brain,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Squamous cell carcinoma of the head and neck,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;2
12348;NM_000546.6(TP53):c.772G>A (p.Glu258Lys);GRCh38,NC_000017.11:g.7674191C>T GRCh37,NC_000017.10:g.7577509C>T;TP53;Pathogenic/Likely pathogenic;Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Neoplasm of ovary,not provided,not specified;2
12347;NM_000546.6(TP53):c.742C>T (p.Arg248Trp);GRCh38,NC_000017.11:g.7674221G>A GRCh37,NC_000017.10:g.7577539G>A;TP53;Pathogenic;Acute myeloid leukemia,Adrenocortical carcinoma, hereditary,B-cell chronic lymphocytic leukemia,Brainstem glioma,Breast and/or ovarian cancer,Breast neoplasm,Carcinoma of esophagus,Choroid plexus carcinoma,Cognitive impairment,Congenital fibrosarcoma,Gallbladder cancer,Gastric adenocarcinoma,Gastric cancer,Glioblastoma,Hepatocellular carcinoma,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Li-Fraumeni syndrome 1,Lip and oral cavity carcinoma,Lung adenocarcinoma,Malignant lymphoma, large B-cell, diffuse,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Medulloblastoma,Multiple myeloma,Myelodysplastic syndrome,Neoplasm,Neoplasm of brain,Neoplasm of ovary,Neoplasm of the large intestine,Ovarian serous cystadenocarcinoma,Pancreatic adenocarcinoma,Prostate adenocarcinoma,Small cell lung carcinoma,Squamous cell carcinoma of the head and neck,Squamous cell carcinoma of the skin,Squamous cell lung carcinoma,Transitional cell carcinoma of the bladder,Uterine carcinosarcoma,not provided;3
